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Abstract
Chirality, the phenomenon of optical activity, is extremely important in natural, living 
systems and therefore interactions with such systems are of interest. A large number 
of pharmaceuticals are chiral and since biological activity is often stereospecific it is 
important that the properties and toxicity of the individual enantiomers are properly 
evaluated. In order to study enantiomers, analytical methods are required that are 
capable of distinguishing between them.
Resolution of enantiomers by chromatography can be achieved by reaction of the 
enantiomers with an optically pure single enantiomer of another compound to yield 
diastereoisomers. Alternatively a chiral environment can be created within the 
chromatographic system, by making one of the chromatographic phases chiral. Under 
such conditions the enantiomers can be separated via the formation of transient 
diastereoisomers as they pass through the system.
The evaluation of some commercially available liquid cyclodextrin chiral stationary 
phases for capillary gas chromatography was performed with the separation of some 
chiral epoxide pharmaceutical intermediates. The mechanism responsible for the 
resolution of the enantiomers was investigated by determination of the thermodynamic 
parameters involved in the separation. The use of the columns for chiral separations of 
larger, more polar compounds was then considered.
The use of chiral stationary phases for the bioanalysis of chiral compounds was also 
investigated. The analysis of p-trifluoromethylmandelic acid and a-methoxy-a- 
I (trifluoromethyl)phenylacetic acid in urine was achieved using the cyclodextrin GC 
phases following derivatisation of the compounds (formation of methyl esters). A
HPLC method for | a-methoxy-a-(trifluoromethyl)phenylacetic acid was also 
developed. Determination of enantiomer levels in the urine of rats dosed with the 
compounds revealed that a-methoxy-a-(trifluoromethyl)phenylacetic acid
enantiomers were excreted unchanged, while racemic p-trifluoromethylmandelic 
acid underwent a unidirectional enantiomeric interconversion.
Acknowledgement
I am extremely grateful to my supervisor, Dr. D. Stevenson, for his valuable advice 
and support throughout. I would also like to express my thanks to Dr. R. Briggs and 
Mr. V. Zettel for their advice and technical assistance. Thanks are due to M.Bekele, 
J.Shahterheri, B.Rashid and A.Savage for their help and humour.
I would also like to acknowledge the support of my parents and would like to thank 
my cousins, John and Alan for the use of their PC and printer during the writing of 
this thesis.
Contents
1.0 Chirality 1
1.1 Introduction to Chirality 1
1.2 Nomenclature-Specification of absolute configuration 6
1.3 Biological Importance of Chirality 8
1.3.1 Chiral Xenobiotics 9
1.3.2 Pharmacology 11
1.3.3 Stereospecific Pharmacology of Chiral Drugs 14
1.3.3.1 Stereoselective Drug Action 15
1.3.3.2 Metabolism of Chiral Drugs 16
1.3.3.3 Stereochemical Influence on Distribution,
Bioavailability and Storage 18
1.3.3.4 Overall Implications of the Stereoselective
Metabolism of Chiral Drugs 19
2.0 Analytical Methodology 23
2.1 Chromatography 23
2.1.1 Chromatographic Theory 24
2.1.2 Bioanalysis using Chromatography 29
2.2 Immunoassay 31
2.3 Electromigration techniques 32
2.4 Nuclear Magnetic Resonance (NMR) 34
2.5 Chiroptic techniques 35
2.6 Other techniques 36
2.7 Chiral Chromatographic Separations 37
2.7.1 Chiral Stationary Phases (CSP’s) for HPLC 37
2.7.1.1 The Pirkle Phases 3 8
2.7.1.2 Polymer CSP’s 41
2.7.1.3 Ligand exchange 42
2.7.1.4 Cyclodextrins 44
2.7.1.5 Protein CSP’s 47
2.7.2 Chiral Stationary Phases for GC 51
2.7.2.1 Amino-acid/Peptide CSP’s 51
2 .1.22 Complexation 53
2.7.2.3 Cyclodextrins 55
2.7.3 Chiral Stationary Phases for TLC 60
2.7.4 Chiral mobile phase additives (CMA’s) in HPLC 61
2.7.4.1 Chiral counter ions 61
2.7.4.2 Chiral metal complexes 62
2.7.4.3 Cyclodextrins 62
2.7.4.4 Proteins 63
2.7.5 Chiral mobile phase additives in TLC 63
2.7.6 Indirect chiral separation 64
2.8 Aim of Thesis 67
3.0 Materials and Methods 68
3.1 Reagents 68
3.1.1 Model Compounds 68
3.1.2 Solvents and other reagents 68
3.1.3 Gases 69
3.1.4 Solid Phase Extraction Cartridges 71
3.2 Chromatographic Equipment 71
3.2.1 Columns 71
3.2.1.1 GC 71
3.2.1.2 HPLC 71
3.2.2 Chromatographic Systems 71
3.3 Chromatographic measurements - Interpretation of Chromatograms 72
3.3.1 Peak measurement - Quantitation 73
3.4 GLC of some racemic epoxides 73
3.5 Determination of column polarity for Chiraldex columns 73
11
3.6 Derivatisation procedures for the GLC of some
P-blockers and benzodiazepines 74
3.7 Bioanalysis of a-Methoxy-a-(trifluoromethyl)phenylacetic
acid (Moshers acid) and p-trifluoromethylmandelic acid 75
3.7.1 HPLC of Moshers acid and p-trifluoromethylmandelic^ci^ 76
3.7.2 Sample preparation for the analysis of Moshers acid
in urine by HPLC 77
3.7.2.1 Liquid-liquid Extraction 77
3.7.2.2 Solid Phase Extraction 77
3.7.3 GLC of Moshers acid and p-TFM 78
3.7.3.1 Analysis of p-TFM and Moshers acid in urine 78
3 .8 Enantioselectivity of the Chiraldex GC columns and
regeneration of the G-TA column 79
3.9 Regeneration of the Cyclobond I HPLC column 80
3.10 Validation of final methods 80
4.0 Results and Discussion 83
4.1 GLC of some racemic epoxides with cyclodextrin capillary columns 83
Discussion 89
4.1.1 Investigation of thermodynamic parameters and chiral
recognition mechanism 89
Discussion 97
4.1.2 Modelling of the chiral epoxides 102
4.1.3 Experiments above Tiso 103
Discussion 106
4.2 GLC of some chiral drugs 107
Discussion 110
4.3 Evaluation of Chiraldex column polarity 112
Discussion 113
111
4.4 GLC of some chiral benzodiazepines
4.5 Loss of column enantioselectivity
4.6 Bioanalysis with Chiral Stationary Phases
4.6.1 HPLC separation of Moshers acid and p-TFM
4.6.1.1 Chiral-AGP column
4.6.1.2 Cyclodextrin columns
4.6.1.3 HPLC analysis of Moshers acid from urine
4.6.2 GLC of p-TFM and Moshers acid
4.7 General Discussion
114
Discussion 119
Discussion
Discussion
Discussion
Discussion
Discussion
120
123
124 
124 
126
129
130 
140 
143
167
168 
191 
194
5.0 References 200
IV
1.0 Chirality,
1.1 Introduction to Chirality
A molecule is said to be chiral (from the Greek word chiros - hand, referring to the 
handedness of the molecule) if it is not identical with its mirror image, i.e. its mirror 
images are non-superimposable. [lUPAC 1976]. Such structures can be created when 
atoms form non-planar structures by covalent bonding to other atoms. All chiral 
molecules are optically active and will rotate the plane of plane polarized light.
In 1844 Pasteur, working with sodium ammonium salts of active (+)-tartaric acid and 
inactive (racemic) tartaric acid, observed that the salts appeared isomorphous and 
identical except for their optical activity. Upon crystallization of the salts he obtained 
two sets of crystals related as non-superimposable mirror images, which he 
mechanically separated with tweezers. With solutions of these crystals he found that 
one set corresponded to (+)-tartrate with a positive specific optical rotation. The 
solution of the enantiomorphous crystals gave a specific optical rotation of the same 
magnitude, but in the opposite direction (i.e. negative). He therefore concluded that 
the molecules of (+) and (-) tartaric acid were stereochemically dissymmetric or chiral. 
[Mason 1988, Turner 1995]
In 1874 Le Bel and Van’t Hoff, working independently, proposed the tetrahedral 
carbon atom. Van’t Hoff in his publication ‘La chimie dans l’espace’ ( The 
arrangement of atoms in space) stated that differences between isomeric molecules of 
the same constitutional formula were due to the different arrangement of their atoms 
in space. He continued that compounds containing a carbon atom with four different 
groups attached exist as two different isomers and will be optically active. [Riddell 
1974]
An atom tetrahedrally bonded to four different atoms or groups is termed a chiral 
centre and the resulting molecule will be asymmetric, i.e. it will have no element of 
symmetry (Fig.l.). Atoms such as carbon, nitrogen, sulphur and phosphorous can
form such structures. However not all chiral molecules are asymmetric, some 
molecules with an axis of rotation (eg. C 2 axis) are also chiral.
A A
B
D
Mirror
Fig.l. Example of a chiral centre.
The two stereoisomers (mirror images) of a chiral molecule are called enantiomers. 
Enantiomers have identical chemical and physical properties, except in a chiral 
environment, and differ only in their direction of rotation of plane polarized light. If 
an enantiomer rotates the plane of light clockwise then it is said to be dextrorotatory, 
denoted by ‘d’, or *+’. If the rotation is anti-clockwise (negative) then the molecule is 
lev orotatory, ‘F, or There is no correlation between the sign or direction of 
rotation and the absolute configuration (arrangement of the atoms in space) of the 
molecule. Absolute configuration can be denoted in two ways and will be dealt with 
later. A mixture containing equal quantities of each enantiomer is termed ‘racemic’ 
and will be optically inactive, as the rotations of the individual enantiomers will 
cancel out.
The presence of a chiral centre is the most common cause chirality and as previousty mentitmed |
is a result of the tetrahedral, sp  ^hybridization of atomic orbitals. A special case arises 
vyith tetrahedral, trivalent nitrogen, such as amines, where a lone pair occupies one of 
the hybrid orbitals. A rapid interconversion via an sp  ^ transition state turns the
molecule ‘inside out’ making it identical to its mirror image, fig.2.. This self- 
racemization makes it impossible to distinguish between the enantiomers, except 
under special circumstances.
C H 0 C H 2 N" 
C H /
H
---H—  IN -^CH0CH2 
CH3
Fig. 2. Interconversion of nitrogen containing enantiomers.
There are two other causes of chirality, namely axial and planar. An example of axial 
chirality is demonstrated by some alkenes, fig.3.. The terminal CR2 groups exist in 
mutually perpendicular planes due to the rigidity and directional character of the 
double bonds. If Ri and R2 are different groups then two non-superimposable forms 
will result.
R- R.
R
R.
.C = C
R
Mirror
Fig.3. Substituted allene - an example of axial chirality.
A chiral plane is formed when suitably placed groups destroy a plane of symmetry, 
such as with some cycloalkenes. An example is trans-cyclooctene, fig.4., its chiral 
plane is the one containing the double bond. [lUPAC 1976, Mislow 1984].
Fig. 4. Trans-cyclooctene.
Molecules which assume helical or spiral arrangements for steric reasons can also be 
enantiomeric. An example of this is demonstrated by the helicenes, the simplest case 
being observed with six o-fused benzene rings (fig.5). The two enantiomeric forms 
have either a left or right handed spiral arrangement.
Fig.5. Hexahelicene.
A compound containing only one asymmetric atom can only exist as two different 
stereoisomers (enantiomers), however if more than one is present then the situation 
becomes more complex. A compound containing N chiral centres can exist as 2^ 
stereoisomers, i.e. a compound with two chiral centres will exist as four stereoisomers 
comprising two pairs of enantiomers. The relationship between an enantiomer from 
one pair with enantiomers of the other is termed diastereoisomerism, so stereoisomers 
that are not enantiomers are termed diastereoisomers. Diastereoisomers have different, 
though similar, chemical and physical properties and can therefore be distinguished 
from each other by standard procedures such as distillation.
It is possible for molecules to contain multiple chiral centres yet still be 
superimposable on their mirror images, a phenomenon known as ‘meso-isomerism’. 
Tartaric acid demonstrates this, it has two chiral centres so exists as four 
stereoisomers, fig.6..
COOH 
H - C - O H  
H O - C - H  
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H - C - O H  
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Fig.6. The stereoisomers of tartaric acid.
The 2R,3R and 2S,3S are a pair of enantiomers. The other pair, the 2R,3S and 2S,3R 
isomers are identical, as one is a 180° rotation of the other due to a plane of symmetry
through the C2-C3 bond making one half of the molecule the mirror image of the 
other. Therefore the 2R,3S and 2S,3R forms are achiral and are termed the meso-form.
1.2 Nomenclature - Specification of absolute configuration
In order for consistency when designating an enantiomer’s stereochemistry (absolute 
configuration) two systems of nomenclature have been developed. The D,L - system 
relates the configuration of a molecule to that of D or L - glyceraldehyde, fig.7., which 
were arbitrarily assigned by Fischer.
H
CHO
OH
CH2OH
D-(+)-gIyceraldehyde
HO
CHO
H
CH2OH
L-(-)-glyceraldehyde
Fig.7. D- and L- glyceraldehyde.
The system requires the structure to be drawn in Fischer projection, a convention 
where the longest carbon chain is drawn vertical, with the most oxidized end of the 
chain at the top. The horizontal bonds point towards the viewer and the vertical bonds 
point away. The configuration with the OH group to the right of the asymmetric 
carbon atom was assigned the D - configuration, OH on the left assigned L. With this 
system molecules chemically related to D - glyceraldehyde were assigned D-, and 
similarly with L. This method is of limited applicability, and can give conflicting 
results with some groups of compounds. [Rosanoff 1906] Also the Fischer system 
merely indicates the ‘relative configuration’, there is no correlation between the 
assigned D and L and the direction of rotation of plane polarized light, d or 1.
A more useful system was developed by Cahn, Ingold and Prelog, and is referred to as 
the RS system or sequence rule [Cahn and Ingold 1951, Cahn, Ingold and Prelog 
1966]. The four substituents (a,b,c, and d) bonded to the chiral centre are arranged in 
order of decreasing priority, the rules of which are as follows.
The substituents are assigned priority in order of decreasing atomic number of the 
atom directly bonded to the chiral centre. The highest number is first, a, the lowest d. 
If substituents are bonded by similar atoms then the next atom in the substituent group 
is compared, and so on until a difference is found. Lone pairs are considered as atomic 
number zero, multiple bonds are considered as an equivalent number of singularly 
bonded atoms. With the substituents ordered a to d, they are viewed such that d is 
pointing backwards away from the viewer, fig.8..
d  C '------------ >  VIEWER
Fig.8. Viewing of chiral molecule for assignment of configuration by Cahn, Ingold, 
Prelog system.
Finally the remaining substituents are followed from highest priority a to c. If this 
operation is in the clockwise direction then the chiral centre is assigned Rectus,’R’, 
configuration, fig.9. If the operation is anti-clockwise then the configuration is 
Sinister, ‘S’.
R -  Configuration
Fig.9. The Rectus, ‘R’, configuration.
1.3 Biological Importance of Chirality
Shortly after his separation of the enantiomers of tartaric acid, Pasteur observed that 
only one of the enantiomers was metabolized by mould. He concluded that the 
phenomenon must involve diastereomeric interactions between the enantiomers and a 
dissymmetric receptor site.[Ariens et al 1988, Lehman 1986]
Biological systems/environments are predominantly chiral as they are composed of 
chiral structures, such as the right-handed a-helices of DNA, proteins and 
polypeptides containing exclusively L-amino acids. In fact the helical configuration of 
such polypeptides would not be maintained if significant amounts of D-amino acids 
were present.[Blout, Doty and Young 1957, Mason 1988, Caldwell 1995]. In addition 
naturally occurring carbohydrates are all of the D-configuration.
Living systems are therefore asymmetric and so many of processes occurring within 
such systems will be stereospecific. Interactions which involve the chiral 
macromolecules o f the living system, such as drug/hormone enzyme and receptor 
interactions and transport processes may be stereospecific and so discriminate 
between enantiomers. However not all interactions are involved at the 
macromolecular level, passive processes such as diffusion across membranes will be 
little influenced by stereochemistry.[Ariens et al 1988, Caldwell 1995]
1.3.1 Chiral Xenobiotics
Probably the most famous (or infamous) chiral drug is thalidomide (fig. 10), used in 
the early 1960’s as a sedative and cure for morning sickness. It was responsible for the 
birth of seriously malformed children by women who had taken the drug early on in 
their pregnancy. Thalidomide was prescribed as a racemic mixture, the desired 
sedative properties resided in the R-form ( R-(+)-N-phthalylglutamic acid imide) 
while the S-form caused the teratogenic effects. [ Blaschke 1980, Knoche and 
Blaschke 1994]
O
S-(-)-N-phthalylglutamic acid imide R-(+)-N-phthalylglutamic acid imide
Fig. 10. The enantiomers of thalidomide.
There are many examples of chiral drugs, including p-blockers, benzodiazepines and 
non-steroidal anti-inflammatory drugs (NSAID’s) such as the profens, p-blockers are 
so named due to their action in blocking P-adrenergic receptors in blood vessels.
These receptors are responsible for the relaxation of muscle cells. In the heart the 
receptors cause excitation, and so their blockage prevents this and subsequently 
lowers the heart rate. They were originally developed for the treatment of angina and 
cardiac arrhythmias, but are also used to control blood pressure and hypertension.
Benzodiazepines are a group of structurally related drugs with anti-anxiety and 
sedative-hypnotic properties, although not all are chiral. The P-blockers all contain a 
common aryloxypropanolamine chain which contains a chiral centre. The profen 
NSAID’s, 2-arylpropionic acids are chiral due to their arylpropionic acid group, 
example structures of some chiral drugs are given in fig.l 1.
Ç H 3
H - C - C H p
I
CH3
Ibuprofen
CHq
I
C-COOH
I
H
OH
Warfarin
O
Fig.l 1. Structures of some chiral drugs.
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It is estimated that approximately 40% of the drugs currently marketed are chiral 
[Ariens 1993]. As demonstrated with thalidomide the enantiomers of such chiral drugs 
can have markedly different biological properties and may be discriminated against 
during the various processes involved in a living body.
The interaction of enzymes with substrates was considered by Fischer at the end of the 
last century as being analogous to that of a lock and key [Caldwell 1995]. This idea 
has since been expanded upon resulting in the three point fit model. This considers the 
receptor or enzyme as a surface with three dissymmetric and rigidly disposed points 
which interact with chiral compounds. So if an enantiomer ‘fits’ or interacts at all 
three points, then the other enantiomer of the pair could only interact at two of the 
points resulting in discrimination between the two enantiomers. [ Easson and Stedman 
1933, Ariens 1983]
In addition to chiral drugs, there are many other chiral compounds that are of 
biological importance, including endogenous compounds, dietary ingredients and 
pesticides. The use of chiral pesticides as racemic mixtures can also result in increased 
environmental pollution if only one enantiomer is the active ingredient [Ariens 1988, 
Ariens et al 1988].
1.3.2 Pharmacology
Pharmacology can be considered in two parts, pharmacodynamics and 
pharmacokinetics. Pharmacodynamics is concerned with the effect of a drug on a 
body, such as its therapeutic action or toxicity. Pharmacokinetics studies the fate of 
the drug within the body following administration and so covers the absorption, 
distribution, metabolism and excretion (ADME) of the drug, see fig. 12. This is not 
limited to drugs and applies to all xenobiotics.
Absorption of a drug can take place at sites such as the gastro-intestinal (G.I.) tract 
and buccal cavity. Following absorption the drug is distributed around the body via
11
the blood stream before being excreted from the body either unchanged or following 
metabolism.
ABSORPTION
Plasma
Bound
Unbound
EXCRETION METABOLISM
Tissues
Bound
EXCRETION
Unbound
Fig. 12. Diagrammatic representation of the time course of ADME.
The basic purpose of metabolism is to make a drug molecule, or foreign body, easier 
to remove from the body. This usually involves increasing the polarity of the 
molecule, thereby making it more water-soluble and therefore easier for the body to 
excrete. A living body contains numerous enzyme systems which are responsible for 
transforming the drug molecules via a variety of pathways. The majority of 
metabolism occurs in the liver, although organs such as the intestine, lung, blood, 
brain and kidney are also responsible for some metabolism [Gibson and Skett 1986].
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The effect of a drug, that is the intensity and duration of its action is proportional to 
the concentration of the drug at the site of action. Therefore if the drug concentration 
at the site is altered then so will the pharmacological response. The biotransformation 
of a drug to its metabolites will obviously affect the parent drug concentration and so 
affect response. As the metabolite of a drug, is chemically different it may not be 
recognized by the relevant drug receptor system and so the metabolite might elicit 
little or no response. This situation is termed pharmacological deactivation.
On the other hand the metabolite may be better recognized, i.e have a better 
interaction with the receptor, and thereby cause an increase in response - 
pharmacological activation. Alternatively the metabolites may interact with totally 
different receptors and so produce different pharmacological responses compared to 
the parent drug. This can result in toxicological activation if the metabolites produce 
toxic effects that were not produced by the parent.
In addition to changes in pharmacological response, the metabolism of a drug may 
affect other properties. It can affect drug uptake or absorption, which is important 
when considering the route of administration for the drug. For example if the drug is 
metabolized rapidly at/near the point of administration then little of the drug will 
reach the intended site, this is known as first pass metabolism, where a large 
proportion of the drug is excreted before reaching the site of action. Similarly the 
metabolism may affect the distribution of the drug. A highly lipophilic drug will be 
localized at higher concentration in fatty tissues (high lipid content), but the 
metabolites, being less lipid soluble will have a higher affinity for lower-fat tissues, 
eg. the high water tissues like blood.
Metabolism can be considered as occurring in two different independent phases, 
although they may be sequential. Phase 1 metabolism is responsible for 
functionalization of the drug so as to provide suitable groups in order to prepare the 
molecule for phase 2. The functionalization of the drug molecule can involve a variety 
of reactions, such as oxidation, reduction, hydrolysis and hydration (a form of 
hydrolysis).
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An example of oxidation is the introduction of a hydroxyl group onto an aliphatic 
chain or aromatic ring, epoxidation of aromatic rings, dealkylation and 
dehalogenation. Such reactions are performed by microsomal mixed-function oxidase 
systems, found in the endoplasmic reticulum (liver). Some oxidations are also 
performed by enzymes, non-mixed-function oxidase, although these systems require a 
co-factor (catalyst). The conversion of nitro groups to amines is an example of a 
reductive functionalization. Such reactions are catalysed by hepatic microsomes and 
also require a co-factor (e.g NADPH).
Phase 2 metabolism involves conjugation of the drug, (eg. glucoronidation or 
sulphation) in order to produce a more water-soluble, excretable product. These 
conjugation reactions involve a diverse group of enzymes. A general feature is the 
requirement of an ‘activated’ intermediate (i.e. energy rich and unstable) such as a co­
factor or activated drug.
The most important, quantitatively, of the phase 2 reactions is glucuronidation. The 
reaction is catalysed by the enzyme glucuronyltransferase with a co-factor, uridine 
diphosphate glucuronic acid (UDPGA). Another important conjugation is that with 
glutathione, common in the removal of electrophilic compounds and catalysed by the 
glutathione-S-transferase enzymes.
1.3.3 Stereospecific Pharmacology of Chiral Drugs
Stereoselectivity refers to the degree of discrimination by enzymes or receptors within 
living systems for one enantiomer compared to its antipode. If a receptor exhibits a 
response with one enantiomer but not with the other then it has behaved 
stereospecifically. These stereoselective or specific interactions can be considered in 
terms of the three point model.
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1.3.3.1 Stereoselective Drug Action
The active enantiomer of a chiral drug for a specified therapeutic response is termed 
the eutomer, with the inactive or less active enantiomer the distomer. If the 
enantiomers have totally opposite activities then the eutomer for one action may be 
the distomer when referring to the opposite action. The ratio of the two activities, a 
measure of the degree of stereoselectivity, is referred to as the eudismic ratio (eutomer 
over distomer).
If the eutomer is highly active, a result of a very good ‘fif of that enantiomer at the 
receptor site, then it is likely that the distomer will not ‘fif so well at the site. Such a 
situation may result in a large eudismic ratio. A large eudismic ratio which decreases 
with the activity of the eutomer arises when the chiral centre of the drug molecule is 
located in a part of the molecule which is directly involved in the interaction with the 
receptor.
The first report of stereoselective drug action was that of Cushny in 1903. He reported 
that the (-)-enantiomer of hyoscyamine had a greater effect on the iris and glands than 
the (+)-enantiomer. [Bridges et al 1987]. Since then many other examples have been 
reported, a few of these will be covered here to illustrate the importance of such 
stereoselective action.
As mentioned earlier, the desired activity of the drug thalidomide resides exclusively 
in the R-enantiomer. The psychotomimetic activity of amphetamine is exhibited by 
the R-enantiomer, and the cyclooxygenase inhibiting action of the NS AID ibuprofen 
resides exclusively in its S-enantiomer. [Gal 1977, Tracy and Hall 1992]. With the p- 
blocker propranolol, the l-(-)-enantiomer is 100 times more active than the d-(+)- 
enantiomer. Similarly, the 1-enantiomer of the calcium channel blocker verapamil is 8 
to 10 times more active than the d-enantiomer. [Silber and Riegelman 1980, 
Eichelbaum 1988].
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While the main therapeutic action may reside in only one of the enantiomers, it is 
possible that both enantiomers may also exhibit other different effects. For example, 
while (-)-propranolol is almost exclusively responsible for the drugs p-adrenergic 
blocking activity, both enantiomers exhibit a local anaesthetic and histamine releasing 
effect. (+)-propranolol also inhibits the conversion of thyroxine to triiodothyronine, 
whereas (-)-propranolol does not. [Stoschitzky et al 1994]
A more complex situation is found with labetalol, which has two chiral centres. The 
drug is prescribed as a mixture of all four stereoisomers and is considered as a single 
drug with both a- and p- adrenergic blocking action. The a-blocking action resides in 
one stereoisomer (S,R-configuration), the P-blocking action resides in another isomer 
(the R,R) and the other two stereoisomers (S,S and R,S) are inactive. [Ariens 1983, 
Ariens 1988, Ruffolo 1983].
1.3.3.2 Metabolism of chiral drugs
The metabolic reactions of the body can result in a number of products being formed. 
An achiral, or prochiral drug may give rise to chiral metabolites, a chiral drug may 
give rise to chiral or diastereoisomeric metabolites. The enzymes involved may 
stereoselectively metabolize the two enantiomers, the two enantiomers may even be 
metabolized by different enzymes and pathways. This can result in different 
metabolites for enantiomers of the same compound.
The enantioselectivity of enzymes is due to the chirality of its substrate binding site, a 
hydrophobic ‘pockef on the enzyme. This can be considered, in a similar way to the 
receptors, as analogous to a glove, with the two enantiomers being hands. Only one of 
the hands will fit ‘properly’ into the glove. The site may not necessarily be 
enantiospecific, in fact it is more often the case that such sites are selective, accepting 
both enantiomers, but with one being preferred. If both enantiomers do ‘fit’ the 
‘glove’ to similar extents, i.e both are substrates for the same site, then there is the 
potential for them to compete or inhibit each other.
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Although the functionalization reactions of phase 1 add achiral functional groups to 
the drug molecule, the positioning of the groups can create chiral metabolites from 
prochiral molecules. Due to the chirality of the enzymes involved there is also the 
possibility of different metabolizing reactions for the different enantiomers of a chiral 
entity. A few examples to illustrate this are given.
Mephenytoin undergoes stereoselective aromatic hydroxylation by a specific 
cytochrome P450. The (S)-mephenytoin is rapidly hydrolysed in the para-position, 
resulting in the major metabolite. The (R)-enantiomer however is slowly N- 
demethylated, resulting in an active metabolite which goes on to be further 
metabolized. [Kupfer et al 1980, Testa 1988].
Other stereoselective cytochrome P450’s are responsible for the stereoselective 
epoxidation of some polycyclic aromatic hydrocarbons. The resulting epoxide 
metabolites are then further enantioselectively hydrated by microsomal epoxide 
hydrolase to form chiral diol metabolites. [Yang 1988]. Stereoselective phase 1 
metabolism is not restricted to hydroxylation, amphetamine and warfarin for example 
are oxidized via enantioselective routes. [Kupfer et al 1981].
The conjugation of the drug molecules with sugars also has the potential to be 
enantioselective, and may produce chiral and diastereoisomeric metabolites as the 
conjugating sugars are themselves chiral (eg. P-D-glucuronic acid). The degree of 
enantioselectivity obviously depends on the species and the enzymes and inducing 
agents involved.
Propranolol undergoes stereoselective glucuronidation, which is species dependent. In 
humans the rate of glucuronidation of (-)-propranolol is 3.4 times that of the (+)- 
enantiomer.[Silber and Riegelman 1980]. A similar preferential conjugation ((-) 
preferred to (+)) is found in the dog. In the dog the (-)-propranolol behaves as a non­
competitive inhibitor of the (+). In the rat and rabbit the opposite is true, with the (+)- 
propranolol being preferred, also in the rabbit the (+)-enantiomer non-competitively 
inhibits the glucuronidation of the (-) [Testa 1986]. Stereoselective glucuronidation of
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the profens has also been reported. The resultant diastereoisomeric conjugates are 
preferentially excreted depending on the species. [Caldwell et al 1988].
1.3.3.3 Stereochemical Influence on Distribution, Bioavailabilitv and Storage
The transport of drugs from the site of administration to their desired destination/site 
of action is via the blood stream. In the blood the drug molecules may be free, or 
bound to serum proteins, although it is the free concentration that controls the rate at 
which they can pass through the capillary walls. The binding of drugs by proteins in 
the blood provides temporary protection from the effect of the drug as it is 
‘unavailable to proceed with its intended business’. While bound there is time for the 
metabolism and excretion of the drug before it can perform its pharmacological 
action. [Van Ginneken et a l l  983, Testa 1990]
There are two major proteins in human blood which are responsible for drug binding, 
human serum albumin (HSA), and acid glycoprotein (AGP). HSA is the most 
abundant of the two being approximately 30 times as concentrated as AGP in the 
blood. The chiral secondary structure of the proteins results in chiral sites or ‘pockets’, 
not dissimilar to the enzymes and receptors. The fitting or binding of enantiomers into 
such environments is therefore likely to be enantioselective, resulting in the 
enantiomers having different binding strengths and therefore different bioavailability.
The enantiomers of verapamil exhibit differences in their binding, with the 
bioavailability of the d-(+)-form (50%) being greater than that of the l-(-) (20%). 
Administered as the racemic mixture the overall bioavailability is between 20 to 30%. 
The clearance of the (-)-enantiomer is faster than that of the (+), with extensive 
hepatic presystemic elimination (first pass effect). This can have a dramatic effect on 
the therapeutic response depending on the route of administration. If the drug is 
administered orally then a far higher dose is required to elicit a response similar to a 
small i.v. dose.
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Propranolol also suffers from a stereoselective first pass effect. In humans the 
bioavailability of (-)-propranolol is 1.4 times that of the (+), whereas in dog the 
availability of the (-) is only 50% of that of the (+). Propranolol predominantly binds 
to AGP, with the (-)-enantiomer being bound more tightly than the (+). HSA exhibits 
opposite enantioselectivity for the propranolol enantiomers (the (+) is bound more 
tightly), but the HSA binding is not as significant. [Simonyi et al 1986]
Enantioselective accumulation in tissues is not necessarily related to the 
stereoselective transport of the enantiomers to the tissues. For example, with time D- 
aspartame accumulates in the brain. This is not because only the D- is transported 
there, but is due to the slow racémisation of the natural L-aspartame by the slow 
metabolizing tissues. [Simonyi et al 1986]
The enantioselective metabolism and subsequent different metabolites .of enantiomers 
can lead to differences in the clearance of such entities from the body. The 
enantiomers of mephenytoin as already mentioned undergo different metabolic routes, 
with the S-mephenytoin metabolized and excreted rapidly. The R-mephenytoin is 
metabolized more slowly and so is eliminated at a slower rate.
1.3.3.4 Overall Implications of the Biological Discrimination of Chiral Drugs
It is clear that stereoselectivity within a living body is the norm with optically active 
drugs. Stereochemically dependent interactions may be involved at numerous 
junctures following administration of a chiral drug, affecting the therapeutic action, 
metabolism, distribution and excretion. As a result it is not surprising that enantiomers 
can behave differently within a living system.
Unless a stereospecific, asymmetric reaction scheme is followed, standard organic 
synthesis of a chiral molecule will result in a racemic mixture. Many drugs produced 
in such a way have been evaluated, marketed and prescribed as the racemic mixture, 
the two enantiomers being considered as one drug. Due to the potential for dramatic
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differences between the enantiomers it would be more appropriate to consider the two 
enantiomers as two separate drugs. Since 1987, the regulatory authorities such as the 
FDA have recognized this and have taken an interest in chirality and its implications 
in pharmaceuticals.
The problem of racemic mixtures can be avoided with the development of single 
enantiomer drugs. In order to obtain single enantiomers asymmetric synthetic routes 
have been developed and it is now possible to prepare most chiral compounds as 
single enantiomers. Many highly functionalised single enantiomer synthons and 
intermediates are now commercially available from chirotechnology companies 
[Carey 1993, Fuji 1993].
The choice o f stereochemical form for a particular use, racemate or single enantiomer.
must be justified on chemical and clinical grounds. Until the mid 1980’s the majority 
of chiral drugs were marketed and to a large extent evaluated as their racemic 
mixtures. The examples used earlier to demonstrate the stereoselectivity of the body, 
propranolol, verapamil, ibuprofen andlabetalol were all marketed as ‘mixtures’.
If the racemate is chosen as the therapeutic formulation, which may be justified if 
there is little difference between the action of the two enantiomers, it is necessary to 
prove this by pharmacokinetic evaluation o f the individual enantiomers. If the single 
enantiomer is chosen then its enantiomeric purity and stability in the final formulation 
must be evaluated, along with its stability in vivo.
If only one enantiomer is active, with its antipode being totally inactive (the simplest 
case), then it is still advantageous to remove the inactive form. By doing so the 
amount of foreign material introduced to the body, the dose of the drug, can be 
reduced. The argument for using the single active enantiomer is ftirther strengthened if 
the other enantiomer is responsible for unwanted effects (eg. side-effects, toxicity).
With the ‘old’ racemate chiral drugs such as those described it may still be 
advantageous to switch from using the racemate to the active single enantiomer.
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labetalol for example could benefit from the removal of the two inactive stereoisomers, 
the isomeric ballast. With thalidomide it would appear that removal of the teratogenic 
S-(“)-enantiomer would be advantageous. However thalidomide racemizes in vivo via 
opening of the phthalimide ring (fig. 13) with a half-life of less than 10 minutes in 
blood [Knoche and Blaschke 1994, Caldwell 1995].
O
Fig. 13. Racemization of thalidomide.
Therefore administration of the single R-(+)-enantiomer would still result in the 
patient being exposed to both forms. This racémisation also casts doubt on the validity 
of previous toxicology studies.
The situation with the profens is slightly different. Interconversion of the inactive R- 
profen to the active S-profen appears to be an advantage, however it is only a partial 
conversion and the rate depends on the patient [Carey 1993, Caldwell 1995]. This 
makes it difficult to control a patients exposure to the active enantiomer. Therefore the 
use of the single enantiomer would make determination of dose easier.
The mechanism responsible for the interconversion is controlled by an enzyme, 
acylcoenzyme A synthetase (CoA), and is shown in fig. 14. The R-profen forms a 
thioester with the CoA which subsequently undergoes racémisation to give the S-
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profen-CoA thioester, which is hydrolysed to give the S-profen. The inversion is 
unidirectional as the S-profen does not form the CoA-thioester.
At COOH
R-profen
Acyl-CoA synthetase
SCoAAt
O
R-profen-CoA
Profen-CoA racemase
C H .
Ar COOH
S-profen
Hydrolase 
"4--------
.C H 3
SCoA
O
S-profen-CoA
Fig. 14. Profen interconversion pathway.
22
2.0 Analytical Methodology
In order to monitor the therapeutic activity of a chiral drug and its ADME in 
pharmacodynamic and pharmacokinetic studies it is necessary to have analytical 
methodology capable of discriminating between enantiomers. This methodology is not 
limited to use in metabolism studies, and can be used for other applications such as 
monitoring the progress of organic reaction schemes. For example if asymmetric 
synthesis has been used to prepare a single enantiomer drug then it would be 
advantageous to monitor the reaction by determination of the enantiomeric purity of 
starting materials and intermediates in addition to the final product.
2.1 Chromatography
Chromatography is a group of widely used and important separation techniques 
whereby components of a sample are distributed between two phases. One of the 
phases is stationary, whilst the other is mobile. The stationary phase may be a solid, 
liquid, or gel, whereas the mobile phase may be liquid, giving rise to liquid 
chromatography (LG), or it may be gaseous - gas chromatography (GC) or a 
supercritical fluid (SFC). The stationary phase may be packed in a column (LC or 
GC), coated on the wall of a column (GC), or coated/layered onto an inert support 
(TLC - Thin layer chromatography) [lUPAC 1973].
The separation of enantiomers by chromatography can be achieved either directly or 
indirectly. The indirect approach involves the formation of diastereoisomers by 
reaction/derivatisation of the chiral analyte with a pure enantiomer of another chiral 
reagent, followed by chromatography using standard non-chiral phases. Alternatively 
one can create a chiral environment by making one of the chromatographic phases 
chiral, this is known as the direct approach.
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2.1.1 Chromatographic Theory
Martin and Synge were responsible for laying the foundations of chromatographic 
theory [Martin and Synge 1941]. They applied concepts used in distillation to describe 
the efficiency of chromatographic separations, the height equivalent to a theoretical 
plate being proportional to the flow of the mobile phase and the square of the particle 
diameter. A theoretical plate is a hypothetical place/step where a partition of the solute 
between the two phases occurs, i.e. at each plate there is an equilibrium between the 
two phases. Therefore the smaller the height of a theoretical plate the more of them 
can be fitted into a column. The greater the number of plates or partitions then the 
better the separation.
The basic concepts and theories of chromatography are the same regardless of the 
mode, whether the mobile phase is gas or liquid, or stationary phase is liquid or solid. 
The following equations and concepts can therefore be used to describe separations 
obtained in a chromatographic run. Fig. 15. shows the various measurements that can 
be taken from a chromatogram for use in the equations.
R2
Injection
w,
Fig. 15. Chromatographic measurements.
24
The retention time (tR) of a solute is the time from injection of the sample into the 
system to the peak maximum of the eluted peak. The time taken for an unretained 
sample to travel through the system is termed the column dead time (to). The retention 
time of a solute can therefore be related to the column dead time to give an adjusted 
retention time (tR’).
 ^R ~  ~  0^
Efficiency is a measure of the broadening of a chromatographic peak, broadening 
being undesirable as it may cause peak overlap and hence reduce resolution. Thus 
efficiency is the square of the ratio of retention time of an analyte divided by the peak 
broadening and is expressed as the number of theoretical plates (N). Peak broadening 
is defined as the standard deviation of the retention times of the individual molecules 
(ct) which is related to the peak width. Therefore:
2
N = = 16
In order to make measurement easier, the width of a peak at half height (wi/2) may be 
used as this can be easier to measure than the width at the baseline, particularly if the 
peak tails.
N  = 5.54
Alternatively efficiency can be expressed as the number of effective plates (N eff):
K ff  =
Efficiency is dimensionless (has no units) and in theory should be the same for all the 
peaks in the same chromatographic run. However this is not usually the case in 
practice. All peaks will be affected by a degree of extra-column band broadening, that
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is broadening due to the system (eg. dead-volumes at various points/connections) 
rather than the separation process. This extra-column broadening is constant for all of 
the peaks, and so will be more significant for the earlier eluting peaks, causing them to 
have lower efficiencies.
The ratio of time a solute spends in the two chromatographic phases is called the 
capacity factor (k^), or the mass distribution ratio. The capacity factor should be 
independent of flow rate and column dimensions.
Where Vs and Vm are the volumes of the stationary and mobile phases in the column, 
i.e. the phase ratio (P).
The resolution (Rs) of two peaks, the degree of separation, is usually described in 
terms of the difference between the peak maxima and their average peak width.
=
R^2 R^\
'A (w, + w j j  (w, + Wj)
Resolution is dependent on the separation factor (a) and efficiency, such that:
a  -  I
4v a ■Jn
Baseline resolution would give an Rs of 1.5.
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The separation factor is the ratio of the distribution coefficients of the two 
components under identical conditions and is thus a measure of the net retention 
volumes of the two compounds. The separation of enantiomers is commonly referred 
to using the separation factor of the two enantiomers.
a  =
Ideally a solute should travel through the chromatographic system as a sharp band. In 
practice however the band v^ll broaden as it passes through the system. This 
spreading of the chromatographic bands can be considered as having two causes, 
spreading occurring in the column, and spreading due to extra column effects, as 
mentioned earlier.
The extra column effects are generally caused by the geometry and fittings of the 
chromatographic system, such as dead volumes in the injector, detector, connections 
and fittings. (A dead volume being a stagnant area, an area not swept by the mobile 
phase flow). In such areas the sample will be caught up in eddy currents and will be 
dispersed (mixed) into a greater volume of mobile phase. In GC there is an inherent 
broadening due to the gas pressure drop across the column. As mentioned before these 
extra column effects will be the same for all the samples in a run.
The majority of the band spreading occurs in the column and can be considered as 
caused by three factors; molecular diffusion, eddy diffusion, and mass transfer effects. 
A rate theory for the combined processes related to the HETP was proposed by Van 
Deemter.[ Van Deemter et al 1956, Knox and Scott 1983].
HETP = A  + — -V Cu 
u
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The A term represents diffusion due to the non-uniform flow of the mobile phase 
through/around the mobile phase packing, sometimes termed eddy diffusion. As the 
mobile phase passes through the column the routes of the individual mobile phase 
molecules around the particles of stationary phase are different. This multi-path 
process resulting in band broadening is proportional to the packing particle diameter 
and the uniformity of packing.
The B term represents the contribution of the diffusivity of the solute in the mobile 
phase. The solute molecules diffuse in all directions within the mobile phase, however 
due to the flow of the mobile phase complete, uniform distribution cannot occur. The 
diffusivity of the solute in the mobile phase is therefore inversely proportional to the 
linear velocity of the mobile phase.
The C term represents the resistance to mass transfer, that is the tendency of the solute 
to stay in a particular phase. Transfer of the solute from one phase to the other 
requires it to overcome an energy barrier. The solute has to travel from the bulk of one 
phase, to the interface of the two phases, and then into the other phase, which takes a 
finite amount of time. The resistance to this transfer of mass is controlled by the 
solvation energy, fugacity, and the diffusivity of the solute in the two phases.
The three terms and their individual and combined effect on efficiency are graphically 
demonstrated in fig. 16. as a Van Deemter plot.
o>
C u
Average Linear Velocity, u
Fig. 16 Van Deemter plot.
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With GC there are two types of column, packed and open-tubular or capillary 
columns. Capillary columns tend to have much higher numbers of theoretical plates 
(ie. higher efficiency) than packed columns, as they are much longer. In capillary 
columns the stationary phase is coated onto the wall of the capillary, as a result the 
Van Deemter equation can be modified to take account of the lack of eddy diffusion, 
as the carrier gas flows through the centre of the column [Jennings 1980]. So with 
capillary columns:
lE T P  = —  + (Cm + C s)u
u
Sample introduction is also different for the two column types, with packed column 
GC the sample is usually injected directly onto the top of the column. For capillary 
columns there are two main injection techniques, split and splitless [Jennings 1985]. 
In split injection only a pre-determined amount of the sample reaches the column, the 
rest being blown (split) to waste by a split vent gas flow. Splitting allows the use of 
high flow rates through the injection chamber, the sample once split to the column is 
followed by carrier gas and thus broadening of the sample band is prevented.
Splitless injection concentrates the sample at the column inlet, making it useful for 
dilute samples. A further technique for the concentration of a dilute sample at the 
injection point is the ‘on-column’ retention gap technique. Basically a short pre­
column is used to concentrate the sample and remove it from the majority of the 
solvent, before the sample band passes into the analytical column.
2.1.2 Bioanalvsis using Chromatography
Sample preparation or ‘clean-up’ is an important consideration when dealing with 
‘dirty’ samples, such as those of biological origin and is commonly the most time 
consuming step in an analytical method. In addition to the removal of unwanted
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interferences contained in the sample matrix to obtain clean, uncluttered 
chromatograms, it can also help prolong the useful lifetime of the chromatographic 
column and prevent fouling of the system.
If biological fluids are injected into a chromatographic system without prior treatment 
then large molecules such as proteins contained in the sample can block column frits 
and tubing, contaminate detectors and even cause reduction in column efficiency due 
to irreversible binding to the stationary phase. There are many ways in which analytes 
can be separated from bulk interferences, such as filtration, dialysis, chemical 
extraction and chromatography.
The use of chromatography as an extraction technique has proved popular. TLC can 
be a useful extraction technique as once compounds have been separated on a TLC 
plate they can be removed, by ‘scraping off the particular sample spot and extracting 
the sample from the stationary phase with an appropriate solvent.
The use of HPLC to separate compounds from background interferences has also been 
reported. The technique of ‘column switching’ involves the use of a pre-column 
before the main analytical column for the separation/removal of interfering entities. 
The separated analytes are then passed or ‘switched’ onto an analytical column for 
determination. For chiral separations from complex matrices, an achiral column can 
be used to remove interferences, followed by switching to a chiral column for 
separation and determination of the enantiomers.
Liquid-liquid extraction is at present the most frequently used sample clean-up 
technique. The technique requires selection of a suitable extraction solvent, that is one 
in which the compound to be extracted is more soluble, whereas the bulk impurities 
are not. The extraction solvent must also be immiscible with the original sample 
solvent.
The use of solid phase extraction cartridges is an extremely useful clean-up technique, 
which is gaining in popularity [Berrueta et al 1995]. It has the advantage over liquid-
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liquid extraction in that it generally requires less solvent. The ease of automation of 
the technique also makes it an attractive technique for the analysis of large numbers of 
samples. A large number of different phases are commercially available, with various 
modes of action.
The different phases available can be grouped in terms of their primary method of 
interaction with an analyte. Non-polar phases, analogous to reversed phase 
chromatographic phases, include octadecyl (C l8), octyl (C8), ethyl (C2), phenyl, 
cyclohexyl and cyanopropyl - bonded silica. Polar phases (normal phase) include 
silica gel, diol, aminopropyl and cyanopropyl. There are also ion-exchange phases, 
such as the cation exchangers, benzenesulphonic acid, propylsulphonic acid and 
carboxylic acid, and anion exchangers such as quaternary amine and aminopropyl. 
[Martin, Leadbetter and Wilson 1993, Varian 1987].
2.2 Immunoassay
Immunoassay is a highly selective analytical method using antibodies or antibody- 
related reagents for the determination of sample components. The technique is 
governed by the reaction between antigen and antibody and it is the specificity of this 
reaction which is mostly responsible for the high selectivity of the technique. [Findlay 
1987] However other interactions such as those between the antibody or label and the 
support can also play a part.
An immunoassay combines the immune reaction, as mentioned, with a suitable 
measurement technique such as radioisotope methods, spectrophotometric enzyme 
assays, light-scattering, particle counting and chemiluminescence. The two most 
common techniques are the enzyme linked immunosorbent assay (ELISA) and 
radioimmunoassay (RIA). [Hage 1993]
In the ELISA method the antibody/antigen is coupled to an easily assayed enzyme. In 
RIA the competition between unlabelled antigen and a finite amount of radiolabelled
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antigen for a limited amount of antibody (in a fixed quantity of serum) is measured by 
a suitable radioactivity counter. For RIA it is therefore necessary to produce 
radiolabelled antigen making the method costly and hazardous. The ELISA method is 
relatively cheap and also lacks the radiological hazard. [Wilson and Walker 1994]
Due to their relatively small size drug molecules are not normally immunogenic and 
so in order to produce antibodies to a particular drug it is necessary to form a more 
immunogenic carrier, a drug-protein conjugate. This conjugate is then injected into a 
living system (e.g. a sheep), which will in time produce antibodies against it. 
Antibody production may be increased, or boosted, by re-injecting the conjugate at 
various intervals. If an enantiomer of a chiral drug is used then an antibody may be 
produced that can distinguish between the two enantiomers. This was demonstrated by 
Landsteiner who raised antibodies capable of distinguishing between the enantiomers 
of N-(p-aminobenzoyl)phenylglycine and the enantiomeric and meso-forms of tartaric 
acid [Hutt 1990].
2.3 Electromigration techniques
The electromigration techniques exploit differences in electrophoretic or 
electroosmotic flow in order to achieve separations. Electrophoresis refers to the 
migration of charged solutes to the relative electrodes under an applied potential, ie. 
positive solute migrates to negative electrode. High field strengths are required for 
efficient separations and the subsequent Joule heating due to the buffers resistance to 
current flow results in large amounts of heat being produced. Small capillaries allow 
this heat to be dissipated, allowing the use of high voltages, giving rapid and efficient 
separations.
Electroosmosis produces flow due to the surface charge on the capillary wall. If the 
surface charge, or zeta potential, of the capillary is negative then there will be an 
electoosmotic flow towards the negative electrode. The velocity of the electroosmotic 
flow is uniform along the entire length of the capillary, and results in a cross-sectional
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flow profile. The lack of a flow velocity gradient results in very little band 
broadening. [Terabe et al 1994, Novotny, Soini and Stefansson 1994, Ward 1994]
Capillary Zone Electrophoresis (CZE). Separations are produced due to differences in 
the electrophoretic mobility, charge to mass ratios, (migration to the relative 
electrode) of solutes. The electroosmotic flow is not involved in the selectivity of the 
separation as it carries all of the solutes at the same velocity. Enantiomer separation by 
CZE tends to be via the direct method as opposed to diastereomer formation as the 
charge differences of diastereomers tend to be too small for CZE separation. The 
direct approach involves the use of chiral selectors/additives in the buffer. Ligand 
exchange, using metal ions in the buffer to create chiral chelate complexes, and host- 
guest inclusion complex formation with cyclodextrins and crown ethers, and proteins 
have been successfully employed for chiral CZE separations [Valko et al 1993, Terabe 
et al 1994. Ward 1994, Wistuba et al 1995].
Electrokinetic Chromatography (EKC). In electrokinetic separations it is the 
electroosmotic flow which is responsible for separation along with interaction with 
another entity, a pseudo-stationary phase. Electrically neutral solutes migrate with the 
electroosmotic flow while free, but on interaction/incorporation with the pseudo- 
stationary phase it travels with the pseudo-stationary phase velocity. Therefore the 
distribution of the solute between the pseudo-stationary phase and the aqueous buffer 
phase controls its relative migration.
The pseudo-stationary phase may take the form of an immobilized film on the 
capillary wall, or more commonly micelle forming additives (surfactant). Chiral 
separations can be achieved using a chiral stationary phase, chiral surfactants, or chiral 
additives in conjunction with a non-chiral surfactant [Bereuter 1994, Terabe et al 
1994, Novotny, Soini, Stefansson 1994].
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2.4 Nuclear Magnetic Resonance (NMRI
Some atoms possess nuclear spin (I), which means they behave in a similar way to bar 
magnets. In the presence of a magnetic field such atoms can orientate in a number of 
ways (21+1 ways). Nuclei containing an odd number of nucleons (^H, ^^Si,
^*P), have a spin of a 1/2 (1= ±1/2) and therefore have only two possible orientations. 
The nuclei are distributed between the two orientations, aligned with the applied field 
the nuclei are in the low energy orientation, alignment opposed to the applied field 
being the high energy orientation.
If a radio signal (rf) of the correct frequency is applied to the system then the relative 
distribution of the nuclei will be disturbed, ie. nuclei in the low energy orientation 
absorb the energy and are promoted to the higher energy orientation and the nuclei is 
said to be in resonance. The absorption of the rf energy is monitored and reported by a 
detector. As the nuclei of the various atoms are shielded by the electron ‘clouds’ of 
neighbouring atoms then their electronic environments will be different, as a result the 
effective magnetic field that an individual nuclei experiences is not the same for all 
the nuclei in a molecule. Each unique nuclei will give a unique NMR signal at a 
particular chemical shift.
NMR was initially developed to give structural information of pure compounds, but 
can also be used for quantitative measurement. It is also capable of being used with 
more complex mixtures including biological matrices. In addition NMR can be 
coupled with HPLC and used as a highly selective detector [Albert and Bayer 1992].
In order to distinguish between enantiomers a single enantiomer of another reagent 
can be added in order to cause a difference in the chemical shift via the formation of a 
diastereomenc complex. Non-equivalent NMR spectra for the enantiomers of some 
chiral secondary alcohols and amines were obtained following the formation of 
diastereomeric esters and amides using a-methoxy-a-(trifluoromethyl)phenylacetic 
acid [Dale, Dull and Mosher 1969]. Pirkle et al obtained non-equivalent NMR spectra 
for some chiral oxaziridines using chiral solvating reagents (eg. 2,2,2-trifluoro-l-(9-
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anthryl)ethanol) to form short-lived diastereomeric chelate complexes [Pirkle and 
Rinaldi 1978].
2.5 Ghiroptic techniques
The use of the optical rotation of a chiral molecule is an obvious candidate for the 
measurement of such a compound. There are three basic methods that can be 
employed, polarimetry, optical rotary dispersion (ORD) and circular dichroism (CD).
Polarimetry measures the direction of rotation of plane polarized light at a specific 
wavelength, giving the specific rotation [a]. The sodium D-line is the wavelength 
most commonly used (589nm), giving an [a]o value. The optical rotation is affected 
not only by the wavelength of light used, but also by factors such as the solvent used, 
concentration of the sample solution, temperature and presence of impurities. This 
tends to limit the usefulness and precision of the method.
ORD measures the rotation of plane polarized light as a function of the wavelength 
used. The resulting ORD spectrum should therefore change monotonically with 
wavelength. However if a sample molecule contains a chirophore, that is a 
chromophore adjacent to the chiral centre, then the resulting absorption produces a 
phenomenon called the ‘Cotton Effect’. This effect causes a peak and trough 
(sigmoidal curve) on the ORD spectrum and can make it difficult to interpret. 
[Djerassi 1960, Purdie and Swallows 1989]
A beam of plane polarized light is made up of left and right components of circularly 
polarized light. If these components are transmitted through a medium at unequal 
velocity, due to differences in the refractive index of the medium for the two 
components, then there will be a shift in phase upon recombination of the 
components, resulting in the rotation of the plane of the polarized light.
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If in addition to passing through the medium at unequal velocity the two left and right 
circularly polarized components also suffer unequal absorption, then upon 
recombination the beam will be elliptically polarized. Circular dichroism (CD) 
measures the rotation and absorbance, with the CD spectrum being a plot of ellipticity 
(0) versus wavelength (X). Modem CD spectrometers actually measure the difference 
in absorbance (A) versus wavelength, although the spectrum is still the same, as 
ellipticity is related to absorbance (0 = 33 AA).[Purdie and Swallows 1989, Wilson et 
al 1994]
Although a technique for enantiomer determination on its own, CD may also be used 
as the detector in a chromatographic (HPLC) system. This provides a highly selective 
detection system, with the ability to determine enantiomer elution order and 
enantiomeric excess directly [Bertucci et al 1994]. Originally, conventional lamp 
CD spectrometers suffered fi*om poor sensitivity, however this has been addressed and 
improved with the use of laser-based systems. Detection limits are governed by the 
intensity of a compounds CD spectmm at the chosen wavelength, and can be 
increased by analyte derivatisation.
As the detector can distinguish between enantiomers there is no need for a 
chromatographic chiral separation and so cheaper achiral stationary phases can be 
used. Alternatively a CD detector used in conjunction with CSP’s provides a highly 
selective system whereby enantiomers can be separated and identified, i.e. the 
enantiomeric elution order established by the detector. As a result CD detection is not 
a replacement for chiral chromatography, but a complimentary technique for 
enantiomer analysis.
2.6 Other TechniGiies
Many of the techniques used for analysis can and have been adapted for the analysis of 
chiral substances. This section briefly covered some of the more common techniques. 
Other techniques are also available for enantiomer discrimination, for
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example the crystal picking manual separation of enantiomers as first performed by 
Pasteur. However this technique is of no practical analytical use, although it may still 
be of use in the bulk preparation of single enantiomers [Asaoki et al 1988]. Other 
methods include calorimetric measurement and isotope dilution, although these are 
uncommon and so it is not intended to cover them in this thesis. The interested reader 
is directed to the chapter on ‘Determination of enantiomer and diastereomer 
composition’ in the book by Eliel.[Eliel et al 1994]
2.7 Chiral Chromatographic Separations
The chromatographic separation of enantiomers can be achieved via two approaches, 
either directly or indirectly. The direct approach involves making one of the 
chromatographic phases chiral, in GC this is limited to the use of chiral stationary 
phases, whereas LC can employ chiral mobile phases as well. With a chiral 
chromatographic phase enantiomer separations are achieved as a result of the 
formation of transient diastereomeric complexes between the analyte and the chiral 
phase. The indirect approach is to form diastereoisomers by reaction/derivatisation 
with a suitable optically pure single enantiomer.
2.7.1 Chiral Stationary Phases (CSP’s) for HPLC
The interaction of a chiral molecule with a CSP resulting in a discrimination of the 
enantiomers was proposed by Dalgliesh, who suggested that the attachment could be 
considered in terms of three points [Dalgliesh 1952]. This theory was further clarified 
by Pirkle, with the statement that one of the three interactions must be 
stereochemically dependent. If an enantiomer attaches to a CSP via three points 
(fig.l7A) then its antipode will only be capable of attachment with two of the points 
(fig.l7B) and is thus discriminated against [Pirkle, House and Finn 1980].
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Fig. 17. Three point model for enantiomer discrimination.
2.7.1.1 The Pirkle Phases
The donor-acceptor phases, referring to their %-n interactions, were the first CSP’s to 
be commercially available. They were developed by Pirkle from his work on NMR 
shift reagents, and are therefore named after him, although they are sometimes 
referred to as the ‘brush-type’ CSP’s. Pirkle originally used an NMR chiral solvating 
agent, (R)-(-)-2,2,2-trifluoro-l-(9-anthryl)-ethanol bonded to silica gel (fig. 18), to 
separate the enantiomers of some sulphoxides, lactones, and the 3,5-dinitrobenzoyl 
derivatives of some alcohols and amines. [Pirkle and Rinaldi 1977, 1978, Pirkle and 
House 1979] From this Pirkle developed a range of CSP’s, the second generation 
Pirkle phases.
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Fig. 18. (R)-(-)-2,2,2-trifluoro-l-(9-anthryl)-ethanol bonded to silica gel.
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The second generation phases were conceived via a reciprocal rule. If a CSP derived 
from an enantiomer (-)-A can separate the enantiomers of a compound B, ie. (+)-B 
and (-)-B, then a CSP derived from (-)-B may distinguish between (-)-A and (+)-A. 
Therefore CSP’s based on compounds separated by the fluoroalcohol CSP, should 
separate the enantiomers of a range of fluoroalcohols.
The first commercially available CSP was (R)-N-(3,5-dinitrobenzoyl)phenylglycine 
ionically bound to y-aminopropyl silica, see fig. 19, providing a ‘broad spectrum’ ti- 
acidic phase. [Pirkle et al 1981] Chiral recognition was considered a result of three 
simultaneous interactions, with at least one of them being stereochemically dependent. 
The chiral fluoroalcohols distinguished between enantiomers via a two point chelate 
type interaction, by hydrogen bonding. With the second generation phases a third 
point of interaction is provided by the n-n interactions of the 3,5-dinitrophenylbenzoyl 
group.[Pirkle, House and Finn 1980].
o
coo- +NH3-(CH2)3-Si
Fig. 19. (R)-N-(3,5-dinitrobenzoyl)phenylglycine ionically bound.
As the CSP is ionically bound mobile phases are restricted to the normal phase, non­
polar organic solvents. By covalently bonding the CSP’s to silica more polar mobile 
phases can be used. The organic groups on the modified silica project away from the 
silica like bristles on a brush, the CSP is attached to these chains, resulting in the 
‘Brush-type’ name of the CSP’s. The length of the organic chains is important, as
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longer chains keep the CSP further from and so prevent interactions with the silica 
surface.
Changes in the derivative have resulted in a number of different Pirkle CSP’s. In all 
cases the chiral discrimination is considered in terms of the three point model. Various 
interactions are involved, including the ti-ti donor/acceptor interactions with aromatic 
ring systems, hydrogen bonding, dipole-dipole stacking and steric effects. Analytes 
therefore require functional groups to take part in such interactions, although these can 
be introduced by derivatisation. Analysis of various drugs have been achieved on 
these phases, including the separation of some a-arylacetic acids (profens) as amide 
derivatives on the (R)-N-(3,5-dinitrobenzoyl)phenylglycine column. [McDaniel and 
Snider 1987]
Two different methods/mechanisms of approach to the CSP have been postulated, 
Intercalative and non-intercalative.. The intercalative mechanism involves the analyte, 
if ‘recognized’ by the CSP, penetrating the CSP units, ie. getting between the bristles 
of the brush. This method is favoured with long chains between the CSP and silica. 
Once amongst the strands of CSP dipole stacking occurs between planar 
functionalities on the analyte and the planar amide units of the CSP. The non- 
intercalative method does not involve such penetration, with interactions such as 
hydrogen bonding occurring on top of the CSP. [Taylor 1992, Pirkle and Murray 
1993, Pirkle, Murray and Burke 1993].
The Pirkle phases are undoubtedly a valuable group of CSP’s, resulting in many 
useful separations. However the large number of phases that have been developed, 
(over 60), while providing useful insight into chiral recognition models, also make 
CSP selection veiy difficult. In addition, the need to derivatise analytes in some cases 
provides another source of problems with regard sample manipulation, i.e. sample 
loss.
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2.7.1.2 Polymer CSP’s
The use of natural and synthetic polymers as CSP’s has also proved useful. 
Separations of D,L-tryptophan were achieved on unsupported natural cellulose, 
although retention times were long [Yuasa et a ll980]. Cellulose is formed by the 
linear p-1,4-linkage of D-(+)-glucose units (fig.20), which form into helical strands. 
Natural cellulose proved disappointing for chiral separations due to slow diffusion, 
poor mass transfer and non-stereoselective binding of its polar hydroxyl groups 
[Taylor 1992].
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Fig.20. Cellulose.
Derivatisation of the hydroxyl groups, such as acétylation, provided improved 
resolution. The derivative groups provide additional points for interaction with 
analytes and do not disrupt the helical structure. Microcrystalline cellulose triacetate 
has been used as both a bulk packing, although its pressure resistance is low, or 
adsorbed on silica gel, such a phase is commercially available. Other polysaccharides 
have also been used including amylose and dextran [Koller et al 1983, Okamoto 1984, 
Dappen 1986, Rizzi 1990].
The mechanisms responsible for the enantioselectivity depend on the derivatisation. A 
degree of inclusion of part of the analyte into shape selective chiral cavities within the 
polymer network may be involved, in addition to interactions such as hydrogen 
bonding, n-n , dipole and steric interactions with the external environment. Due to the 
importance of the hydrogen bonding and dipole-dipole interactions better separations
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are obtained with organic mobile phases, although aqueous-alcohol mobile phases 
may also be used [Wainer and Alembik 1986, Okamoto 1984].
Synthetic chiral polymers with helical structures have also been developed in an 
attempt to improve on the natural polymers. Such polymers have been synthesized by 
various methods, polymerization in a chiral environment, such as with a chiral 
catalyst, chiral monomers and molecular imprinting. Polyphenylacetylene based 
CSP’s produced using a chiral monomer, (R)-(+)-4-(l- 
phenylethylcarbamoyl)phenylacetylene, have been used for the separation of some 
aromatic and polyaromatic racemates [Yashima, Huang and Okamoto 1994].
Molecular imprinting involves polymerization in the presence of a template (print) 
molecule, this template is then removed from the polymer which retains affinity for 
the original template molecule. The temperature of polymerization and the form of 
reaction initiation used has an affect on the enantioselectivity of the resulting polymer 
[G’Shannessy, Ekberg and Mosbach 1989]. Methacrylate polymers imprinted with L- 
amino acid aromatic amide derivatives separated the enantiomers of racemic amino 
acid derivatives, the best separations being achieved for the enantiomers of the 
template [Andersson et al 1990]. As a result molecular imprinted CSP’s are of limited 
use.
2.7.1.3 Ligand Exchange
Chiral separations on ligand exchange stationary phases are achieved via 
diastereomeric metal chelate complexes formed between the analyte, and a chiral 
metal complex. A chiral complexing agent (ligand) is bound to a support, such as 
silica, and metal ions are added to the aqueous mobile phase [Boue et al 1981]. The 
metal ions complex with the support and with the analyte, which behaves as a mobile 
ligand. Differences in the stability of the diastereomeric complexes formed with the 
enantiomers results in chiral separation.
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The first CSP for complexation based enantiomer separations used a stationary phase 
of consisting of L-proline attached to a chloromethylated styrene-divinylbenzene 
polymer, fig.21. Copper (II) ions in the mobile phase formed reversible ternary 
complexes with the L-proline in the stationary phase and the enantiomers of amino- 
acids [Davankov et al 1983].
HO
OH
L-Proline
Fig.21. L-proline chloromethylated styrene-divinylbenzene polymer.
Ligand exchange phases are commercially available, however they are not widely used 
due to limitations in structural requirements of the analyte and low efficiency. The 
analyte must be capable of acting as a ligand, requiring two functional groups spaced a 
correct distance apart and so are limited in their application. The amino acids fulfill 
this requirement due to their acid (COO ) and amine (NH2) groups. Column efficiency 
can be as low as 100 plates, although increasing column temperature can improve 
efficiency and chiral separation, indicating that resolution is entropy controlled [Boue 
et al 1981, Dappen, Arm and Meyer 1986].
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2.7.1.4 Cvclodextrins
Cyclodextrins (CD’s) are cyclic oligosaccharides formed by the a-(l,4)-linkage of 
glucose (P“D-(+)-glucopyranose) units via the enzymatic degradation of starch. The 
number of glucose units can vary from 6 to 12, although the three predominant and 
commercially available forms a , p, and y, contain 6, 7 and 8 glucose units 
respectively. Fig.22. shows the structure of p-cyclodextrin.
MO
Fig.22. p-cyclodextrin
The CD’s are toroidal in shape, see fig.23, (like an open bucket) with the glucose units 
arranged so that the secondary hydroxyls, in the 2 and 3 positions, form a rim at the 
larger opening.
Glycosldic  
Oxygon Bridge*
Secondary
Hydroxyl*
Primary
Hydroxyl*
Fig.23. Toroidal shape of cyclodextrin.
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The primary hydroxyls, at position 6, form the outside of the smaller opening. The 
result is a relatively hydrophobic cavity containing glucoside and methylene linkages, 
leaving the outside relatively hydrophillic. The different numbers of glucose units 
result in the cavities having different diameters, although the height of the cavity 
remains constant. [Armstrong et al 1990, Li and Purdy 1992, Taylor 1992].
The initial experiments with CD’s as CSP’s for HPLC used CD’s attached to silica gel 
via ethylenediamine links. However these proved unsuccessful, having low CD 
loading and were hydrolytically unstable. Hydrolytically stable CD CSP’s using a 6 to 
10 atom spacer to link the CD to silica gel have proved much more successful. 
[Armstrong 1984, Armstrong and Demond 1984, Armstrong et al 1985]. The 
orientation of the CD on the silica can also effect the enantioselectivity.
Such CD bonded phases can be used in both reversed and normal phase mode, and 
can be useful in the separation of geometric and structural isomers as well as 
enantiomers. It is also possible to modify the CD’s by derivatisation of their hydroxyl 
groups. For example P-CD has 21 hydroxyl groups available for 
modification.[Armstrong et al 1990, Harhitai 1993, Ciucano 1994]. The modified 
cyclodextrins tend to be much more useful in the normal phase mode than native CD 
for enantioseparations.
In the reversed phase mode the enantioselective mechanism involves inclusion 
complexation and interactions with the CD rim. A non-polar part/substituent of the 
analyte, such as an aromatic ring system occupies the CD cavity, this host-guest 
interaction relying on van der Waals and/or Londons Dispersion forces. For 
enantiomeric resolution drugs require at least one aromatic ring, although this can be 
introduced by derivatisation, as with the Pirkle phases. Therefore the guest group must 
be of a suitable size as to provide a ‘tight fit’. If the molecule is too small then the 
inclusion may be too weak, resulting in no enantioseparation. However this can be 
overcome by using a smaller CD.
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With some isomeric compounds such as some disubstituted benzenes, the elution 
orders are altered on changing the size of the CD cavity. The elution of meta, ortho 
and para obtained on p-CD becomes ortho, meta, para on a-CD. The discrimination 
being due to the different stabilities of the inclusion complex due to the different 
spatial orientation.
In addition to inclusion there will also be interactions between the other groups on the 
molecule, which may ‘stick out’ from the CD cavity, with the groups on the CD rims. 
These interactions can involve hydrogen bonding, or steric interactions or repulsions. 
The overall mechanism can be considered in terms of Dagliesh’s ‘three-point model’. 
[Hinze 1985, Armstrong et al 1986].
The mechanism of enantiomer discrimination is different in the normal phase mode, 
although it can still be considered in terms of three points of interaction. Inclusion 
complexation is not involved under such conditions, as the non-polar mobile phase 
molecules occupy the CD cavity, thereby preventing the analyte from entering it. 
Interactions are restricted to those with the external groups on the CD, such as 
hydrogen bonding and dipolar interactions. This explains why the derivatised CD’s 
tend to be better than native CD under normal phase conditions. CD’s modified with 
aromatic or carbonyl groups have the additional capability for n-n interactions. Steric 
factors, such as repulsion, may also play a part in the overall mechanism, in fact 
selectivity may be enhanced or lost by steric factors. [Chang et al 1993]
Alteration of the mobile phase can be used to improve or obtain separations. In normal 
phase, changes in the stereoselective hydrogen bonding can cause a dramatic change 
in resolution. Acetonitrile, being aprotic, has little hydrogen bonding ability and so 
does not compete with the analyte for such interactions. Methanol however can 
hydrogen bond to both the CD and the anal}4e, an excess of methanol can therefore 
prevent chiral separation. Changing the ionization of the analyte, using glacial acetic 
acid or triethylamine, can also be useful in the optimization of enantiomer separations.
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In the reversed phase mode changes in the analyte ionization can be achieved using 
buffers of different concentrations and pH. Organic modifiers not only influence the 
hydrogen bonding but also compete with the analyte for the CD cavity, as already 
mentioned.
A number of CD columns, both native and derivatised, are available commercially and 
are useful in the enantiomeric separation of a wide range of compounds. Native and 
derivatised p-CD columns have been used to separate amino-acids, barbituates [Hinze 
1985], P-blockers, benzodiazepines and many other drugs [Armstrong et al 1985, 
Chang 1993, Sallstrom Baum 1994, Fukushima 1995, Cyclobond Handbook]. A new 
CD CSP has recently become available, the CD derivatives being bound onto 
polyhydroxymethacrylate. The polymeric backbone allows mobile phases of high pH 
to be used. [Majors 1995].
The CD phases have very broad applicability and have been used to separate a diverse 
range of chiral compounds. The problem of phase selection remains, although for 
most drugs the p-CD based phases have proved the most suitable.
2.7.1.5 Protein CSP’s
Due to their natural chirality and stereoselective affinity for drug molecules it seems a 
natural progression to use proteins and enzymes as chiral discriminators for 
chromatography. HPLC stationary phases incorporating proteins are therefore 
potentially very attractive for the enantiomer separations of chiral pharmaceuticals. A 
number of phases have been developed, each with differing enantioselective 
properties, the most popular of which is the a i-acid  glycoprotein phases (Chiral- 
AGP).
Although the exact mechanisms are not known, due in part to a lack of detailed 
structural information on the proteins. The enantioselectivity of the phases involves
47
hydrophobic interactions, interactions of polar groups, and steric factors. The overall 
mechanism may still be considered in terms of the three point model.
Bovine Serum Albumin (BSA). BSA is a globular transport protein consisting of a 
single chain of 581 amino-acids. It has a molecular weight of 66210, is relatively 
acidic (isoelectric point 4.7) and is very water soluble. [Allenmark 1986]. BSA was 
the first protein to be used as a CSP, initially being bound to agarose and used to 
separate the enantiomers of D- and L- tryptophan.[Allenmark 1983]. Covalently 
binding the BSA to silica resulted in an improved phase useful for the separation of 
anionic and neutral compounds.
More recently BSA has been ionically immobilized on an anion exchanger and found 
to have one enantioselective site per BSA molecule, leading to the conclusion that the 
hydrophobic cavity of the molecule is the enantioselective site. Only one in five of the 
sites is in an orientation available to the analyte, explaining the low sample capacity of 
the CSP. [Jacobson 1992].
The chiral discrimination mechanism involves two main types of binding, 
hydrophobic and electrostatic (coulombic). With a series of N-benzoyl-D,L-amino 
acids retention order was found to parallel hydrophobicity [Allenmark et al 1984]. 
Hydrophobic interactions are strongest with mobile phases of high ionic strength. At 
lower ionic strength coulombic interactions become more favourable. Other 
interactions such as those of polar groups, and steric interactions can also affect 
enantioselectivity, and so the overall mechanism can still be considered in terms of the 
three point model.
The mobile phase pH, ionic strength and organic modifiers are all factors that can be 
adjusted to optimize separations. Retention decreases with pH and decreasing ionic 
strength, due to the reduction of the charge on the BSA. Organic modifiers such as 
propanol, which affect the hydrophobic interactions, also decrease retention and can 
therefore be useful for obtaining more practical run times for highly retained samples.
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Temperature also has an affect, with a lO^C increase causing a 20-30% decrease in 
retention. [Williams 1993]
ai-Acid glycoprotein (Chiral-AGP). AGP is a human serum transport protein, 
consisting of a peptide chain of 181 amino-acids and 5 carbohydrate units. Its detailed 
structure and features have not been established. AGP is immobilized onto silica via 
covalent linkage and cross-linking of adjacent protein molecules. While this 
immobilization affects its conformation, resulting in a more unfolded structure, some 
similarities to native AGP remain. The isoelectric point of AGP is 2.7, giving it acidic 
properties, as a result mobile phase pH is important as it will affect the charge of the 
AGP as well as the analyte.
Mobile phases are aqueous, commonly buffers, allowing the pH (between 5 and 9) 
and the ionic strength (0 to 0.5M) to be adjusted. Addition of organic,modifiers may 
also be used to optimize separation. In fact reversal of enantiomer elution order has 
been reported with changes in pH or organic modifier. Chiral-AGP has been used to 
separate the enantiomers of many drugs [Enquist 1989a, Kirkland 1991, Evans 1992], 
including p-blockers. [Enquist 1989b, 1990, Hagina 1992, Vandenbosch 1992].
Human Serum Albumin (HSA). HSA is similar to BSA in both selectivity and 
performance. As a result most of the factors influencing the separations on BSA 
CSP’s are also involved with HSA. For use as a CSP HSA was immobilized onto a 
diol phase via covalent bonding and retains much of the selectivity of native HSA 
[Domenici 1990]. There have been reports of reversals of enantiomer elution order 
between BSA and HSA. With warfarin the elution order is (R) followed by (S) on 
HSA, whereas on BSA it is (S) followed by (R).[Noctor 1991].
Ovomucoid. Ovomucoid is a glycoprotein (MW approx. 28000) obtained from egg 
white and has an isoelectric point of 4.3. For use as a CSP it has been bound to 
aminopropyl silica. [Miwa 1987, Williams 1993]. Retention is based on strong 
hydrophobic interactions as with the other proteins. Ovomucoid CSP’s have been used 
for chiral separations of drugs such as propranolol [Tamai 1990], and profens [Miwa
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1987]. Recently turkey ovomucoid bonded to silica has been used to separate the 
enantiomers of some benzodiazepines, with an investigation into the enantioselectivity 
of the individual ovomucoid domains [Pinkerton 1995].
Vancomycin macrocyclic antibiotics have been reported for use as CSP’s in HPLC 
and TLC. Vancomycin is an amphoteric glycopeptide, MW 1449, containing 18 chiral 
centres, fig.24. Rifamycin B (MW 755) containing 9 chiral centres and Thiostrepton 
(MW 1665), with 17 chiral centres have also been evaluated. All three have been 
covalently bound to silica and are stable under both the reversed and normal phase 
conditions, although enantioselectivity differs between the two modes. The 
separations of over 70 racemic compounds have been evaluated on the columns, with 
efficiency and selectivity found to be affected by flow rate, temperature, and mobile 
phase [Armstrong et al 1994]. Columns of these antibiotic based CSP’s are now 
commercially available (Astec Inc., USA).
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Fig.24. Vancomycin.
As with all of the other groups of CSP, the number of protein phases available can be 
a problem with regards selection of most suitable phase. The AGP columns have the 
broadest range of applications, however there is overlap between the phases, i.e. some 
compounds can be separated on more than one of the phases.
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2.7.2 Chiral Stationary Phases for GC
In 1966 Gil-Av reported the successful use of CSP’s with capillary columns, for the 
separation of some N-trifluoroacetyl amino-acid esters using N-trifluoroacetyl-L- 
isoleucine lauryl ester as the CSP. [Gil-Av, Feibush, Charles-Sigler 1966]. Chiral 
discrimination was based on hydrogen bonding between the amide and carbonyl 
oxygen groups of the CSP and the analyte. This has led to the development of a range 
of CSP’s based on amino-acid and peptide derivatives.
Two other categories of CSP have since been developed. Complexation phases, using 
transition metal chelates, first described by Feibush, and cyclodextrin based phases.
2.7.2.1 Amino-acid/Peptide CSP’s
The early amino-acid ester type phases of Gil-Av gave enantiomer separations with 
small a  values, although this was not a problem when combined with very efficient 
capillary columns. Increased separation factors were achieved with N-trifluoroacetyl- 
L-valyl-L-valine cyclohexyl ester as CSP, which was successfully used in the 
monitoring of peptide synthesis, in order to confirm that the configuration of the 
amino-acids was retained [Bayer et al 1970].
The enantiomer discrimination of the CSP’s is based on hydrogen bonding, with 
diastereomeric associations via three hydrogen bonds between the CSP and analyte. 
This explains the lack of enantiomer resolution of proline, which after N-TFA 
derivatisation no longer possesses a hydrogen on its amide nitrogen and so could only 
form two hydrogen bonds. The retention of N-TFA derivatives of amino-acids was 
found to increase with the size of the ester derivative, with straight chain esters 
experiencing greater retention than branched chain [Nakaparksin et al 1970].
Increasing the molecular weight of the CSP, by increasing the size of amino-acids 
used, was found to increase the operating temperature range and efficiency. Using N-
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TFA-L-phenylalanyl-L-leucine cyclohexyl ester, shorter retention times and 
consequently a lower limit of detection was achieved for N-TFA amino-acids [Konig 
et al 1970]. Feibush found that even better efficiency and resolution could be achieved 
using diamide derivatives, such as N-lauroyl-L-valyl-t-butylamide. The diamides 
contain the same chiral discriminating group, (-NH-CO-CHR-NH-CO-), as the di- and 
tripeptides, but have greater thermal stability [Feibush 1971].
The thermal stability of the phases was further increased by chemically binding the 
CSP’s to polysiloxane. The separation of some carbohydrates and ketones, as oxime 
derivatives, was achieved on an XE-60-S-valine-S-a-phenylethylamide phase [Konig, 
Benecke and Ernst 1982]. With N-propionyl-L-valine-t-butylamide bound to 
polysiloxane it was possible to separate, for the first time, all of the common protein 
amino-acids in a single temperature programmed run.
This led to the widely used, commercially available Chirasil-Val CSP, fig.25, 
although its applications are limited to compounds such as amino acids and alcohols. 
Chirasil-Val was produced by peptide linkage of N-tert-butyl-L-valinamide to the 
carboxyl group of organosiloxane. The L-configuration of the phase Chirasil-L-Val, 
was found to be more stable than the D-, due to its ability to stabilize itself via van der 
Waals forces between molecules. Enantiomer elution order may be reversed by 
switching between the two columns. [Frank et al 1978a, 1978b, Bruckner and Lupke
1991].
H
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Fig.25. Chirasil-Val
52
The separation of the enantiomers of some alcohols on Chirasil-Val led to the 
assumption that chiral recognition may be possible with just one strong interaction, 
although in such situations van der Waals or some other interactions provide the other 
two interactions [Koppenhoefer and Allmendinger 1986]. Derivatisation of analytes 
can also be used to promote enantioselectivity. [Abdalla, Bayer, Frank 1987, Konig 
1982].
Although the hydrogen bonding mechanism is well established, van der Waals forces 
and dipole-dipole interactions may be sufficient for chiral discrimination. This was 
demonstrated with the separation of the enantiomers of N-TFA-proline isopropyl ester 
on an N-TFA-L-prolyl-L-proline cyclohexyl ester CSP [Konig 1982].
2.1,12 Complexation
The use of metal chelate complexes for enantiomeric separations was first described 
by Feibush from his work on NMR shift reagents. The method was further developed 
by Schurig, who used solutions of chiral metal p-diketonates in squalane for coating 
into capillary columns (fig.26.). Selectivity is achieved by fast, reversible interactions 
by electron donation between the analyte and the electronically and coordinatively 
unsaturated transition metal complex.
CH
OF
Fig.26. Example of a chiral metal p-diketonate.
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Such phases are therefore capable of separating chiral molecules with little or no 
functional groups. The compounds must however be capable of electron donation and 
so contain lone-pairs or n-electron systems, which therefore limits the uses of these 
CSP’s. The overall retention of an analyte is governed by its physical partition 
between the two phases and the chemical equilibrium of the molecular association 
[Schurig and Weber 1984, Schurig 1988].
Schurig [Schurig and Burkle 1982] used various transition metal bis[(lR)-3- 
(heptafluorobutyryl)camphorate] complexes coated in a nickel capillary column to 
separate some racemic cyclic ethers. Manganese, Mn(II) was found to be a weak 
acceptor for the cyclic ethers. Nickel, Ni(II), was found to be a strong acceptor. As a 
result the Ni(II) complex is the best choice for the separation of enantiomers of weak 
electron donor molecules. The complexes were also useful for the separation of 
molecules containing chiral nitrogen and sulphur atoms.
With 1 -chloro-2,2-dimethylaziridine, a nitrogen containing racemate, there is the 
potential of inversion from one enantiomer to the other. This inversion is prevented 
due to the molecules constraining ring structure. When the enantiomers were 
separated on the Ni(II) column a plateau was observed between the two enantiomer 
peaks. This plateau, termed ‘peak coalescence of the second kind’ was due to a degree 
of inversion of the enantiomers. The metal chelate complex formed for separation 
lowered the activation barrier for the inversion.
The initial work using metal capillaries gave problems due to their surface properties 
and the ability for electrolytic metal exchange between the metal complex and the 
capillary. The use of glass and fused silica capillaries proved advantageous as their 
surfaces exhibit little activity towards the CSP once it has been deactivated, ie. 
removal of the free silanol groups. Squalane was chosen as the stationary phase 
solvent so as to keep chemical interactions between the metal complex and the solvent 
to a minimum [Schurig and Weber 1984].
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Changing the ligand used also affects the enantioselectivity. Experiments on the 
separation of some chiral homoallyl methyl ethers found that Ni(II) bis[(lR,2S)-(3- 
heptafluorobutyryl)pinan-4-onate] gave the best separations with aromatic analytes, 
whereas Ni(II) bis[( 1 R)-(3 -heptafluorobutyryl)camphorate] was better for separations 
of compounds of high molecular weight and low volatility, due to its higher operating 
temperature. By switching the chirality of the ligand (eg. from R to S) it is possible to 
reverse the enantiomer elution order. Elution order tends to be consistent within a 
homologous series [Halterman et al 1987, Schurig 1988].
Other factors affecting the enantiomer separation are column length, coating 
thickness, column temperature, pressure drop, concentration of the chirametal 
selectand and carrier gas used. Hydrogen is best avoided as a carrier gas as it interferes 
with the metal chelate. Separations of alcohols, diol acetonides, oxiranes, spiroacetals, 
esters, pheromones and ethers have been achieved on chirametal phases, with 
derivatisation rarely required [Schurig and Burkle 1982, Halterman et al 1987, 
Schurig 1988].
2,1.12 Cvclodextrins
The hydrophilic nature and high melting points of native CD’s makes them of little 
use as GLC coatings. Derivatisation of the CD’s can make them more useful. The 
choice of derivative is important, alkylated CD’s are more chemically and thermally 
stable and less susceptible to hydrolysis compared to acylated CD’s. The alkyl 
derivatives are also less polar, with subsequently lower melting points. Two 
approaches have been used in the utilization of CD derivatives as CSP’s in capillary 
GC. They can be used in a diluted form, dissolved in a polysiloxane solvent, or they 
may be coated direetly, undiluted, if liquidity allows. Both approaches have proved 
successful.
Using the CD derivatives dissolved/diluted in liquid phases allows them to be used 
over a wide temperature range, although at low temperature the solubility in highly
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non-polar polysiloxanes may be limited. A range of peralkylated CD’s have been used 
successfully dissolved in OV1701. The lower molecular weight derivatives are 
preferable as the longer the alkyl chain the greater its shielding of the CD cavity 
[Schurig et al 1990, Schurig and Nowotny 1990]. Changing the polysiloxane solvent 
may affect the enantiomer separation, due to change in distribution constant, however 
this was not observed using PS-086 instead of OV1701 [Jung, Schmalzing and 
Schurig 1991].
2.3.6-tri-O-methyl-P-CD dissolved in OV1701 has a useful operating temperature 
range from 25 to 200®C and has been used to separate the enantiomers of many 
compounds, including cyclic ethers, ketones, lactones, secondary alcohols, aromatic 
alcohols, alkenes, and some imfunctionalised saturated monocyclic hydrocarbons 
[Schurig and Nowotny 1990].
2.3.6-trimethyl a-, p- and y- CD’s have been used in both OV1701 and hydroxy 
terminated OV1701 (OV1701-OH). Reversal of enantiomeric elution order was 
obtained by changing the size of the cyclodextrin cavity, ie. in going from a  to p. 
With few exceptions, dilution of the CD derivative caused a dilution of the 
enantioselectivity [Bicchi et al 1991].
Dilution or loss of enantioselectivity was also experienced with the separation of some 
y-lactones on 2,6-di-0-pentyl-3-0-acetyl-a-CD in OV1701. With 10% CD, 
resolutions (Rg) of around 1.5 were achieved. Increasing the concentration of the CD 
derivative caused an increase in resolution, finishing with the undiluted derivative 
resulting in an Rg of 6.5. Conditions favouring low elution temperatures gave the best 
chiral resolution [Schmarr et al 1991].
Theoretical considerations of the effect of CD concentration on the separation was 
dealt with by Schurig [Jung, Schmalzing and Schurig 1991]. For most analytes, unless 
they are hardly retained, it is not advantageous to increase the CD concentration above 
O.IM. This is because the increasing concentration of CD causes retention increases, 
resulting in longer analysis time.
56
2,6-di-0-methyl-3-0-trifluoroacetyl-P-CD dissolved in OV1701 has been used to 
separate a number of bomane and aromatic analytes. A partially trifluoroacetylated 
derivative was compared to the fully derivatised phase, while both gave similar 
selectivity, a  values, the partially derivatised phase gave lower resolution. This was 
due to tailing of the peaks caused by hydrogen bonding between the analytes and the 
underivatised 3-hydroxy groups [Stoev 1992]. Some useful biological and 
pharmaceutical chiral precursors, such as carboxylic acids, hydroxy acids and some 
profens, have been separated on 2,6-di-0-methyl-3-0-pentyl p- and y-CD’s in 
OVl 701 [Konig and Gehrcke 1993].
A logical progression from dissolving the CD’s was the chemical anchoring of the CD 
derivatives to the polysiloxane. Schurig attached alkenylated CD to the silicon- 
hydrogen bonds of polysiloxane by catalytic hydrosilation. A greater concentration of 
the CD in the phase was achieved (0.17M) compared to that achieved by dissolving 
(0.07M). This type of phase is commercially available as Chirasil-Dex [Schurig et al 
1990].
The use of CD derivatives in an undiluted form requires them to have low melting 
points. Konig used some per-n-pentylated a  and p CD’s, which are thermally stable 
and liquids below room temperature, to separate the trifluoroacetyl derivatives of 
some alcohols, epoxy alcohols, diols, triols, and carbohydrates [Konig et al 1988].
In 1990 Armstrong developed a range of liquid, relatively polar, hydrophilic CD 
derivatives. Their physical state, liquidity, is governed by their functional groups, 
overall molecular weight and most importantly their homogeneity. Three different 
derivatives were prepared for all three CD’s.
The 0-(S)-2-hydroxypropyl derivative was synthesized, resulting in a solid at room 
temperature. Liquidity was achieved by permethylation, to varying degrees, of the 
remaining hydroxy groups. The configuration of the hydroxypropyl substituent was 
not found to play a significant role in the chiral recognition of the phase, whereas the 
parent CD’s chirality does. The phase is thermally stable, and has been used to
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separate a large number of different chiral compounds, such as sugars, amines and 
alcohols [Armstrong, Li, Chang and Pitha 1990].
The other two derivatives were the dipentylated, 2,6-di-O-pentyl-CD, relatively 
hydrophobic compared to the hydroxypropyl, and the trifluoroacetylated dipentylated 
derivative, 2,6-di-0-pentyl-3-0-trifluoroacetyl-CD. The dialkyl CD columns tend to 
exhibit opposite enantioselectivity to the hydroxypropyl phase. For example, with the 
methyl ester of mandelic acid the elution order is (S) followed by (R) on the a- 
hydroxypropyl phase (A-PH), and (R) followed by (S) on the P-dialkyl (B-DA) phase. 
There have also been enantiomer elution reversals observed between the 
hydroxypropyl and trifluoroacetylated dialkyl (TA) phase [Armstrong, Li, Pitha 1990].
The CD phases are the most useful of the GC CSP’s, capable of separating a very 
broad range of compounds. The trifluoroacetyl (TA) derivative has a polarity 
intermediate between the PH and DA phases. The y-TA colunm appears to be the 
most useful of the TA columns, with well over 120 different chiral compounds 
reported resolved on it, including alcohols, diols, amino alcohols, amines, carboxylic 
acid esters and halohydrocarbons. With the other derivatives the p column proved the 
most widely applicable. The a-TA column has proved useful for the separation of 
some long chain epoxides [Li, Jin and Armstrong 1990]. The P-PH and y-TA columns 
exhibited similar selectivity in their separation of some enantiomeric hydrocarbons, 
although retention times were longer on the y-TA. All three of the derivatives for each 
CD size are commercially available as Chiraldex -TA, -DA and -PH, A, B, and G are 
used to denote the CD, a-, P-, and y [Chiraldex, Astec Inc.].
The chiral discrimination mechanism for the CD derivatives involves a number of 
potential interactions, whether diluted or undiluted. Inclusion (host-guest formation), 
hydrogen-bonding, van der Waals and dispersion, dipole-dipole interactions, 
electrostatic and steric interactions may be involved. The three-point model, with 
inclusion or partial inclusion with two other interactions with the outside of the CD 
cavity may account for the separations of compounds with chiral centres in side
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chains. The model is not so suitable to describe the interaction of compounds with a 
chiral centre in a ring system.
There is evidence both for and against the formation of inclusion complexes. Some 
separations appear to exhibit a degree of size selectivity. With the separation of 
bomane compounds on diluted CD derivatives, addition of methyl groups to the 
bomane skeleton could cause or destroy enantiomer separation depending on the 
positioning of the group. This suggested differences in the ‘fitting’ of the molecules 
into the cavity [Stoev 1992].
However there are also examples of enantiomeric separations of molecules that are 
too big to ‘fit’ into the cavity. Further evidence against the formation of strong 
inclusion complexes is that if  they were formed then band broadening would be 
expected due to slow mass-transfer from the CD. Such broadening is not commonly 
observed, so it is assumed that the association is looser, with perhaps partial inclusion.
The thermodynamic parameters responsible for enantiomeric resolution can be 
. established and can give information on separation mechanisms. The distribution of a 
compound (or enantiomer) between the chromatographic phases is described by a 
distribution constant (K). This constant is related to the energy change (Gibbs free 
energy, AG) during the interactions/distribution;
-AG = RTlnK
(Where R is the gas constant (8.314 J K'^ mol"^), T is column temperature)
The capacity factor, l / , can be substituted in place of K and so by plotting In k' 
against 1/T (Van’t Hoff plots) the energy changes can be determined. Non-linear 
Van’t Hoff plots indicate that more than one retention mechanism or binding site are 
involved [Schurig 1984, Pirkle 1991].
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2.7.3 Chiral Stationary Phases for TLC
In 1980 Yuasa reported the separation of D- and L-tryptophan, and DL-histidine, on a 
crystalline cellulose coated plate [Yuasa et al 1980]. Microcrystalline cellulose was 
found to be better than native cellulose, possibly due to greater surface area [Lederer
1992]. Separations of tryptophans have also been performed using cellulose in 
conjunction with a chiral eluent. Using an aqueous mobile phase containing a-CD was 
found to have an additive effect on the chiral separation [Huynh and Lederer 1994]. 
With eluents containing metal salts only copper (II) was found to have an effect, 
causing a decrease in chiral discrimination of some tryptophans [Huynh and Lederer
1993].
Pirkle type CSP’s have also been incorporated on TLC plates. The enantiomers of 
2,2,2-trifluoro-1 -(9-anthryl)ethanol were separated using - (R)-N-(3,5-
dinitrobenzoyl)phenylglycine ionically bound to y-aminopropyl silica [Wainer, 
Brunner and Doyle 1983]. The problem with the use of Pirkle CSP’s in TLC is that 
they tend to have a high background UV absorbance, making detection of the 
separated enantiomers awkward. This problem was addressed by the use of a 2-phase 
approach whereby the bottom half of a plate was the Pirkle and the top was 
unmodified silica. The enantiomers of 2,2,2-trifluoro-l-(9-anthryl)ethanol and 1,1’- 
binaphthol were separated on such a plate, with detection by fluorescence quenching 
after elution of the separated spots onto the unmodified silica. [Witherow et al 1991]. 
Detection problems were not encountered with (R)-(-)-l-(l-naphthyl)ethyl isocyanate 
bound to silica, which has been used to separate the enantiomers of some profen 
drugs, with detection possible by UV [Brunner and Wainer 1989].
The first commercially available chiral TLC plates were the ligand exchange 
‘Chiralplates’. Reversed phase (RP18) plates were treated with a copper (II) acetate 
solution and (2S,4R,2R’S)-4-hydroxy-l-(2-hydroxydodecyl)proline, and have been 
used to separate the enantiomers of underivatised amino acids, dipeptides and some 
a-hydroxycarboxylic acids [Brinkman and Kamminga 1985, Gunther 1988].
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The use of CD’s as CSP’s for TLC has also been reported. Armstrong successfully 
separated the enantiomers of dansyl- and naphthylamide amino-acid and ferrocene 
derivatives on a bonded P-CD plate. This phase was also used to separate some 
diastereomers and structural isomers [Alak and Armstrong 1986].
2.7.4 Chiral Mobile Phase Additives (CMA’s) in HPLC
2.7.4.1 Chiral counter ions
Diastereomeric ion-pairs can be formed by the addition of chiral counter ions to the 
mobile phase, i.e. a charged analyte and a counter ion of the opposite charge form a 
neutral ion-pair. These ion-pairs have differing distribution properties, mobile phase 
solvation and stationary phase adsorption, and can therefore be separated using 
standard achiral columns. Resolution may be optimized by changes in counter ion 
concentration, mobile phase modifiers and the type of achiral phase used.
The separation of enantiomers of some p-blockers was achieved using (+)-10- 
camphorsulphate (fig.27) in an organic mobile phase [Pettersson and Schill 1981].
S0o“ 0
Fig.27.1 (+)-10-camphorsuiphonate
61
Separations of some sulphonic and carboxylic acids, including Moshers acid, were 
obtained using quinine as the counter ion, on a diol stationary phase [Pettersson 
1984]. Oxazepam and mandelic acid ethyl ester have been separated with dihexanyl- 
trans-1,2-cyclohexanediamide in the mobile phase [Sinibaldi et al 1987]. The mobile 
phase needs to be of low polarity so as to promote ion-pair formation via electrostatic 
and/or hydrogen bonding. The presence of water in the mobile phase can cause a 
decrease in both separation factor and retention.
2.7.4.2 Chiral Metal Complexes
Similarly, diastereomeric complexes can be formed by ligand exchange with metal ion 
complexes in the mobile phase. Separations of underivatised amino-acid enantiomers 
and RS-mandelic acid have been performed using copper(II) complexes with various 
ligands, such as N,N-dimethyl-L-phenylalanine and N- (p-toluenesulphonyl)-D- 
phenylglycine, on C l8  columns [Nimura et al 1984, Wernicke 1985]. P- 
aminoalcohols have been separated with a mobile phase containing copper(II) acetate 
and R-mandelic acid [Yamazki et al 1995].
2.7.4.3 Cvclodextrins
Resolution of analytes with CD’s in the mobile phase is achieved due to the different 
stabilities and subsequent adsorption differences of the analyte-CD inclusion 
complexes. The enantiomers of mandelic acid and related derivatives have been 
separated on 0DS/C18 columns with both a- or P-CD in the mobile phase 
[Debowski, Jurczak and Sybilska 1983]. The addition of p-CD to the mobile phase 
has also been used to improve the separation of some steroid stereoisomers 
[Lamparczyk and Zarzycki 1995].
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2.T.4.4 Proteins
As with their use as CSP’s, the enantioselectivity of the proteins makes them useful 
CMA’s. In addition to the separation of drug enantiomers, it is also possible to use the 
chromatographic separations of the proteins to determine the affinity constants of their 
binding to the drugs. One drawback with the use of proteins in the mobile phase is 
their UV absorbance, which can cause UV-detector response to become non-linear, 
however this can be overcome by indirect detection [Pettersson et al 1986].
Changes in the achiral column used can dramatically affect the retention, 
stereoselectivity is however unaffected, as this occurs within the mobile phase. For 
example the retention of tryptophan with HSA in the mobile phase was increased 30 
times by changing from a Diol column (hydrophilic) to an RP18 phase (hydrophobic) 
[Pettersson et al 1986].
The enantiomers of some neuroleptic and tricyclic antidepressants have also been 
separated on a Diol phase using AGP in the mobile phase [Hermansson 1984]. The 
enantiomers of a-methoxy-a-(trifluoromethyl)phenylacetic acid (Moshers acid) were 
separated on a phenyl Hypersil column with HSA in the mobile phase (pH 6.5) 
[Pettersson et al 1986].
2.7.5 Chiral Mobile Phase Additives in TLC
The use of CMA’s for TLC chiral separations is similar to HPLC. N-carbobenzyloxy- 
glycyl-L-proline (ZGP) and ( 1 R)-(-)-ammonium-10-camphorsulphate (CSA) have 
both been used for the separation of aromatic amino-acids and aminoalcohols, 
including some p-blockers, by normal phase TLC. Solvents and plates must be 
thoroughly dried in order for separations to be obtained, as the presence of water 
interferes with the formation of the diastereomeric ion-pairs [Duncan 1990].
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The use of CD’s is restricted by their low solubility, although this can be increased by 
increasing pH, addition of urea, or modification of the CD although this can be at the 
expense of enantioselectivity. Urea solubilized p-CD has been used for the separation 
of some disubstituted benzenes, native and hydroxypropyl CD’s have been used to 
increase the separation of p-nitroanilines.[Armstrong, Faulkner and Hun 1988, Hinze 
et al 1989, Politzer et al 1995].
Proteins have also been employed as CMA’s, BSA in aqueous mobile phase enabled 
the separation of derivatised amino-acids on RP18 TLC plates. Variation of mobile 
phase pH can be used to effect reversal of enantiomer elution order, although high pH 
resulted in low retention of analytes [Lepri et al 1992, Lepri et al 1993]. Recently 
Armstrong has reported the use of vancomycin, a macrocyclic antibiotic, as a CMA 
for the separation of dansyl amino acids and drugs, including warfarin and indoprofen 
[Armstrong and Zhou 1994]. In addition to being a useful separation technique in its 
own right, TLC may also be useful for the rapid screening of analytes and conditions 
for HPLC separations.
2.7.6 Indirect Chiral Separation
Indirect chiral separation is achieved by derivatisation of the enantiomers with a chiral 
derivatising reagent to form covalently bonded diastereoisomers for separation by 
standard achiral chromatography. In order to maximize the difference in 
chromatographic properties of the diastereomers the two chiral centres should be as 
close as possible to each other. There are four factors to be satisfied in the formation 
of such diastereoisomers.
Firstly the chiral derivatisation reagent (CDA) used must be of veiy^  high purily, and 
be chemically and stereochemically stable in storage, ie. it must not degrade or 
racemise on storage. The reaction of the CDA with the analyte enantiomers should be
64
quantitative, stereoselective derivatisation or kinetic resolution must not occur. The 
conditions employed in the derivatisation reaction must not lead to racémisation of the 
CDA or analyte. Finally the resultant derivatives should exhibit similar detector 
responses. Enantiomer elution order may be reversed by using the CDA of opposite 
chirality [Burden et al 1987, Srinivas and Igwemezie 1992].
An example of unsatisfactory diastereomer formation was reported by Silber and 
Riegelman [Silber and Riegelman 1980]. The separation of (+) and (-) propranolol by 
derivatisation with N-trifluoroacetyl-L-prolyl chloride (TPC, see fig.28) was initially 
found to be unsatisfactory due to racémisation of the CDA in storage and during the 
derivatisation reaction. The storage problem was overcome by using freshly prepared 
CDA (98% pure) which was then stored at -20°C to prevent racémisation, and by 
reaction at -78^C, conditions which resulted in only 2% racémisation.
N ^ C O C I
COCF3
TPC
Fig.28. N-trifluoroacetyl-L-prolyl chloride.
The choice of CDA is obviously dependent on the structure, or functionality of the 
analyte in question. The separation of chiral alcohols for example can be achieved by 
reaction with suitable reagents to form diastereomeric carbamates and esters.
Separations of chiral secondary alcohols have been reported by GC following 
derivatisation with R- ( + ) - 1 -phenylethyl isocyanate and R-(-)-( 1 -naphthyl)-ethyl 
isocyanate [Deger et al 1986]. Chiral amines have also been resolved as urea 
derivatives after derivatisation with chiral isocyanates [Demian and Gripshover 1989].
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The latter reagent has also been used for the separation of p-blockers as diastereomeric 
derivatives by HPLC [Gubitz and Mihellyes 1984]. The enantiomers of p-blockers 
have also been separated by HPLC following derivatisation with optically pure 0 ,0 -  
disubstituted tartaric acids [Lindner, Leitner and Uray 1984]. Tartaric acids (such as 
R,R-(+)-0,0-dibenzoyltartaric acid anhydride) have also been used for the separation 
of amines such as 3-aminoquinuclidine dihydrochloride, a useful intermediate in the 
synthesis of some pharmaceuticals [Demian and Gripshover 1989].
The enantiomers of Ibuprofen have been separated as diastereomeric amides by 
derivatisation with R-(+)-a-phenylethylamine [Brooks and Gilbert 1974]. Chiral 
amines and alcohols have also been used for the separation of other chiral acids 
[Kaneda 1986].
The formation of diastereomeric ester derivatives by reaction with chiral acid 
chlorides (eg. (-)-menthyloxyacetic acid chloride) was reported for the separation of 
some chiral triazole alcohols by GC [Burden et al 1987]. Acid chlorides (e.g. acyl 
amino acid chlorides) have also been used for the formation of diastereomers of chiral 
amines [Souter 1975]. Similarly, the enantiomers of pantolactone were resolved by 
GC after chiral acylation, using a-methoxy-a-(trifluoromethyl)phenylacetic acid 
chloride [Takasu and Ohya 1987].
While there are a number of pitfalls in the formation of diastereomers, such as the 
need for optically pure and stable reagents, the separation of enantiomers as 
diastereomeric derivatives is still the most popular method of chiral separation. This 
may in part be due to the high cost of the chiral columns and the fact that selection of 
the optimum CSP for enantiomer separation remains rather ‘hit and miss’ at the 
present, although educated guesses based on previous separations and analyte 
structure can ‘narrow the field of potential candidates’.
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All of the methods covered have their own advantages and disadvantages. While the 
literature appears to indicate that diastereoisomer formation is the most frequently 
used chiral separation technique at present this is not to say it is the better technique. 
Suitability of a particular technique and its ease of use for a particular study is a more 
important criteria than ‘popularity’ for the selection of a method.
2.8 Aim of Thesis
The initial aim of this thesis was to separate the enantiomers of some racemic 
epoxides by capillary GLC with CSP’s and ascertain factors involved in the 
separations. Knowledge of the separation mechanism would be useful for the selection 
of CSP’s for future separations. Two commercially available cyclodextrin derivative 
CSP’s were evaluated, trifluoroacetyl-y-CD and 2 -(S)-hydroxypropyl-P-CD, as 
developed by Armstrong and co-workers (Chiraldex, Astec Inc.). The model 
compounds were a range of structurally related pharmaceutical intermediates 
containing an epoxide functionality.
The applications of the two phases for pharmaceutical analysis and bioanalysis was 
also considered. The use of the Chiraldex columns for the resolution of enantiomers of 
some pharmaceutical compounds was evaluated with some p-blocker and 
benzodiazepine drugs. For analysis from biological matrices, p-trifluoromethyl 
mandelic acid and a-methoxy-a-(trifluoromethyl)phenylacetic acid were selected as 
model compounds. The determination of their enantiomer levels in urine was 
considered by GC using the Chiraldex CSP’s and compared with HPLC using CSP’s. 
The methods developed were to be used to study the pharmacokinetic fate of the 
enantiomers in the urine of dosed rats.
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3.0 Materials and Methods
3.1 Reagents
3.1.1 Model Compounds
The chiral epoxides (chromenes) were supplied as racemic mixtures, except the cyano 
substituted epoxide which was also supplied as the single enantiomers, by SmithKline 
Beecham Pharmaceuticals, Harlow, Essex. The epoxides differed in their substituent 
group at position 6 , the general structure is given in fig.29. The epoxides were referred 
to by their substituent groups.
The p-blockers (Zeneca, Macclesfield) and benzodiazepines were obtained as 
racemates and were already available in the laboratory. Moshers acid -(a-methoxy-a- 
(trifluoromethyl)phenylacetic acid) as single enantiomers and racemic p- 
trifluoromethyl mandelic (p-TFM) were obtained from Aldrich Chemical Company 
Ltd., Dorset. The structures of all the model compounds are given in figs.29, 30 and 
31.
3.1.2 Solvents and other reagents
HPLC grade acetonitrile and methanol, and the following analytical grade reagents; 
acetone, ethyl acetate, dichloromethane, diethyl ether, acetic anhydride, hydrochloric 
acid, sodium dihydrogen orthophosphate, di-sodium hydrogen orthophosphate and 
ammonium nitrate, were obtained from Fisons, Loughborough. Absolute alcohol was 
obtained from Hayman Ltd., Essex, and glacial acetic acid (pronalys AR grade) from 
May and Baker Ltd, Dagenham. De-ionized water for HPLC was produced in the 
laboratory using an ELGA Option 4 water purifier, all other laboratory reagents (AR 
grade) were obtained from Aldrich Ltd.. All pH’s were determined using a PTL-15 
digital pH meter, calibrated before use with standard buffer solutions (BDH Ltd., 
Poole).
68
3.1.3 Gases
Helium, hydrogen and oxygen free nitrogen (OFN) were supplied by B.O.C. Ltd., 
Guildford, Compressed air was produced by a Jun-Air compressor, Jun-Air (UK.) 
Ltd., Paisley.
R =
R
CFs
C2F5
Cl
CN
NO2
Fig.29. The structure of the chiral epoxides.
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Fig.30. Structures of the p-blockers.
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Fig.31. Structures of model compounds.
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3.1.4 Solid Phase Extraction Cartridges
Bakerbond Quatamine (NH4), C2, C8, C18 and CN (cyano) cartridges were obtained 
from JT Baker Ltd., Reading. Varian bond-elute C2, C8 and C l8 cartridges were 
obtained from Jones Chromatography, Mid Glamorgan. The cartridges were used on a 
Vac-Elut SPS24 extraction station.
3.2. Chromatographic Equipment
3.2.1 Columns
3.2.1.1 GC
The BP 1, BP 10, and OV1701 capillary columns used were manufactured by SGE Ltd. 
Milton Keynes. The chiral capillary columns used were Chiraldex G-TA, and 
Chiraldex B-PH, both 10m  ^ 0.2mm i.d., obtained from Astec. Inc., Whippany, USA, 
although supplied to us by SmithKline Beecham Pharmaceuticals, Harlow.
3.2.1.2 HPLC
Astec. Cyclobond 1 and Cyclobond 1-Ac (native and acetylated P-cyclodextrin) 
columns, 250 x 4 . 6  mm, and Chromtech Chiral-AGP, 100 x 4 . 6  mm, columns were 
obtained from Technicol Ltd, Cheshire.
3.2.2 Chromatographic Systems
For GC, a Perkin-Elmer Sigma 3B capillary gas chromatograph, with FID and ECD 
was used with a JJ Instruments chart recorder or Spectra-Physics SP4270 integrator. A 
Hewlett Packard 5890A gas chromatograph (with FID and ECD) with a HP3396A
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integrator was also used. The Sigma 3B was used with manual injection, the 
HP5890A was used with manual and automatic injection with a HP7673A automatic 
sampler. Split injection was used throughout.
For HPLC, an Altex IlOA solvent metering pump and a Beckman HOB solvent 
delivery module were used. Injection was either manual, with a Rheodyne 7125 
syringe loading sample injector, or automated using a Waters WISP 71 OB system. 
Sample detection was by UV absorption using a Spectromonitor 3200 or 
Spectromonitor III 1204A variable wavelength detector. Results were recorded on a JJ 
Instruments chart recorder.
3.3 Chromatographic measurements - Interpretation of Chromatograms.
In addition to the parameters as described in chapter 2, to give a clearer indication to 
the extent to which two peaks were separated the ‘Kaiser’ resolution parameter (Rp) 
was used [Dyas et al 1991]. This is a measure of the depth of the valley between the 
two peaks (a) expressed as a percentage of the overall peak heights (a+b), fig 32. A 
baseline separation of two peaks gives an Rp of 100%.
f a
\ a  h
X 100
Fig.32. Measurements for calculation of ‘Kaiser’ resolution parameter (Rp).
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3.3.1 Peak Measurement - Quantitation
It was decided to use peak height rather than peak area for the quantitation of peak 
size. This was in part due to the instrumentation available, with an integrator only 
available on the HP5890 GC.
In addition to the ease of measurement, in many cases the use of peak height can be 
more accurate than peak area. This is especially true for partially resolved peaks, 
tailing peaks, and small peaks adjacent to large neighbouring peaks [Meyer 1995a]. 
Integration errors in the determination of peak areas of incompletely resolved peaks 
are generally greater than peak height errors [Foley 1987, Meyer 1995b]. Therefore 
when data collection was performed with the integrator peak height was still used for 
peak size measurement.
3.4 GLC of some racemic epoxides
Solutions of the epoxides (5mg/ml) were prepared in dichloromethane. These 
solutions were used without further dilution. Split injection, with a split flow of 
50ml/min, was used to inject Ipl of the solutions. The basic conditions used with both 
the G-TA and B-PH columns were as follows. Helium carrier gas, inlet pressure 
45Kpa., air 175Kpa., hydrogen 150KPa., nitrogen make up gas 30ml/min. Injector and 
FID at 250 “C.
3.5 Determination of column polarity for Chiraldex columns
The McReynolds constants for the two chiraldex columns (G-TA and B-PH) were 
determined in order to obtain their relative polarities. This was achieved by running 
five test solutes; butan-l-ol, pentan-2-one, benzene, nitroethane and pyridine on the 
columns at 120°C and calculating their retention indices. The McReynolds constant is 
the difference between the calculated values and those obtained for the same solutes
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on a non-polar squalane phase. The values for squalane were obtained from the 
literature. [Poole and Poole 1989].
The retention index of a compound x, (1% ), is calculated as follows:
Ix = 100 ( log (tR )x - a)/b
The values ‘a’ and ‘b’ are constants related to the retention of n-alkanes and their 
carbon number. In order to determine the values of ‘a’ and ‘b’ a series of n-alkanes, 
heptane to dodecane (C7 to C l2) were run on both columns under the same conditions 
as the test solutes [Budahegy et al 1983]. The values of ‘a’ and ‘b’ were then obtained 
from a plot of the log. of the adjusted retention time of the n-alkane against its number 
of carbon atoms, (N) using the relationship:
log (tR’)N = a + bN
3.6 GLC of some (3-blockers and benzodiazepines
The acetyl derivatives of atenolol, alprenolol, metoprolol tartrate and propranolol were 
prepared using the following method. 5mg of p-blocker was dissolved in 0.5ml of 
pyridine. Acetic anhydride 0.5ml was added to the solution and the reaction allowed 
to proceed for 2 hours, at room temperature. Excess reagent was removed by bubbling 
nitrogen through the solution for 5mins. prior to injection into the GC system.
The trifluoroacetyl derivative of lormetazepam was formed by dissolving 
approximately Img of lormetazepam in 0.2ml of dichloromethane. Trifluoroacetic 
anhydride (0.1ml) was then added, the vial capped and the reaction left to prnref^H At
room temperature for 30 minutes. The solution was then evaporated to diyness in a 
stream of nitrogen. The residue was redissolved in 0.2ml of ethanol for injection.
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The silyl ester was produced by dissolving approximately 5mg of lormetazepam in 
0.4ml of N,0-bis(trimethylsilyl)acetamide. The vial was capped and the solution 
shaken and heated to 60°C for 3 hours. After reaction the solution was evaporated to 
dryness in a stream of nitrogen and the residue redissolved in toluene prior to 
injection.
3.7 Bioanalvsis of a-Methoxv-a-(trifluoromethvl)phenvIacetic acid (Moshers 
acid) and p-trifluoromethvl mandelic acid.
Urine samples from rats dosed with Moshers acid, either single enantiomer, or 
pseudo-racemate (503.62mg of R-Moshers acid and 505.92mg of S-Moshers acid), 
and from rats dosed with racemic p-trifluoromethyl mandelic acid were provided by 
the School of Biological Sciences (University of Surrey) for determination of 
enantiomer levels of the respective compounds. Sample details are listed in table 1.
The protocol for the dosing of the rats was as follows. For p-TFM, three male rats 
(150-250g) were dosed with lOOmg/kg racemic p-TFM in sodium 
bicarbonate/isotonic saline. Urine was collected over ice, in two batches, from 0-24 
hours and 24-48 hours and frozen in plastic sample tubes. For Moshers acid, one rat 
was dosed with the R-Moshers acid, one with S-Moshers acid and one with the 
pseudoracemic mixture, at a concentration of 50mg/kg and the urine collected as with 
p-TFM.
The chromatographic separation of the enantiomers was investigated first, using 
solutions of the pure compounds. Upon successful chromatographic resolution of the 
enantiomers the extraction and determination in urine was considered.
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Table 1. Rat Urine Samples for enantiomer level determination.
Rat/Sample No. Compound Dosed Sample
Time
Date Total Volume 
of Urine (ml)
1 Racemic p-TFM 0-24 Hrs. 10/2/94 8.5
24-48 Hrs. 11/2/94 9.5
2 Racemic p-TFM 0-24 Hrs. 10/2/94 3.5
24-48 Hrs. 11/2/94 5.5
3 Racemic p-TFM 0-24 Hrs. 10/2/94 7.5
24-48 Hrs. 11/2/94 9.5
4 R-Moshers acid 0-24 Hrs. 10/2/94 7.0
24-48 Hrs. 11/2/94 7.0
5 S-Moshers acid 0-24 Hrs. 10/2/94 11.5
24-48 Hrs. 11/2/94 ' 11.0
6 Racemic 
Moshers acid
0-24 Hrs. 10/2/94 10.5
24-48 Hrs. 11/2/94 12.0
3.7.1 HPLC of Moshers acid and p-trifluoromethyl mandelic acid
For the HPLC analysis of both compounds 1 mg/ml stock solutions of racemic p-TFM, 
S- and R- Moshers acid and a pseudoracemate R,S-Moshers acid (i.e. 50:50 of each 
enantiomer) were prepared in water (sonication was required to aid dissolution). 
These solutions were diluted to provide sample solutions of various concentrations.
Sodium phosphate buffers were prepared and pH adjusted by varying the amounts of 
sodium dihydrogen orthophosphate and di-sodium hydrogen orthophosphate used. 
Triethylamine acetate buffer was prepared by pH adjusting triethylamine with acetic 
acid. Ammonium nitrate solutions at 0.1, 0.05 and 0.025M were prepared in water and 
their pH measured.
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3.7.2 Sample preparation for the analysis of Moshers acid in urine by HPLC
Optimization of sample preparation was performed using pooled human urine. Stock 
solutions were prepared in water for evaluation of sample recovery, removal of 
interferences was determined using blank urine. For final method validation and 
analysis of the rat urine samples, standard curves were produced using a stock solution 
made up with pooled human urine. Pooled rat urine from undosed rats was used for 
urine blank.
3.7.2.1 Liquid-liquid extraction
The basic method involved acidifying the sample with 6M hydrochloric acid and 
extraction into either ethyl acetate or diethyl ether. The aqueous-organic mixture was 
whirlimixed, then centrifuged (2000rpm, lOmins.), followed by removal of the 
organic layer. This process was then repeated and the combined organic layers evaporated 
to diyness under a stream of nitrogen. The residue was redissolved in mobile phase for 
injection onto the HPLC system.
3.7.2.1 Solid Phase Extraction
Five different phases were evaluated, an ion-exchange, quatamine phase, and C2, C8, 
Cl 8 and cyano bonded silica. The basic procedures for the cartridges were as follows.
Quatamine: Conditioning was performed by passing one cartridge volume of methanol 
followed by two volumes of distilled water through the cartridge. 1ml of sample was 
then applied and the cartridge washed with 1ml of hexane and one volume of water. 
After drying at increased pressure the sample was eluted with 2 x 1ml of 1.5 M 
hydrochloric acid. The Moshers acid was then extracted from the acid with ethyl 
acetate.
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C2, C8, Cl 8 and CN: All cartridges were conditioned with one volume of methanol 
and two volumes of water. The sample (1ml) was acidified with lOOpl of 6M 
hydrochloric acid before loading onto the cartridge. Various washes were used and the 
cartridge dried as before. The sample was then eluted with 2 x 1ml of ethyl acetate. 
The extract was blown down in a stream of nitrogen and the residue redissolved in 
mobile phase.
For the determination of recovery a solution of R,S-Moshers acid in water (0.1 mg/ml) 
was prepared by dilution from a 1 mg/ml solution, 1ml of this diluted solution was 
then extracted. The extract was then 1 evaporated to dryness and the residue 
redissolved in lOOpl of eluent. The peak heights obtained upon injection of this 
solution onto the HPLC system were compared to those obtained with unextracted 
standard solution (1 mg/ml).
3.73 GLC of Moshers acid and p-TFM
The methyl esters of both compounds were produced by reaction with methanolic 
hydrochloric acid. Concentrated hydrochloric acid was diluted to 2M with methanol, 
1ml of this solution was then added to Img of sample in glass tubes and capped with 
PTFE lined plastic caps. The solutions were then heated to lOO^C and left for SOmins 
initially, although optimum reaction times were investigated. The solutions were then 
evaporated in a stream of nitrogen and redissolved in methanol. The ester derivatives 
were chromatographed on both of the Chiraldex columns using the same conditions as 
for the epoxides.
3.73.1 Analysis of p-TFM and Moshers acid in urine
The p-TFM was derivatised without prior extraction from the urine. To 200pl of urine 
was added 2M methanolic hydrochloric acid (2ml), the solution was then heated to
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lOO^C for 2 hours. (This reaction time was determined by comparing the peak heights 
obtained from a range of reaction times). After cooling for SOminutes, 400pl of 
hexane was added and the mixture centrifuged for 5mins. at 2000rpm. Ipl of the 
hexane layer was then injected into the GC system.
With Moshers acid the derivatisation/extraction procedure was the same as for p-TFM 
except that the reaction was allowed to proceed for Ihour.
3.8 Enantioselectivitv of Chiraldex GC columns and regeneration of the G-TA 
column
D,L-Pantolactone (5mg/ml in dichloromethane) was used as a test-mixture to test the 
enantioselectivity of the B-PH column. Conditions were as for the racemic epoxides 
with a column temperature of lOO^C. The enantioselectivity of the G-TA column was 
tested with racemic 3-chloro-2-butanone (1 mg/ml in dichloromethane) at 60^C, using 
the same conditions as used with the racemic epoxides.
The enantioselectivity of the G-TA column was restored by following the regeneration 
procedure suggested by the supplier [Chiraldex Handbook]. Trifluoroacetic anhydride 
(TFA) was passed through the column with an inlet pressure of 5 KPa. The gas eluting 
from the column was monitored for the presence of TFA by immersing it in an 
alkaline solution of methyl red. Once TFA was detected (indicator solution changes in 
colour from yellow to red) the column temperature was increased from 40 to 150 ^C at 
5 °C/min. The column was then run on the same temperature program with just carrier 
gas passing through it. Restoration of the enantioselectivity was confirmed with 3- 
chloro-2-butanone at 60^C (all other conditions as for the epoxides).
79
3.9 Regeneration of the Cvclobond I HPLC column
The procedure was as suggested by the manufacturer in the literature supplied with the 
column [Cyclobond Handbook]. The column was washed with water (0.5ml/min for 
20minutes), followed by ethanol (0.5ml/min, 90mins.), water (0.5ml/min, 60mins.), 
acetonitrile (0.5ml/min, 90mins.) and finally water again (0.5ml/min, 60mins.). The 
column was then reconditioned with mobile phase. The restoration of 
enantioselectivity was confirmed with the enantiomer separation of propranolol. This 
procedure was performed periodically.
3.10 Validation of final methods
In order to validate the chromatographic methods developed, precision and accuracy 
were evaluated on a day to day, and within day basis by determination of the 
enantiomer levels of spiked samples.
Stock solutions of R,S-Moshers acid (prepared from the individual enantiomers in the 
same volumetric flask) and p-TFM were prepared in pooled human urine. These 
solutions were then used to prepare spiked solutions of known concentration (low, 
medium and high) for determination of the precision and accuracy of the methods. 
Aliquots of the spiked solutions and the stock solution were then frozen in plastic 
tubes for use on subsequent days. A fresh calibration curve was produced for each run 
(each day) with diluted solutions prepared from the frozen stock solution. The 
calibration solutions were of the following concentrations:
Moshers Acid 
HPLC method
R-Moshers acid; 0.025, 0.051, 0.101, 0.253, 0.505,1.011 mg/ml.
S-Moshers acid; 0.026, 0.052, 0.104, 0.260, 0.520,1.040 mg/ml.
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GC method
R-Moshers acid; 0.030, 0.061, 0.121, 0.302, 0.605,1.209 mg/ml.
S-Moshers acid; 0.033, 0.065, 0.131, 0.327, 0.654, 1.309 mg/ml.
p-TFM
Racemate; 0.397, 0.795, 1.987, 3.974, 5.960, 7.947 mg/ml. (each enantiomer 50% of 
racemate concentration).
The calibration solutions and spiked solutions were extracted/derivatised as per the 
particular method and the enantiomer levels of the spiked solutions determined using 
the calibration curve. Accuracy was measured by comparing the value obtained for 
each spiked solution with the known amount, such that:
Accuracy (%) = (determined concentration/spiked concentration) X 100
Day to day precision was evaluated by performing the procedure on 6  separate days 
and calculating the coefficients of variation (CV’s) for the values obtained. Within 
day precision was evaluated by determining the concentration of each spiked solution 
6  times in one day and calculating the CV’s, as with day to day.
The limit of detection (LOD) for each enantiomer was determined from the lUPAC 
equation:
LOD = Blank + ( t X s.d. of blank)
Blank refers to the signal produced by a blank solution, t refers to the Students two- 
tailed t-test value for a particular confidence level [Bonate 19901. In order to allow for 
variability due to the sample preparation, to give a more ‘useful’ method detection 
limit (MDL), the intercept of the calibration curve was substituted for the blank signal 
and the s.d. of the intercepts was substituted for the s.d. of the blank signal, 3 was
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used as an estimate of t, to give:
MDL = Mean of intercepts + ( 3 X s.d of intercepts)
The values obtained from the equation were then converted to concentration values 
using the calibration curves [Miller and Miller 1992]. The worst or ‘highest’ value 
obtained was taken as the MDL.
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4.0 Results and Discussion
4.1 GLC of some racemic epoxides with cvclodextrin capillary columns
All of the epoxides were successfully separated on both of the cyclodextrin based GC 
columns (B-PH and G-TA) without prior derivatisation. The chiral separations 
obtained for each epoxide on the G-TA column (2,6 -di-O-pentyl-3 -0-trifluoroacetyl- 
y-CD) at 130 ®C are listed in table 2. Very good enantiomer separation was achieved 
for all five epoxides, as indicated by the high Rp values and column efficiency (Neff) 
was also good. Figures 33 and 34 show examples of the separations obtained.
Chiral separation was confirmed by chromatographing the individual enantiomers of 
the CN epoxide. Elution order was found to be (-)-enantiomer followed by the (+)- 
enantiomer. Single enantiomers of the other epoxides were unavailable, so it was 
assumed that the two peaks obtained with the racemates were those of the enantiomers 
and that the elution order of the enantiomers was the same as the CN epoxide.
Table 2. Retention and chiral separation of the racemic epoxides on the G-TA column 
at 130%.
Epoxide t ’R (mins.) k ' a Rp % Neff
C2F5 3.05 6 . 8 1.033 91 20614
3.15 7.0 21988
CFs 3.90 8.7 1.026 8 6 23406
4.00 8.9 24622
Cl 14.60 32.4 1.031 79 29523
15.05 33.4 18562
CN (-) 46.35 154.5 1.025 83 36632
CN (+) 47.50 158.3 31493
NO2 84.95 242.7 1.031 1 0 0 55335
87.55 250.1 42464
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Detector
Response
3.50
3.60 :
Time (mins.)
Fig.33. Separation of fluoroalkyl substituted epoxide enantiomers. G-TA column, 
130®C, helium carrier gas at 45Kpa, split injection (split flow 50ml/min), detection by 
FID. Ipl injection of 5mg/ml solutions A) Triflouromethyl (CF3) epoxide, B) 
Pentafluoroethyl (C2F5) epoxide.
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Fig.34. Separation of cyano (CN) substituted epoxide enantiomers. G-TA column, 
130®C, helium carrier gas at 45Kpa, split injection (split flow 50ml/min), detection by 
FID. Ipl injection of 5mg/ml solution.
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The chiral separations of the epoxides obtained on the B-PH column (Permethylated 
0-(S)-2-hydroxypropyl-P-CD) at 130 are listed in table 3. The enantiomer 
separations of the less retained (CF3 , C2F5, and Cl) epoxides are similar to those 
obtained on the G-TA column. The more retained epoxides (CN and NO2) were less 
resolved on the B-PH column. Poorer efficiency was also achieved the B-PH column, 
with much lower plate numbers than the G-TA column. Some examples of separations 
obtained on the B-PH column are given in figures 35 and 36.
Table 3. Retention and chiral separation of the racemic epoxides on the B-PH column 
at 130 “C.
Epoxide t^ R (mins.) k" a Rp % Neff
C2F5 1.90 5.1 1.095 1 0 0 7999
2.08 5.6 9587
CFs 2.60 7.0 1.065 94 14980
2.77 7.5 17003
Cl 9.50 25.7 1.032 62 15432
9.80 26.5 13301
CN (+) 51.00 127.5 1.031 50 11909
CN (-) 52.60 131.5 10644
NO2 89.40 223.5 1.047 57 6972
93.60 234.0 8426
86
Detector
Response
2.973.14
Time (mins)
Fig.35. Separation of chloro and trifluoromethyl substituted epoxide enantiomers. B- 
PH column, 130°C, helium carrier gas at 45Kpa, split injection of (split flow 
50ml/min), detection by FID. Ipl injection of 5mg/ml solutions A) Trifluoromethyl 
(CF3) epoxide, B) Chloro (Cl) epoxide.
87
0suods9y Jop0i9a
-o
_Q
CO
Fig.36. Separation of nitro (NO2) substituted epoxide enantiomers. B-PH column, 
150°C, helium carrier gas at 45Kpa, split injection of (split flow 50ml/min), detection 
by FID. Ipl injection of 5mg/ml solutions.
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Discussion
The epoxides supplied were intermediates, or precursors, in the asymmetric organic 
synthesis of a pharmaceutical compound under development by SmithKline Beecham 
Pharmaceuticals. The separation of the enantiomers of the epoxides was required so as 
the progress and enantioselectivity of the formation of the epoxides could be 
monitored.
Capillary GC was chosen for its high efficiency and the broad range enantioselectivity 
of the Chiraldex cyclodextrin columns. The columns investigated differed in CD size 
and derivatisation, but gave similar separations. Similarities in the enantioselectivity 
between B-PH and G-TA columns have also been reported in the literature, with 
similar enantiomer selectivity being observed with some chiral hydrocarbons. 
[Armstrong, Tang and Zukowski 1991].
Good efficiency (Neff) was achieved with both columns, the G-TA was the most 
efficient of the two. The high efficiency of the columns allows chiral separations to be 
obtained with small separation factors. The gradual increase in plate number with 
increased retention time is due to extra-column effects rather than a result of the 
stationary phase. The results also demonstrate that the separation percentage Rp, gives 
a very good first glance picture of the separations obtained.
4.1,1 Investigation of thermodynamic parameters and chiral recognition 
mechanism
The mechanism of separation of the epoxide enantiomers on the CD phases was 
investigated by evaluation of the energies involved in the separations, so as to ascertain 
factors or interactions responsible.
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To achieve this the epoxides were chromatographed on each of the columns at lO^C 
intervals. The effect of changing column temperature on the chiral separation of the 
epoxide enantiomers is shown in tables 4 and 5 for the G-TA and B-PH columns 
respectively. With both columns increasing temperature resulted in a decrease in 
retention of both enantiomers of each epoxide. This is demonstrated by the reduction 
in k% which in turn leads to reduced enantiomer separation, indicated by the decrease 
in separation factor (a) with increasing temperature.
Plots of (Rina) against 1/T were made, all of which were linear with r values of 0.995 
or greater and are shown in figures 37 (G-TA) and 38 (B-PH). These plots were used 
to calculate A(AH), A(AS) and A(AG) for the separations. The thermodynamic 
parameters calculated from the data (listed in tables 4 and 5) are listed in tables 6  and 
7, along with the isoenantioselective temperature. The isoenantioselective temperature 
(Tiso) is the temperature at which A(AG) is zero and there is no separation of the 
enantiomers.
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Table 4. Effect of column temperature on retention and chiral separation of the racemic
epoxides on the G-TA column.
Epoxide Temp. °C 1’r (mins.) k ' a 1/T (K) 
XI0’^
Rina
C2F5 150 1.35 2.7 1.029 2.36 0.24
1.39 2.8
140 2.00 4.4 1.035 2.42 0.29
2.07 4.6
130 3.05 6.8 1.039 • 2.48 0.32
3.17 7.0
120 4.65 10.3 1.042 2.54 0.34
4.84 10.8
110 7.54 16.8 1.048 2.61 0.38
7.90 17.6
100 12.50 27.8 1.053 2.68 0.44
13.16 29.2
Cl 160 3.00 8.6 1.017 2.31 0.14
3.05 8.7
150 4.40 12.6 1.020 2.36 0.17
4.49 12.8
140 6.85 22.8 1.026 2.42 0.22
7.03 23.4
130 10.70 42.8 1.030 2.48 0.25
11.02 44.1
120 17.20 57.3 1.035 2.54 .0.29
17.80 59.3
110 28.90 96.3 1.038 2.61 0.31
30.00 100.0
CN 160 10.65 35.5 1.015 2.31 0.12
10.81 36.0
150 16.90 56.3 1.018 2.36 0.15
17.20 57.3
140 27.60 98.6 1.022 2.42 0.18
28.20 100.7
130 46.35 154.5 1.025 2.48 0.20
47.50 158.3
120 80.95 252.9 1.030 2.54 0.25
83.40 260.6
CF3 140 1.85 5.6 1.027 2.42 0.22
1.90 5.8
130 2.85 8.1 1.032 2.48 0.26
2.94 8.4
120 4.40 13.3 1.036 2.54 0.30
4.56 13.8
110 7.15 20.4 1.043 2.61 0.35
7.46 21.3
100 11.80 39.3 1.043* 2.68 0.35
12.31 41.0
90 20.60 68.7 1.056 2.75 0.45
21.75 72.5
NO2 170 12.00 34.3 1.017 2.26 0.14
12.20 34.9
160 18.47 52.8 1.018 2.31 0.15
18.81 53.7
150 29.60 84.6 1.022 2.36 0.18
30.25 86.4
140 49.55 141.6 1.026 2.42 0.22
50.85 145.9
130 84.95 242.7 1.031 2.48 0.25
87.55 250.1
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Fig.37. Plot of Rlna against 1/T using epoxide data from the G-TA column (table 4).
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Table 5. Effect of column temperature on retention and chiral separation of the racemic
epoxides on the B-PH column.
Epoxide Temp. °C t’R (mins.) k ' a m  (K) 
X 10-3
Rina
C2F5 160 0.60 1.6 1.050 2.31 0.41
0.63 1.7
150 0.85 2.3 1.059 2.36 0.48
0.90 2.4
140 1.25 3.4 1.080 2.42 0.64
1.35 3.7
130 1.90 5.1 1.095 2.48 0.75
2.08 5.6
120 3.00 8.6 1.110 2.54 0.87
3.33 9.5
110 4.90 14.0 1.129 2.61 1.01
5.53 15.8
Cl 150 3.90 10.3 1.018 2.36 0.15
3.97 10.5
140 6.00 15.4 1.023 2.42 0.19
6.14 15.7
130 9.50 25.7 1.032 2.48 0.26
9.80 26.5
120 15.55 42.0 1.035 2.54 0.29
16.10 43.5
110 26.30 77.4 1.042 2.61 . 0.34
27.40 80.6
CN 160 11.25 28.1 1.018 2.31 0.15
11.45 28.6
150 17.90 48.4 1.022 2.36 0.18
18.30 49.5
140 29.90 74.7 1.027 2.42 0.22
30.70 76.7
130 51.00 127.5 1.031 2.48 0.26
52.60 131.5
120 90.15 231.1 1.035 2.54 0.29
93.30 239.2
CF3 160 0.80 2.0 1.038 2.31 0.31
0.83 2.1
150 1.15 2.9 1.043 2.36 0.35
1.20 3.0
140 1.75 4.6 1.057 2.42 0.46
1.85 4.9
130 2.60 7.0 1.065 2.48 0.53
2.77 7.5
120 4.15 10.9 1,077 2.54 0.62
4.47 11.8
110 6.80 18.9 1.088 2.61 0.70
7.40 20.6
NO2 180 7.70 19.3 1.013 2.21 0.11
7.80 19.5
170 11.75 29.4 1.021 2.26 0.18
12.00 30.0
160 18.75 46.9 1.027 2.31 0.22
19.25 48.1
150 30.55 76.4 1.033 2.36 0.27
31.55 78.9
140 51.30 128.3 1.039 2.42 0.32
53.33 133.3
130 89.40 223.5 1.047 2.48 0.38
93.60 234.0
93
8
X
CQ
CM
n
CM
«
3
CM
CM
to
CM
CM
4 . u
o w
O
s
X
z
Ü
<4
o
Ü
♦
Fig.38. Plot of Rina against 1/T using epoxide data from the B-PH column (table 5).
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Table 6. Thermodynamic parameters calculated for the chiral separation of the racemic
epoxides on the G-TA column.
Epoxide 
R subst.
Temp. Range °C - A(AG) J/mol -A(AH)
kJ/mol.
-A(AS)
J/mol.
Tiso T
min. max. min. max.
C2F5 1 0 0 150 163 1 0 0 0.58 1.15 240
Cl 1 1 0 160 119 59 0.59 1.23 2 1 0
CN 1 2 0 160 98 54 0.52 1 . 1 0 2 1 0
CFs 90 140 164 92 0.70 1.49 2 0 0
NO2 130 170 1 0 1 61 0.53 1.07 2 2 0
Table 7. Thermodynamic parameters calculated for the chiral separation of the racemic 
epoxides on the B-PH column.
Epoxide 
R subst.
Temp. Range °C -A(AG) J/mol -A(AH)
kJ/mol.
-A(AS)
J/mol.
Tû. °C
min. max. min. max.
C2F5 110 160 385 176 2.02 4.33 200
Cl 110 150 130 63 0.78 1.69 190
CN 120 160 112 63 0.60 1.24 210
CFs 110 160 269 133 1.35 2.83 210
NO2 130 180 154 49 0.99 2.08 200
Plots of Ink versus 1/T were also made in order to determine the enthalpy and entropy 
values for the individual epoxide enantiomers. Straight lines (r=0.995 or greater) were 
obtained, the results are listed in tables 8 and 9. The peaks of the racemic epoxides 
were assigned (+) or (-) based on the elution order of the CN epoxide enantiomers. 
The -A(AH) and -A(AS) values calculated from the individual -AH and -AS values are 
in agreement with those obtained from the plots of Rina versus 1/T (Tables 6 and 7).
95
Table 8 . Enthalpy and entropy values for the separation of the epoxide enantiomers on 
the G-TA column calculated from plots of In k'" v 1/T.
Epoxide 
R subst.
-AH(+)
kJ/mol.
-AH(-)
kJ/mol.
-A(AH)
kJ/mol.
-AS(+)
J/mol.K
-AS(.)
J/mol.K
-A(AS)
J/mol.K
C2F5 59.82 60.40 0.58 184.28 185.44 1.16
CFs 63.44 64.08 0.64 191.32 192.65 1.46
Cl 68.26 68.83 0.56 191.19 192.32 1.13
CN 70.69 71.23 0.53 185.04 186.14 1 . 1 0
NO2 74.07 74.67 0.61 189.69 190.94 1.25
(+) and (-) refer to the individual enantiomers as identified from chromatographing the 
CN epoxide single enantiomers.
Table 9. Enthalpy and entropy values for the separation of the epoxide enantiomers on 
the B-PH column calculated from plots of In k  ^v 1/T.
Epoxide 
R subst.
-AH(-)
kJ/mol.
-AH(+)
kJ/mol.
-A(AH)
kJ/mol.
-AS(-)
J/mol.K
-AS(+)
J/mol.K
-A(AS)
J/mol.K
C2F5 60.51 62.56 2.05 187.75 192.08 433
CFs 61.53 62.86 1.33 187.97 190.74 2.77
Cl 67.69 68.49 0.80 192.41 194.15 1.74
CN 74.20 74.82 0.61 195.10 196.37 1.27
NO2 75.90 76.91 1 . 0 1 194.94 197.05 2 . 1 2
(+) and (-) refer to the individual enantiomers as identified from chromatographing the 
CN epoxide single enantiomers.
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Discussion
In order for the enantiomers to be separated they must exhibit differences in their 
interaction/association with the GSP. This implies a difference in the enantiomers Gibbs 
free energy of association (A(AG)), which can be related to the difference in 
association constants (K) for the enantiomers and hence the separation factor such 
that:
-A(AG) = R Tlna
The Gibbs free energy can be substituted for the relevant entropy (AS) and enthalpy 
(AH) differences, using the Gibbs-Helmholtz relationship (AG = AH - TAS), to give:
R ln a  = -A(AH)/T +A(AS)
Therefore by plotting Rina versus 1/T the values of A(AH) and A(AS) can be obtained 
from the slope and intercept respectively [Katsanos et al 1978, Schurig 1984, Berthod, 
Li and Armstrong 1992]. The isoenantioselective temperature Tiso was calculated from 
A(AH) and A(AS), as follows:
If-A(AG) = 0 , then -A(AH) / T + A(AS) = 0 so:
T i s o  = A(AH)/ A(AS)
Armstrong suggested that compounds could be categorised into one of two groups 
according to the thermodynamic parameters involved in their chiral separation. Group 
1 compounds being those that form dominant inclusion complexes, such compounds 
result in large -A(AH) and -A(AS) values, equal to or greater than 7.5kJ/mol. and 
17.9J/mol.K respectively. Group 2 compounds were those where inclusion 
complexation was not the dominant interaction, this was indicated by lower -A(AH) 
and -A(AS) values, equal to or lower than 5.8kJ/mol. and 13.4J/mol.K. respectively 
[Berthod, Li, Armstrong 1992].
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The results obtained (Tables 6 and 7) with the epoxides put them into the Group 2 
category, although inclusion complexation may still be involved in the chiral 
recognition. A number of interactions and associations may be involved, including 
inclusion or some degree of partial inclusion.
Although single enantiomers were unavailable (except with the CN substituted 
epoxide), it was possible to calculate the -AH and -AS values of the single enantiomers 
from plots of Ink  ^against 1/T, due to the following relationship.
In k' = (-AH / RT) + (AS / R) + Inp
Where P is the phase ratio of the column, the ratio of mobile phase volume to 
stationary phase volume. For capillary columns :
Vg and Vl refer to the volume of gas and liquid phases, dc is the inner diameter of the 
column, df is the stationary phase film thickness, (df = 0.125pm for the Chiraldex 
columns).
The AH and AS values are negative, indicating that energy is evolved during the 
binding of the epoxides with the CSP, and there is also a loss of entropy or disorder in 
the system. As the retention of the epoxides is an exothermic process, then decreasing 
temperature should favour increased retention and separation of the enantiomers, as 
was found with the epoxides. The linearity of the Ink^  versus 1/T plot also indicates 
that the same mechanism is responsible for the retention of the enantiomers over the 
temperature range studied [Pirkle 1991].
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The individual AH and AS values are larger on the B-PH column, in agreement with 
the interactions being stronger within the smaller CD cavity. The interactions of the (-) 
enantiomers are of similar energy on both columns (tables 8 and 9), whereas the (+) 
enantiomer has the stronger interaction with the B-PH column and is therefore retained 
the most and eluted last. On the G-TA column its interactions are not as strong and it 
is less retained and is eluted before the (-) enantiomer.
Recently the validity of thermodynamic data obtained using the relationship between 
chromatographic equilibrium constant (K) and the free energy change in the system 
(AG) has been questioned [Yun, Zhu and Parcher 1995]. The problem arises from the 
inaccuracy in the determination of retention times and volumes and the subsequent 
determination of 1/ . While such inaccuracies may well result in the calculated 
thermodynamic parameters not being an absolutely accurate measure of the exact 
energies involved in absolute terms, the same procedures for peak measurement were 
used for all determinations so trends and relative differences in parameters can be 
considered valid.
If some part of the epoxide molecules is involved in host-guest interaction, then the 
aromatic ring part of the molecule is the most likely candidate to enter the CD cavity. 
The CD cavity contains methylene hydrogens and glucoside oxygens and can 
bind/interact with included molecules via hydrogen bonding, dipole-dipole interactions 
and London dispersion forces.
As the epoxides only differ in substituent attached to the benzene ring, then these 
substituents will affect the orientation and interaction/binding of the molecules within 
the cavity. The nitro and cyano groups, and to a lesser extent the chlorine, are electron 
withdrawing groups and will therefore cause the aromatic ring to be more electron 
deficient. On the other hand the fluoroalkyl groups, being electron donating, will make 
the ring electron rich.
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The NO2 group is the strongest electron withdrawing group, and the epoxide with this 
substituent is the most retained (ie. has the longest retention times) on both columns. 
The CN group is the second strongest electron accepting group, and is also the second 
most retained. The Cl group is not as strong an electron acceptor, and so is less 
retained than the CN or NO2.
The fluoroalkyl groups are electron donating, as opposed to electron withdrawing and 
are the least retained. The retention of the epoxides therefore appears governed by the 
inclusion or partial inclusion of the molecules in the CD cavity, and so the electronic 
influence of the substituent on the aromatic ring controls the degree of retention. The 
cyano and nitro substituents can also hydrogen bond within the cavity [Stoev 1992]. 
As a result they are more tightly bound, resulting in peak tailing and poorer separation.
With the aromatic ring of the epoxide molecule included in the CD cavity, and the rest 
of the molecule ‘sticking out’, then the epoxide and ketone oxygens may interact with 
the external groups of the CD, see fig.39.
Fig.39. Possible inclusion of the epoxides in the CD cavity.
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As the chiral centres of the epoxide molecules are situated at the epoxide functionality 
then the stereochemically dependant interactions responsible for discriminating 
between enantiomers are expected to occur outside the CD cavity. These interactions 
take the form of van der Waals, electrostatic interactions, and in the case of the B-PH 
column hydrogen bonding with the hydroxypropyl moiety. Due to the trifluoroacetyl 
substituents on the G-TA column its hydrogen bonding capability is reduced [Li, Jin 
and Armstrong 1990], so the position of the aromatic ring system in the y-CD cavity 
may be different.
The substituent groups on the CD molecule have been observed to play a significant 
role in the chiral recognition of the phases. It has been reported that the retention of 
some sugars increased with increasing polarity of the CD substituents [Berthod, Li and 
Armstrong 1990]. As for the interaction of analytes with the substituent groups of the 
CD molecule, van der Waals forces may be sufficient for chiral recognition, as a 
number of unfunctionalized racemates have been resolved on the phases. Shape 
selectivity has also been indicated by differences in separation factor (a) observed 
between alcohols of the same molecular mass (eg.4-methyl-2-pentanol and 4-methyl-3- 
pentanol) [Krupcik et al 1994].
Difference in positioning within the y-cavity compared to that experienced in the P- 
cavity may cause the other enantiomer to have a better interaction/binding with the 
interior of the y-cavity and may explain the difference/reversal in enantiomer elution 
order. The greater entropy differences observed with the p-CD phase indicate a greater 
loss of freedom, and so a possible tighter fit in the cavity. As the P-cavity is smaller in 
diameter than the y-cavity this is expected.
In summary, the separation of the enantiomers may be considered as the result of two 
mechanisms working simultaneously. One of these mechanisms, a combination of 
interactions, being responsible for the chiral separation of an enantiomer pair and the 
other controlling the retention of the epoxides. This latter retention mechanism would 
not distinguish between the enantiomers of an individual racemic epoxide but would
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distinguish between the different epoxides, due to the differing substituent groups. The 
retention of the epoxides correlates with the electron withdrawing/donating ability of 
the substituent groups.
4.1.2 Modelling of the chiral epoxides
The structures of the epoxides were modelled on a computer using the COSMIC molecular 
modelling package (Chemistiy Dept, University of Surrey) in an attempt to identify structural 
factors/relationships involved in retention and chiral separations. The structures were 
built up from the individual atoms and then bond angles and energies were optimised 
by the computer. From this the overall dipole moments of the individual epoxides were 
calculated, table 10. No relationship between the overall dipole moment or molecular 
weight of the compounds and their retention and chiral discrimination on the CD 
columns was identified.
Table 10. Results from COSMIC computer modelling of the epoxide structures.
Epoxide substituent R Molecular Weight Overall dipole moment
C2F5 294 4.74
Cl 2 1 0 2.23
CN 2 0 1 3.84
CFs 244 4.63
NO2 221 5.84
Computer modelling of CSP - analyte interactions have been reported in the literature. 
In particular the interaction of analytes with Pirkle type HPLC phases has been 
modelled. Analyte structures were modelled and then ‘rolled’ over the modelled van 
der Waals surface of the CSP (R-phenylglycine and S-naphthylalanine were 
considered). The resulting configurations were sampled and the free energies of the 
diastereomeric interactions were computed.
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The contribution to enantioselectivity and retention of the various sites of interaction 
were determined using a mathematical algorithm. The model successfully predicted the 
retention orders of the analyte enantiomers on each CSP [Lipkowitz et al 1989, 
Lipkowitz and Baker 1990]. The interaction of analytes with Pirkle type CSP’s has 
also been modelled using a SYBYL 6.0 software package [Bargmann-Leyder et al 
1995]. The interaction of R and S- propranolol with a Chryrosine-A phase in both 
HPLC and SFC was modelled. The result showed that the improved resolution 
achieved by SFC was due to the solvating affect of the carbon dioxide, which induced 
conformational changes in the propranolol enantiomers allowing more favourable 
chiral recognition interactions.
The same software has also been used to model the interaction of long chain (C l8) 
molecules with CD molecules in the mobile phase. The inclusion of the chains into the 
CD cavities was found to differ in energetically favoured arrangement. With a-CD a 
linear arrangement of the alkyl chain was most favoured. With P- and y-CD inclusion 
of the chain was energetically favourable when bent in a ‘U’ shape. The y-CD also 
allowed the inclusion of two linear chains [Nowakowski et al 1995].
It was not possible to model the interaction of the epoxides with the cyclodextrin 
phases in such a way as the computer software/programs necessary were unavailable to 
us. As a result no further computational investigations were pursued at this time 
although this is an area for potential further work.
4.1.3 Experiments above T:.»
The epoxides with T^ o values that were below the maximum operating temperature of 
the column (240®C for the B-PH column) were run at up to 50"C above their Tiso, the 
results are listed in table 11. Above this temperature the sign of enantioselectivity 
would reverse and so enantiomer elution order should be reversed.
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Table 11. Experiments above Tiso - Chromatography o f nitro, cyano and chloro
substituted epoxides at high temperatures.
Epoxide Column Temp. C Cr (mins.) a Rp %
NO2 180
200
220
240
7.80
7.95
1.019 10.0
3.55
1.80
0.95
CN 200
220
240
2.30
1.20
0.70
Cl 200
220
240
0.70
0.40
0.25
No reversal of enantiomer elution order was observed, as no enantiomer separation 
was obtained with the NO2, Cl or CN epoxides on the B-PH above their Tiso. Further 
temperature increases were not possible due to the stability of the stationary phase. 
The rapid decrease in k with the increase in temperature results in the epoxide 
enantiomers coeluting, peak coalescence of the third kind (ie. a single peak is obtained, 
as shown in fig.40), retention is reduced and their elution approaches that of the 
column dead volume. A similar result has been reported with sec-butyl-2- 
bromopropanoate on a G-TA column, the enantiomers coeluted as a single peak close 
to the column dead volume at temperatures above its Tiso [Berthod, Li and Armstrong 
1992].
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o
Detector
Response
\---- i
Time (mins.)
Fig.40. Chromatogram of nitro (NO2) substituted epoxide enantiomers at T^o B-PH 
column at 240®C, helium carrier gas at 45Kpa, split injection (split flow 50ml/min), 
detection by FID. 1 pi injection of 5mg/ml solution.
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Discussion
With increasing column temperature decreases and so the 1& /(I + 1& ) term in the 
resolution equation reduces.
&  =
 ^a  -  Ÿ\ ( K ]
\  4a J <1 +
■Jn
Therefore in order for resolution to be observed much larger a  values would be 
required. Above Tiso (A(AG)=0) increasing temperature will cause A(AG) to increase 
again (and therefore so will a) although this is accompanied by decreasing retention of 
the enantiomers.
Only a few examples of reversal of enantiomer elution order above'Tiso have been 
observed, such as with the separation of N-TFA-amino-acid tert-butylamide 
enantiomers on a diamide phase [Watabe et al 1989] and the separation of the 
enantiomers of (E)-2-ethyl-l,6-dioxaspiro[4.4]nonane, using a complexation CSP (a 
nickel (II) complex of bis[3-heptafluorobutanoyl]-(lS)-10-methylenecamphorate) 
[Schurig, Ossig and Link 1989].
Reversals have also been observed with CD CSP’s, for example, isomenthone was 
found to have a Tiso of 63®C on a column coated with di-tert-butyldimethylsilylated CD 
in SE-52. At 50®C the elution order was (+) followed by (-), peak coalescence was 
observed at 60®C, and elution order was reversed to (-) followed by (+) at 120®C 
[Mass et al 1995].
While reversal of enantiomeric elution order was not observed at temperatures above 
Tiso, reversal of the elution order of the epoxide enantiomers can be achieved simply by 
changing column. This could prove a useful tool in enantiomeric purity determination 
as the detection of small peaks in the vicinity of large neighbouring peaks is made 
considerably easier if the small peak is eluted before the large peak. If
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elution is the other way round then the small peak may be lost in the tail o f the large
peak.
4.2 GLC of some chiral drugs
The use of the CD phases for the separation of compounds of pharmacological interest 
was considered, as there is potential for more efficient separations by capillary GC 
compared to the HPLC separations, which are at present the method of choice for 
large drug molecules. The higher efficiency obtainable with capillary GC, combined 
with the superior detectors available make it a potentially very attractive alternative to 
HPLC. It was decided to evaluate the use of the Chiraldex columns for the separation 
of the enantiomers of some p-blocking drugs.
The P-blockers studied were chromatographed as their acetyl derivatives (formed by 
reaction with acetic anhydride) on the B-PH Chiraldex column. Derivatisation was 
confirmed by the single peaks obtained on a BPl column for the various p-blockers 
after derivatisation. Results obtained on both columns (BPl and B-PH) are listed in 
table 12. Figure 41 shows the peak obtained for alprenolol on the BPl column 
following derivatisation. Due to the high elution temperatures required the derivatives 
were not chromatographed on the G-TA column.
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Table 12. GC analysis of some p-blockers as their acetyl derivatives.
p-Blocker Column Temperature
V
t R (mins.) k ' Ncg a
Alprenolol BPl 240 3.30 22.0 6033 “ —
Metoprolol BPl 240 12.40 41.3 21296
Propranolol BPl 240 23.95 43.5 13235 “ —
Alprenolol B-PH 240 6.00 6.0 12172 —
Metoprolol B-PH 240 not detected --- --- —
Propranolol B-PH 240 not detected --- “ — — “
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Detector
Response
Fig.41. Chromatogram of alprenolol (acetyl derivative, approx. 1 mg/ml) on BPl (10m 
X 0.33mm i.d.) column, oven temp. 240^0. Helium carrier gas at 45Kpa., split 
injection of Ipl (split flow 50ml/min), detection by FID.
When chromatographed on the Chiraldex B-PH column only the Alprenolol derivative 
resulted in a peak, shown in fig.42, the others were retained by the column. It was not 
possible to increase the oven temperature any further in order to elute the other 
derivatives. There was no indication of chiral separation of the alprenolol derivative, 
reducing the column temperature merely increased the retention.
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Fig.42. Chromatogram of alprenolol (acetyl derivative, approx. 1 mg/ml) on B-PH 
column, oven temp. 240^0. Helium carrier gas at 45Kpa., split injection of Ipl (split 
flow 50ml/min), detection by FID.
Discussion
Most P-blockers are prescribed as racemic mixtures, and so there is potential for 
racemic switches to be made, ie. the use of the single enantiomers. If the single 
enantiomers are to be used then methods for the determination and measurement of the 
enantiomers for use in pharmacodynamic and pharmacokinetic studies, and for the 
determination of formulation purity.
The separation of the enantiomers of some P-blockers as N-O-heptafluorobutyryl 
derivatives has been reported using an XE-60-L-valine-(R)-a-phenylethylamide CSP.
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However high temperatures were required to elute the derivatives, and in some cases 
there was irreversible adsorption and decomposition on the column [Konig and Ernst 
1983]. The enantiomers of metoprolol were also separated on the same CSP following 
derivatisation with phosgene, resulting in cyclisation of the aminoalcohol side chain. 
The derivative was eluted at a column temperature of 200®C [Gyllenhaal et al 1985].
The chiral separation of propranolol as heptafluorobutyl derivative was attempted by 
G.Kingston [Kingston 1990] on a Chirasil-L-Val column (25m) at 140®C, but the 
derivatives were found to be unstable. The acetyl and trifluoroacetyl derivatives were 
also prepared, but could not be eluted from the column.
Ervik et al, reported the GC of metoprolol following trifluoroacetylation on a methyl- 
phenyl polysiloxane capillary column. The derivative was eluted after 15 minutes at a 
column temperature of 170®C [Ervik, Kylberg-Hanssen and Johansson 1986]. The 
acetyl derivatives of some p-blockers have been chromatographed on cross-linked 
methylsilicone, using temperature programming (lOO^C held for 3mins. to 310®C at 
30‘^ C/min.) [Maurer and Pfleger 1986].
While acyl derivatization is used to increase the volatility of the analyte it can also 
allow the analyte to have greater interaction with the stationary phase. The type of acyl 
derivative can have a considerable effect on the chiral separation on the CD columns, 
and in some cases can make the difference between obtaining a chiral separation or 
not. Differences in enantioselectivity observed by switching from acetyl and 
trifluoroacetyl are assumed to be due to differences in polarity and hydrogen bonding 
ability, as the groups are of similar sizes. Steric factors may be involved with the larger 
chloroacyl derivative groups. The acetyl group was reported to be the optimum 
derivative for most compounds on a B-PH column [Armstrong and Jin 1990].
The temperatures required to elute the derivative from the B-PH column are believed 
too high for the enantiomer discriminating mechanism to function and so no chiral
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separation was observed. Most enantiomer separations reported in the literature were 
performed at lower temperatures (around lOO^C), and chiral resolution is favoured 
with low elution temperatures [Schmarr, Mosandl, Neukom and Grob 1991, Chiraldex 
Handbook].
Even after derivatisation the p-blockers were not sufficiently volatile to allow relatively 
low (less than 150 ^C) temperature elution. As they had been chosen as model 
compounds to investigate the use of the CD columns for the chiral separation of drugs 
it was decided not to pursue this line of investigation any further at present. In order to 
select some more suitable model drug compounds the polarity of the two chiral 
columns/phases were evaluated.
4.3 Evaluation of Chiraldex column polarity
The polarity of the Chiraldex columns was investigated by evaluation of their 
McReynolds constants, with a view to selecting another group of model compounds. 
Comparison of the obtained retention index differences (AT), listed in table 13, with 
those in the literature for achiral phases reveal that the G-TA column has a polarity 
similar to 0V17 and the B-PH similar to OV 210 [McReynolds 1970].
Table 13. Retention Indices (I) for determination of McReynolds constants for the G- 
TA and B-PH columns at 120®C.
IsQ I gta A I gta Ibph A Ibph
Butan-l-ol 590 882 292 966 376
Pentan-2-one 627 676 49 834 207
Nitroethane 622 857 235 975 353
Benzene 653 754 101 874 221
Pyridine 699 960 261 1046 347
IsQ values obtained from literature [Poo e and Poole 1989].
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Figure 43 shows diagrammatically the relative polarities of the chiral phases compared 
to some common achiral GC phases.
Increasing Polarity
Chiral Columns
B-PH-
G-TA- B-TA--------
Chirasil-Val-
B-DA-
-  OV1701, BPIO
-  0V5, BP5
-  OV1,OV101,BP1
Squalane
Fig.43. Relative polarities of some GC stationary phases.
Achiral Columns
BP20, Carbowax 20M
OV225, BP225
Discussion
The established test solutes are used due to their particular interaction with the 
stationary phase. The primary interaction of benzene is dispersion, butanol tests the 
orientation properties of the phase, having both proton donor and acceptor ability. The
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nitroalkane is a marker for dipole orientation, and a weak proton acceptor. Pyridine 
was selected for its strong proton accepting ability, with absence of proton donor 
ability. Finally, Pentan-2-one measures the orientation with proton accepting but no 
donating properties [Poole and Poole 1989].
The Al value for pentan-2-one on the G-TA column is considerably smaller than that 
obtained on the B-PH column. As the major interaction of this solute is hydrogen 
bonding, then with the B-PH column the hydroxyl group of the hydroxypropyl 
substituent is available for such interaction, whereas the G-TA phase does not possess 
such a group.
Armstrong and co-workers [Berthod, Zhou, Le and Armstrong 1995] recently 
published the McReynolds constants for a number of the chiral stationary phases used 
in capillary GC. Their values for the B-PH and G-TA phases, determined at lOO^C 
were similar to those reported here. In addition to the substituent affects on the phase 
polarity (the hydroxypropyl being more polar than the alkylated), it was also found that 
increasing CD size also increased polarity.
4.4 GLC of some chiral benzodiazepines
The polarities of the chiral columns were used to select some model chiral drugs for 
potential chiral separation on the columns. ‘Clarkes Isolation and Identification of 
Drugs’ [Moffat et al 1986] was used identify chiral drugs which had been 
chromatographed on achiral GC columns of similar polarity to the Chiraldex columns. 
It was found that some benzodiazepines, commonly prescribed sedative and hypnotic 
drugs, have been chromatographed on OV-17, a phase similar in polarity to the G-TA 
column.
It was therefore decided to investigate the chromatography of some chiral 
benzodiazepines on the CD phases. Lormetazepam and oxazepam were chosen as
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candidates for chiral analysis as they were available in the laboratory. In order to make 
them more suitable for GC analysis with the CD columns (as the maximum operating 
temperatures of the chiral columns are lower than those of the achiral columns) it was 
necessary to derivatise so as to increase their volatility. Due to limited quantities of 
oxazepam it was decided to concentrate on lormetazepam, and return to oxazepam 
once a suitable separation of lormetazepam was achieved. Two different derivatisations 
were chosen, trifluoroacetylation and silylation. Derivative formation was confirmed on 
a BP-10 column prior to injection onto the chiral columns, example chromatograms are 
shown in figs. 44 and 45. The results obtained are listed in table 14.
Table 14. GC analysis of lormetazepam following derivatisation.
Column Column Temperature °C Derivative tR (mins) a
BPIO 240 COCFs 20.36
B-PH 140 (Imin.) to 200 
at 10°C/min.
COCFs nothing
detected
B-PH 200 COCFs nothing
detected
BPIO 240 BSA ester 15.13
B-PH 140 (Imin.) to 200 
at 10°C/min.
BSA ester 19.70
B-PH 120 to 200 at lOT/min. BSA ester 31.33
.  G H 3
HgC"Si"CHg
O CHq
! I I
H a C -C ^ N - S i -C H g
GHn
BSA - bis-trimethylsilylacetamide
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Lormetazepam (silyl ether derivative)
Detector
Response T 4
Time (mins.)
Fig.44. Chromatogram of lormetazepam following derivatisation (silyl ether 
formation) on BP10(12m X 0.33mm i.d.) column, oven temp. 240^0. Helium carrier 
gas at 45Kpa, split injection of 1 pl(split flow 50ml/min), detection by FID.
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Fig.45. Chromatogram of lormetazepam following trifluoroacetylation on B P l0(12m 
X 0.33mm i.d.) column, oven temp. 240^0. Helium carrier gas at 45Kpa, split 
injection of Ipl (split flow 50ml/min), detection by FID.
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Due to the high temperature required to elute the derivatives from the BP 10 column 
they were initially chromatographed on the B-PH column, as the maximum operating 
temperature of the G-TA column is low (180®C). A single peak was obtained with the 
silyl derivative on the B-PH column, fig.46, whereas no peak was obtained for the TFA 
derivative.
Detector
Response
•o
o.
20
Time (mins)
Fig.46. Chromatogram of lormetazepam following derivatisation (silyl ether 
formation) on B-PH(10m X 0.2mm i.d.) column. Oven temp, program: 140®C (held 
for 1 min.) to 200®C at a rate of lO^C/min.. Helium carrier gas at 75Kpa, split 
injection of Ipl (split flow 50ml/min), detection by FID.
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Discussion
The GC of underivatised benzodiazepines has been reported on achiral phases, such as 
the separation temazepam and 3-hydroxy-prazepam on an SP2250 phase, with 
retention times of approx. 4 and 6 mins. respectively obtained using an oven 
temperature of 280®C [Divoll and Greenblatt 1981]. The GC of benzodiazepines as 
silyl ethers on an SPB-1 phase has also been reported previously [Duthel et al 1992].
Almquist et al reported that the acetyl and trifluoroacetyl derivatives of some chiral 
benzodiazepines (including oxazepam) could not be eluted from a permethylated p-CD 
(dissolved in 0V61) column using oven temperatures up to 215®C. However the 
derivatives were eluted and the enantiomers resolved by SFC using an immobilised 
permethylated P-CD phase [Almquist et al 1994].
Temperature programming was used so as to keep the column temperature low in an 
attempt to promote chiral recognition, followed by elution of the separated peaks at 
high temperature. However no chiral separation was observed, possibly due to the high 
temperatures. As found with the P-blockers, the separation of enantiomers on the CD 
phases is favoured by low temperature. The lormetazepam BSA ester was also 
chromatographed on the G-TA column at 120®C, however no peaks were detected 
(other than the solvent) in over 60mins.
Lowering the oven temperature caused the retention of the silyl derivative to increase 
and reduction in peak height. This may be a reason for the failure to observe a peak for 
the TFA derivative on the B-PH column. The derivative may have been eluted but not 
detected because of small peak size (ie. too small to detect) as a result of a long 
retention time.
To conclude, the high temperatures required for the elution of large drug molecules 
from the CD columns prohibit the discrimination of enantiomers and so chiral 
separations are not observed.
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4.5 Loss of column enantioselectivitv
Following the prolonged use of the B-PH column at such high temperatures separation 
of a chiral test compound revealed that the column had lost some of its 
enantioselectivity. Originally, before chromatographing the lormetazepam derivatives, 
the separation of the enantiomers of the column test compound, pantolactone, at 
lOO^C resulted in Rp of 76%, with a=1.031 (retention times of 4.50 and 4.65 mins.). 
After use at the elevated temperatures the separation under similar conditions was 
reduced to an Rp of 38%, a=1.031 (retention times of 5.60 and 5.80). The cyano 
epoxide was re-chromatographed at 130®C on the B-PH and the resulting 
chromatogram is shown in fig.47.
As can be seen the retention of the compound was greatly reduced along with the 
degree of enantiomer separation. Originally, under the same conditions' a separation of 
Rp=50% with retention times of 51.0 and 52.6 mins. was obtained (see table 3), 
compared to Rp= 26% (retention times of 19.2 and 19.8 mins.) obtained after the 
extensive use (fig.47).
The G-TA column suffered a total loss of enantioselectivity following its use at high 
temperature and was unable separate the enantiomers of the 3 -chloro-2-butanone chiral 
test mixture (fig.48.A). The enantioselectivity was restored by passing trifluoroacetic 
anhydride through the column, the procedure for which is covered in the materials and 
methods chapter. Upon regeneration of the phase the enantiomers of 3-chloro-2- 
butanone were resolved, (fig.48.B.), with Rp=100%.
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Fig.47. Separation of CN epoxide on B-PH column following reduction in column 
enantioselectivity. Helium carrier gas, 45Kpa, oven 130°C, split injection (split flow 
50ml/min.) of Ipl, FID.
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Fig.48. Chromatograms of 3-chloro-2-butanone (Img/ml) on B-PH column, oven 
temp. 60^C. Helium carrier gas at 45Kpa, split injection of Ipl (split flow 50ml/min), 
detection by FID. A) After prolonged use of column at high temperature, B) After 
regeneration of column with trifluoroacetic anhydride.
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Discussion
The loss of enantioselectivity experienced with the G-TA column, a result of hydrolysis 
of the ester linkages attaching the TFA groups to the CD, highlights the importance of 
the groups for chiral recognition. The ease with which the column can be regenerated 
makes the G-TA probably the most useful of the phases evaluated in this study. While 
both columns were found to have similar retention and chiral separation (albeit with 
reversed enantiomeric elution order) with the epoxides, the ability to regenerate the 
phase means it has a longer useful lifetime than the B-PH phase.
The high temperatures required for the elution of the large drug molecule derivatives 
are unfavourable for the chiral recognition mechanisms of the CD columns to 
distinguish between enantiomers and are obviously detrimental to the columns life. 
Even after derivatisation the p-blockers and benzodiazepines remain too polar for 
chiral separation on the CD phases.
In conclusion, while the GC of derivatised (and in some cases underivatised) drug 
molecules is possible on achiral columns, the chiral separations on the derivatised CD 
columns are not possible due to the high polarity of the molecules. This requires high 
temperatures in order for elution, temperatures which are unfavourable for chiral 
discrimination. It would appear that successful chiral separations on the CD columns 
are limited to compounds and derivatives of relatively low polarity.
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4.6 Bioanalvsis with Chiral Stationary Phases
In order to study the use of CSP’s for the measurement of enantiomers in biological 
fluids, rats were dosed with some enantiomeric compounds, within the School of 
Biological Sciences at the University of Surrey. Aliquots of the various urine samples 
were collected and the use of chromatographic separation with CSP’s was considered 
for the determination of the enantiomers of the compounds.
The compounds dosed were p-TFM and Moshers acid the structures of which are 
given in section materials and methods. These compounds were chosen due to their 
similarity in structure to the 2-arylpropionic acids (profens) which undergo 
enantiomeric interconversion in vivo. Separation of the enantiomers of both model 
compounds was investigated by both GC and HPLC with CSP’s.
HPLC was chosen as the initial method for examination. The strategy employed was to 
first obtain a satisfactory separation of pure enantiomers in solvent (or eluent) before 
proceeding to the analysis of the compounds in urine.
4.6.1 HPLC separation of Moshers acid and p-TFM
It was decided to use UV absorbance for detection of the compounds upon elution 
from the column. The UV spectra of both compounds were run between 200 and 
330nm, in order to determine the optimum wavelength for detection. The resulting 
spectra are shown in fig.49.
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Fig.49. UV spectra of Moshers acid and p-trifluoromethyl mandelic acid (both 
50pg/ml in water) between 200 and 330nm.A) Moshers acid, B) p-trifluoromethyl 
mandelic acid.
Three different HPLC columns were evaluated for the separation of the compounds, a 
Chiral-AGP column, and two cyclodextrin based columns, native and acetylated P- 
cyclodextrin.
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4,6.1.1 Chiral-AGP column
The separation of the enantiomers of Moshers acid on a Chiral-AGP column using 
100% phosphate buffer at pH6.0 was reported by J.Gregory in a final year BSc project 
[Gregory 1993]. Two partially resolved peaks were obtained with racemic Moshers 
acid, the chromatogram is reproduced in fig.50, the peaks were assumed to be those of 
the two enantiomers, the single enantiomers however were not chromatographed.
4.0 3.4 mio3.
Fig.50. Chromatogram of racemic Moshers acid on Chiral-AGP column 
(100X4.6mm), taken from J.Gregoiy, Final year project report [Gregory 1993]. 
Mobile phase: O.OIM phosphate buffer pH6.0, flow rate 0.9ml/min, 20pl injection of 
0.02mg/ml solution. Detection by UV at 225nm.
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Using the same column and conditions no separation of the enantiomers was achieved 
in this study, chromatographing the single enantiomers showed them to have identical 
retention times (2.1 mins.), fig.51 shows the chromatograms obtained for the 
enantiomers of Moshers acid and racemic p-TFM.
'T3
00
Time (mins)
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Fig.51. Chromatograms of racemic p-TFM and single enantiomers of Moshers acid on 
Chiral-AGP column (100X4.6mm). Mobile phase: O.OIM phosphate buffer pH6.0, 
flow rate 0.9ml/min, 20pi injection of 0.01 mg/ml solution. Detection by uV at 
260nm. A) R-Moshers acid, B) S-Moshers acid, C) p-TFM.
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The enantioselectivity of the Chiral-AGP column was then tested with racemic 
metoprolol, which resulted in two, baseline resolved peaks of similar size, fig.52, and 
so it was concluded that the column was still functioning enantioselectively.
Detector
Response
metoprolol
§ I
Time (mins)
Fig.52. Separation of metoprolol enantiomers on Chiral-AGP column (100X4.6mm). 
Mobile phase: O.OIM phosphate buffer pHT.O, flow rate 0.9ml/min, 20pl injection of 
0.01 mg/ml solution. Detection by UV at 225nm.
The pH of the phosphate buffer eluent was then varied in the search for chiral 
discrimination of the Moshers acid and p-TFM enantiomers, table 15 lists the results
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obtained. The p-TFM was hardly retained by the column, while Moshers acid was 
retained to a degree, but there were no signs of chiral separation.
Table 15. Effect of mobile phase pH on retention of p-TFM and Moshers acid. 
Column: Chiral AGP, O.OIM Phosphate buffer, flow rate 0.9ml/min.
Buffer pH p-TFM tR (mins.) Moshers Acid tR (mins.)
7.00 0.80 1.30
6.50 0.80 1.70
6.00 1.00 2.10
5.00 1.90 9.70
Discussion
There are three possible explanations for the failure in this study to observe separation 
of the enantiomers of Moshers acid using the conditions described previously [Gregory 
1993]. Firstly, the separation reported by J.Gregory may not have been a chiral 
separation, the two peaks may have been the result of the separation of R,S-Moshers 
acid from some impurity within the sample. Alternatively the column may have lost 
some, but not all, of its chiral discriminating ability, resulting in the loss of the partial 
separation.
The other possibility is that the separation as achieved by J. Gregory was the result of a 
solvent effect due to the sample solvent. Such pseudoseparations or peak splitting, 
caused by differences in sample solvent and eluent have been reported [Wilson 1988]. 
However this is unlikely to be the cause in this case as the samples in both studies were 
prepared in eluent.
Changing the pH of the eluent, affinity for the AGP is increased as the ionisation of the 
analyte decreases resulting in increased hydrophobic interaction between the
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analyte and CSP. With decreasing pH the retention of acidic compounds is increased 
(as ionisation/dissociation of the acid decreases), while the retention of basic 
compounds will be decreased. In addition pH can also have a dramatic effect on the 
enantioselectivity of AGP CSP’s [Williams 1993]. The pH of the eluent was therefore 
reduced in an attempt to obtain some chiral discrimination. The isoelectric point of 
AGP is 2.7, therefore at the pH s used the protein would be negatively charged 
(anionic) and therefore has affinity for binding with cationic molecules [Taylor 1992].
It has been reported that in some cases organic modifiers have resulted in enantiomer 
separation, Tiaprofen for example was found to be unresolved on a Chiral-AGP 
column with a buffered eluent (O.IM Phosphate buffer pH 6.5), on addition of 
propanol to the eluent a separation of the enantiomers was achieved. Charged 
modifiers, such as some tertiary amines (eg. N,N-dimethyloctylamine (DMOA)) were 
also found to have a drastic effect on enantioselectivity, generally resulting in increased 
retention of the most retained enantiomer while not affecting the retention of the least 
retained [Hermansson and Hermansson 1994].
The addition of organic modifiers was not considered for the p-TFM or Moshers acid 
as although they can affect the enantioselectivity they also tend to reduce retention. As 
both compounds were hardly retained any reduction in retention would be 
disadvantageous. No further experiments were considered with the AGP column.
4.6.1.2 Cyclodextrin Columns
An acetylated P-CD column (Cyclobbnd I-Ac, 250x4.6mm) was investigated first, and 
conditions varied so as to optimise separation of the enantiomers of both compounds. 
Although the two CD columns are slightly different the overall trends or effects of 
variations in conditions should be the same for both. It has been reported, with the 
separation of scopolamine enantiomers using an acetonitrile/triethylamine acetate 
buffer mobile phase, that an acetylated-p-CD column yielded similar
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separations to those obtained with two native p-CD columns in series [Stalcup et al 
1991].
The separation of the enantiomers of Moshers acid using a P-CD column has been 
reported, employing a methanol/water eluent (50:50). The resolution obtained was 
however less than 50% (Rs=0.59, k' =7.49 and 9.48). The enantiomer separation of 
other phenylacetic acids and mandelic acid was not achieved under such conditions 
[Hinze et al 1985]. Initial experiments with aqueous/organic eluents (water/methanol 
and water/acetonitrile) were irreproducible, with noisy baselines resulting in peak 
identification being difficult. As a result the use of buffered eluents were considered.
Initial experiments investigated the effect of buffer (triethylamine acetate) pH on the 
separation of the enantiomers. Due to the possibility of prohibitive retention with pure 
buffer an organic modifier was added to aid elution of the compounds. The effect of 
decreasing pH (table 16) was to increase the retention of both compounds, with a very 
slight increase in the chiral separation (Rp). The effect of organic modifier 
concentration was subsequently investigated further.
Table 16. Effect of changing mobile phase pH. Column: Cyclobond I-Ac, mobile phase 
1% triethylamine acetate + 5% acetonitrile.
Buffer
pH
7.1
~6A
T 5
5.0
tR (mins.) 
31.60
32.80
44.00
50.00
p-TFM
a Rp % tR (mins.) 
9.50 
9.90 
10.70 
11.30
14.00 
14.60 
15.40
16.00
VIoshers Acid
g
1.042
1.056
1.043
1.039
Rp % 
58
69
71
72
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The effect of variations in organic modifier type and content were investigated on both 
CD columns and are summarised in tables 17 and 18. On the acetylated column, 
increasing acetonitrile content (table 17) did not affect the separation between the 
peaks (Rp), until its content reached a point at which the drop in retention of the two 
enantiomers caused the peaks to coelute. Increasing methanol content (table 17) with 
the acetylated column caused retention to decrease whereas chiral separation (Rp%) 
increased slightly (however a  remains unaffected). Example chromatograms of the 
separations achieved for each compound on the acetylated CD column are given in 
figures 53 and 54.
Table 17. Effect of organic modifier. Column: Cyclobond I-Ac, Mobile phase 1% 
triethylamine acetate buffer, pH 7.1, flow rate 0.5ml/min
Organic
Modifier
p-TFM
tR (mins.) a Rp %
Moshers Acid
tR (mins.) a Rp %
4%
Methanol
58.40
61.00
1.044 20 15.00
15.80
1.053 56
8%
Methanol
4%
Acetonitrile
8%^  ' 
Acetonitrile
16%
Acetonitrile
51.20
53.60
10.30
1.047 22 13.10
13.80
9.40
9.80
10.40 
10.70
6.60
1.053
1.042
1.029
64
67
67
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Fig.53. Separation of Moshers acid enantiomers on Cyclobond-1-Ac (Acetylated p- 
CD, 250X4.6mm) column. Mobile phase: 4% methanol/ 96% triethylamine acetate 
buffer (1%, pH7.1), flow rate 0.5ml/min, 4^1 injection of 0.01 mg/ml solution. 
Detection by UV at 260nm.
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Fig.54. Séparation of p-TFM enantiomers on Cyclobond-1-Ac (Acetylated P-CD, 
250X4.6mm) column. Mobile phase: 4% methanol/ 96% triethylamine acetate buffer 
(1%, pH7.1), flow rate 0.5ml/min, 4pl injection of O.Olmg/ml solution. Detection by 
UV at 260nm.
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With the native P-CD column, increasing methanol content caused both retention and 
chiral separation to decrease, table 18. The low Rp value initially obtained with 8% 
methanol was a result of degeneration of the cyclobond column. Replacing the column 
with a new one resulted in the expected increase in separation of the enantiomer peaks 
(increased Rp%).
Table 18. Effect of organic modifier. Column: Cyclobond I, mobile phase 1% 
triethylamine acetate buffer pH 7.1, flow rate 0.5ml/min.
Organic
Modifier
p-TFM
tR (mins.) a Rp %
Moshers Acid
tR (mins.) a Rp %
5%
Acetonitrile
13.70
14.80
1.080 71
30%
Methanol
16.80 8.10
8.50
1.049- 54
16%
Methanol
10.70
11.50
1.075 71
8%
Methanol
11.60
12.50
1.077 55
8%  **
Methanol
12.40
13.20
1.065 84
New Cyclobond I co umn.
Changing the eluent buffer to ammonium nitrate was investigated with a view to 
improving the separation and retention of the p-TFM enantiomers. Separation of the 
enantiomers of p-TFM was achieved with O.IM buffer and 5% methanol, the 
separation was similar (Rp=20%) although it took much longer (tR 82.00 and 84.80 
mins.), with retention times 1.5 times those obtained with the TBAA/methanol system.
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Elution order of the Moshers acid enantiomers remained S- followed by R with the 
ammonium nitrate buffer. Decreasing the concentration of the buffer had little effect on 
the chiral separation, table 19, while retention was increased.
Table. 19. Separation of R,S-Moshers acid with Ammonium nitrate buffer eluents.
Buffer Cone, and pH Organic Modifier tR (mins.) a Rp%
O.IM, p H 5.3 5% methanol 16.00
16.60
1.037 57.5
O.IM, pH 5.3 5% ethanol 9.60
0.05M,pH5.19 5% methanol 30.00
31.00
1.033 50.0
0.025M,pH5.18 5% methanol 37.80
38.70
1.024 50.0
Figure 55 shows the chromatogram obtained for Moshers acid with an ammonium 
nitrate/methanol eluent. Replacing the methanol with ethanol, fig.56., showed the 
stronger displacement effect of ethanol, as the retention is reduced sharply, resulting in 
complete loss of chiral recognition.
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Fig.55. Separation of Moshers acid enantiomers on Cyclobond-1-Ac (Acetylated p- 
CD, 250X4.6mm) column. Mobile phase: 5% methanol/ 95% ammonium nitrate 
(O.IM, pH5.3), flow rate 0.5ml/min, 4pl injection of O.Olmg/ml solution. Detection by 
UV at 260nm.
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Fig.56. Separation of Moshers acid enantiomers on Cyclobond-1-Ac (Acetylated p- 
CD, 250X4.6mm) column. Mobile phase: 5% ethanol/ 95% ammonium nitrate (O.IM, 
pH5.3), flow rate 0.5ml/min, 4pl injection of O.Olmg/ml solution. Detection by UV at 
260nm.
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The eluent flow rate was varied in order to ascertain the optimum rate for the 
separation of the enantiomers of Moshers acid with the TEAA buffer, table 20. 
Reducing the flow rate increased the separation of the enantiomers, although retention 
times also increased.
Table 20. Effect of flow rate on separation of Moshers acid enantiomers. 
Column:Cyclobond I-Ac, mobile phase: 5% acetonitrile/95% triethylamine acetate (pH 
7.1), injection volume 4pl.
Flow rate (ml/min.) tR (mins) a Rp %
1.00 4.90 1.041 37
5.10
0.80 5.90 1.034 43
6.10
0.60 7.80 1.038 55
8.10
0.40 11.50 1.035 65
11.90
0.20 22.60 1.031 64
23.30
Reducing the injection volume, thereby reducing the loading of the analyte on the 
column, caused an increase in separation (in terms of Rp%), without affecting the 
retention, as the chromatographic phases are unchanged, table 21.
Table 21. Effect of injection volume on separation of Moshers acid enantiomers. 
Column: Cyclobond I-Ac, mobile phase: 5% acetonitrile/95% triethylamine acetate 
(pH 7.1), flow rate 0.5ml/min.
Injection Volume pi a Rp %
5 1.042 57
4 1.042 58
2 1.053 65
1 1.042 70
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On reducing the injection volume from 4pl to 2pl, the separation of Moshers acid with 
8% methanol/92% triethylamine acetate (pH 7.1) on the Cyclobond I column, as in 
table 18, was improved to almost baseline separation (Rp of 99%).
Discussion
As pH of the eluent decreases so the ionisation (the degree of dissociation of the acid 
groups) of the compounds will decrease. As they became less ionised and therefore 
increasingly non-polar their affinity for the hydrophobic cavity of the CD is increased 
and so retention of the compounds increased.
Increasing the content of organic modifier in the mobile phase should decrease the 
binding of the analyte to the CD and thereby reduce the retention of the analyte. In the 
reversed phase mode, as used here, the organic modifier molecules compete with the 
analyte for the CD cavity. As a result modifiers tend to have little effect on the chiral 
recognition, only really affecting the displacement of the analyte from the cavity 
[Armstrong and Demond 1984, Hinze et al 1985].
Acetonitrile, and the larger alcohols (eg. ethanol and propanol) exhibit a much greater 
displacement ability than methanol. This is reflected in the greater decrease in analyte 
retention with increasing acetonitrile content compared to that observed with 
methanol. While methanol has a weaker displacement effect, compared to acetonitrile, 
it does possess hydrogen bonding capability (both donating and accepting). As a result 
methanol can compete and/or interfere with the hydrogen bonding of the analyte with 
the external groups of the CD. This allows methanol to have a greater effect on the 
chiral recognition than acetonitrile. It has been reported that in some cases a 
combination of both methanol and acetonitrile can be advantageous for optimum chiral 
resolution [Fukushima 1995].
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Flow rate changes should affect both enantiomers to the same degree, therefore a  
should be little affected by the flow rate changes, as was observed. The flow rate will 
however affect the efficiency of the system. Improved efficiency obtained at lower flow 
rate results in better peak shape (i.e. less band broadening because the affects of slow 
mass transfer into the CD cavity are lessened) and so the depth of the valley between 
the peaks (Rp%) is enhanced.
The improved separations achieved with reduced injection volume may be a result of 
the low CD loading (capacity) of the columns. Additionally, if the volume of sample 
introduced is smaller, then the peaks will be smaller. With smaller peaks, ie. smaller 
sample band passing through the detector, then the time taken for the sample to pass 
through the detector will be shorter and so the peaks will return to the baseline 
quicker. The reduction in peak overlap thereby results in an increased valley between 
the peaks and so larger Rp%.
The difference in effect of the organic modifier on the two columns may be explained 
by the derivatization of the CD. The native P-CD has hydroxy groups which the 
methanol can compete for with the analyte. On the other hand the acetylated p-CD 
does not possess the hydroxyl groups, having had them replaced with acetyl groups. In 
this case the methanol mainly affects the displacement of the analyte fl"om the cavity, 
and so as with acetonitrile reduces retention (with increased content) while having little 
effect on the chiral separation. The increase in Rp observed with the increased 
methanol content on the acetylated column may merely be due to increased efficiency 
resulting in better peak shape.
The chromatograms for R,S-Moshers acid with the ammonium nitrate/methanol mobile 
phases, fig.55, revealed an ‘impurity’ peak eluting after the Moshers acid peaks. When 
niethanol w as replaced with ethanol, flg.56, only two peaks were obtained, w^hich at 
first glance resembled a chiral separation. The ethanol caused the two enantiomers to 
co-elute at reduced retention time. The impurity peak was also less retained and almost 
co-eluted with the Moshers acid peaks resulting in a split peak
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similar in appearance to the partial separation of enantiomers. It is possible that a 
similar situation was observed by J.Gregory [Gregory 1993] fig.50, and that the chiral 
separation reported on the Chiral-AGP column was in fact a separation of the 
enantiomers of Moshers acid, as a single peak, from the same impurity as observed 
here.
The purity of the R- and S- Moshers acid obtained from Aldrich, which was similar in 
purity to that used by J.Gregory, was listed as 99+%. Therefore it is unlikely that the 
impurity is present in the stock compounds. The ‘impurity’ peak was not observed on 
injection of pure standard solution (in water). Upon making fi-esh solutions diluted in 
eluent the ‘impurity’ was not observed. However on reanalysis of the same solutions 
after a period of standing (ie. left overnight) the impurity was observed.
It was concluded that the impurity peak was probably caused by reaction of the 
Moshers acid with the alcohol in the eluent. Such reaction would" result in the 
formation of methyl, or in the case of ethanol - ethyl, esters of the acids, a reaction 
scheme is given in fig.57.
F
OH
H—O—CHg
F
0 - C H
H
O
H
Fig.57. Formation of methyl esters of Moshers acid.
The esters would remain chiral, although they may not be separated under the same 
conditions as the pure compound. If this is the case then the esters would be eluted as 
a single peak. It was concluded therefore that in future, fresh solutions should be 
prepared on the day of analysis and analysed as quickly as possible.
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Although the separation of the enantiomers of p-TFM thus far obtained (the best 
separation is shown in fig. 54) was unsatisfactory it was decided to proceed with the 
separation optimised for the Moshers acid* and use it for the determination of the 
Moshers acid enantiomer levels in the rat urine samples. This required the development 
of a sample preparation procedure in order to remove the Moshers acid from the 
complex urine matrix.
(* Cyclobond I column, mobile phase: 8%methanol/92% TEAA (1%, pH=7.1), flow 
rate 0.5 ml/min., injection volume 4|il)
4.6.L3 HPLC analysis of Moshers acid from urine
Urine is a complex, aqueous mixture of components containing many compounds and 
salts of endogenous and dietary origin. Therefore, for the HPLC 'analysis of the 
enantiomers of Moshers acid from rat urine it was necessary to extract the Moshers 
acid from the urine matrix before injection into the HPLC system. Two basic 
approaches to the extraction were considered, liquid-liquid, and solid-phase extraction.
For liquid-liquid extraction, suppressing the ionization of the acid group of Moshers 
acid enables it to be extracted into an organic solvent. Two organic solvents were 
evaluated, ethyl acetate and diethyl ether using a method similar to that reported by 
Midgley [Midgley et al 1990] for the extraction of mandelic acids from pooled human 
urine. The recoveries obtained for each enantiomer from water are listed in table 22.
To evaluate the selectivity of the extraction method, blank pooled urine was subjected 
to the same extraction procedure as the standards (in water). If the chromatogram of 
the resulting extract was clear of interfering peaks, (ie. clear of peaks of a similar 
retention times' to the enantiomers of Moshers acid) then in was deemed ‘ satisfactory \  
Correspondingly the extract was deemed ‘unsatisfactory’ if there were interfering 
peaks. As urine contains a large number of ionizable compounds and salts, and while
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both solvents extracted the Moshers acid, they were unselective and extracted a large 
number of ‘interfering’ compounds which co-eluted and disguised the Moshers acid 
peaks, fig.58. shows the chromatograms of the water and urine extracts using diethyl 
ether, fig.59. shows the chromatograms obtained with ethyl acetate.
Table 22. Recovery of the Moshers acid enantiomers following liquid-liquid extraction 
with different organic solvents.
Extraction Solvent Recovery from water % Urine Blank
S-enantiomer R-enantiomer
Ethyl acetate 60 75 Interfering peaks
Diethyl ether 80 82 Interfering peaks
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Fig.58. Chromatograms of RS-Moshers acid and a urine blank following liquid-liquid 
extraction with diethyl ether. A) RS-Moshers acid (0.1mg/ml)in water. B) Blank urine 
(pooled human). Cyclobond 1 column (p-CD 250X4.6mm), mobile phase: 8% 
methanoF92% TEAA (1%, pH7.1), flow rate 0.5ml/min, 4pl injection volume, UV 
detection at 260nm.
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Fig.59. Chromatograms of RS-Moshers acid and a urine blank following liquid-liquid 
extraction with ethyl acetate. A) RS-Moshers acid (0.1mg/ml)in water. B) Blank urine 
(pooled human). Cyclobond 1 column (p-CD 250X4.6mm), mobile phase: 8% 
methanol/92% TEAA (1%, pH7.1), flow rate 0.5ml/min, 4pl injection volume, UV 
detection at 260nm.
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As liquid-liquid extraction had thus far proved unsatisfactory, SPE using commercially 
available cartridges was considered. The extraction of Moshers acid was considered by 
two distinct modes, ion-exchange via the ionizable acid group, and by non-polar 
interaction between the aromatic ring and a non-polar phase. For ion exchange 
extraction a quaternary amine cartridge was selected. C l8, C8 and C2
cartridges were initially selected for non-polar extraction, the results of which are listed 
in table 23. Recovery was determined in a similar way to that used with the liquid- 
liquid extraction, by comparison of extracted sample peak heights with the peak 
heights obtained with an unextracted sample of the same concentration.
Table 23. Recovery of Moshers acid using Varian alkyl-silica SPE cartridges.
Cartridge Recovery from water % Urine Blank
S-enantiomer R-enantiomer
Varian Bond-Elut C2 75 72 Interfering peaks
Varian Bond-Elut C8 69 69 Interfering peaks
Varian Bond-Elut C l8 85 84 Interfering peaks
Elution solvent: Ethyl acetate. 
Wash solvent: Water.
In the case of the quatamine cartridge only one cartridge was available (the last one 
from a Bakerbond Methods Development kit). As a result spiked urine was extracted 
so as to determine, in the single run, the recovery of the Moshers acid and the 
cleanliness of the urine extract, see fig. 60. The extract obtained contained a large 
number of interfering peaks which resulted in the ‘loss’ of the Moshers acid peaks, i.e. 
the peaks were hidden. Obviously under the conditions used the quatamine was not 
selective enough and, as with the liquid-liquid extractions, also extracted many other 
ionic species from the urine. No further experiments were performed with ion- 
exchange SPE.
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Fig.60. Chromatogram of RS-Moshers acid (0.1 mg/ml) in pooled human urine 
following solid-phase extraction with Bakerbond quatamine cartridge. Cyclobond 1 
column (p-CD 250X4.6mm), mobile phase: 8% methanol/92% TEAA (1%, pH7.1), 
flow rate O.Sml/min, 4pl injection volume, UV detection at 260nm.
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The urine extract from the C8 cartridge was considerably cleaner than those of the C2 
and Cl 8, and so it was decided to continue with the C8 phase. Fig.61 gives an example 
of the extraction using C8 cartridges. Different wash solvents were evaluated with two 
different brands of C8 cartridge in order to achieve better recovery and a cleaner 
extract, table 24.
Table 24. Extraction of Moshers acid using C8 phases with various wash solvents.
Wash Solvent Cartridge
Make
Recovery from water % Urine Blank
S-enantiomer R-enantiomer
Water Bakerbond 42 42 Interferences
Varian Bond elut 25 27 Interferences
1:1 Bakerbond 0 0 No
peaks
interfering
Water/Acetone Varian Bond EWe 0 0 No
peaks
interfering
2:1 Bakerbond 17 19 No
peaks
interfering
Water/Acetone Varian BondEIute 11 12 No
peaks
interfering
4:1 Bakerbond 59 59 No
peaks
interfering
Water/Acetone Varian BondElute 39 43 No
peaks
interfering
Elution solvent: !ithyl acetate.
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Fig.61. Chromatograms obtained following SPE with Varian C8 cartridges. A) RS- 
Moshers acid (0.1 mg/ml) in water. B) Blank pooled human urine. Cyclobond 1 
column (p-CD 250X4.6mm), mobile phase: 8% methanol/92% TEAA (1%, pH7.1), 
flow rate 0.5ml/min, 2pl injection volume, UV detection at 260nm.
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The recovery of the Varian Bond-Elut cartridges with the water wash was not the 
same as originally obtained, due to an increase in the volume of wash solvent used in 
the later experiments (from 2ml to 5ml). The cartridges used in the original 
experiments were ‘old stock’, so it was not possible to tell if the cartridges used were 
from the same batch.
As recovery was better with the Bakerbond cartridges (table 24), they were selected 
for further optimisation. To improve recovery it was decided to try an acidic wash, as 
the lack of retention by the cartridges may be due to ionization of the Moshers acid 
during the aqueous wash step affecting the retention interactions. Washing with 2M 
hydrochloric acid gave recovery of 70% for both enantiomers and so validation of the 
method with this wash was considered.
The reproducibility of the WISP autosampler to inject 2pl samples was evaluated, and 
found to be poor, with CV’s of 4-6% over six injections of the same solution (from 6 
different vials). However this was overcome with the use of the solvent (methanol) 
peak as an ‘injection standard’, the sample peak height was divided by the height of the 
solvent peak which was assumed to be affected to a similar degree to the Moshers acid 
peaks, therefore the resulting ratio counters the variation in amount injected.
Table 25. Reproducibility of WISP for 2 [i\ injections of R,S-Moshers acid.
Vial No.
Low Concentration Sample High Concentraition Sample
Peak Height 
(mm)
Height ratio Peak Height 
(mm)
Height ratio
R - S - R - S - R - S - R - S -
1 25.5 20.0 0.80 0.62 160.0 165.0 4.57 4.71
2 23.0 19.0 0.74 0.61 142.0 145.0 4.58 4.68
3 26.0 21.5 0.75 0.62 142.5 145.0 4.59 4.68
4 27.0 20.5 0.83 0.63 152.5 156.5 4.55 4.67
5 27.0 21.0 0.79 0.62 151.0 154.0 4.58 4.67
6 26.0 21.0 0.79 0.64 135.0 138.0 4.65 4.76
Mean 25.75 20.5 0.78 0.62 147.2 150.6 4.59 4.69
s.d. 1.48 0.89 0.03 O.OI 8.99 9.75 0.04 0.04
CV.% 5.7 4.4 4.1 1.3 6.1 6.5 0.8 0.8
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As the results in table 25 demonstrate the use of the ratio counters the effects of 
fluctuations in the actual amount injected, resulting in the CV for six injections being 
less than 2%, which was considered acceptable. Therefore the ‘peak ratio’ was used in 
place of peak height.
A standard solution of R,S-Moshers acid in pooled human urine (approx. 1 mg/ml of 
each enantiomer) was prepared using the individualaiantiomers . Dilution of this stock 
solution with pooled human urine was performed to give solutions of the following 
concentrations; S-enantiomer:- 0.021, 0.053, 0.106, 0.212, 0.530, and 1.060 mg/ml, R- 
enantiomer:- 0.021, 0.052, 0.103, 0.206, 0.516, and 1.032 mg/ml. These solutions 
were then extracted and used to obtain a calibration curve. A linear regression (y=mx + 
c) was performed with the data, and found to be linear over the range used. The 
concentration range for the method was decided by considering the maximum 
concentration of Moshers acid that would be contained in the rat urine samples if all of 
the dose was excreted in the 0-24hour urine sample. The lower limit was considered as 
the lowest concentration that resulted in a peak height which could be reliably 
measured. Example chromatograms are shown in fig.62.
In order to determine the accuracy and precision of the method, three spiked solutions 
were prepared in urine, at high, intermediate and low concentration. Aliquots of these 
solutions were then frozen and the concentrations of the solutions determined on 
consecutive days, table 26, and used to determine the day to day reproducibility, table 
27. A new calibration curve was created each day (correlation coefficient was 0.990 or 
greater). The within day precision of the method was determined by extracting and 
determining the concentration of six aliquots of the same spiked solution in the same 
batch (same day), see table 28.
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Table.26. Validation of HPLC method for Moshers acid in urine using SPE with C8
cartridges - Found concentrations of spiked solutions.
R-Moshers Acid S-Moshers Acid
Day Concentration (mg/ml) spiked
0.041 0.413 0.929 0.042 0.424 0.954
Concentration (mg/ml) found
1 -0.024 0.473 0.875 -0.023 0.483 0.900
2 0.014 0.467 0.905
0.738
0.598
0.866
0.748
0.671
0.023 0.486 0.909
0.870
0.659
0.738
0.590
0.734
3 0.018 0.394 0.858 0.051 0.404 0.961
4 -0.014 0.366
0.401
0.683
0.586
0.737
0.371
0.808 -0.008 0.367
0.388
0.699
0.583
0.725
0.371
0.789
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Fig.62. Chromatograms of Moshers acid following SPE using Bakerbond C8 
cartridges. A) Blank urine sample, B) Moshers acid ( 0.021 mg/ml S-enantiomer, 
0.021 mg/ml R-enantiomer) in urine, C) Moshers acid ( 1.060mg/ml S-enantiomer, 
1.032mg/ml R-enantiomer) in urine. Cyclobond 1 column (p-CD 250X4.6mm), 
mobile phase: 8% methanol/92% TEAA (1%, pH7.1), flow rate 0.5ml/min, 2pl 
injection volume, UV detection at 260nm.
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Table 27. Day to Day Reproducibility of HPLC method for Moshers acid in urine using
SPE with C8 cartridges.
Moshers
Acid
Enantiomer
Spiked
Cone.
mg/ml
Determined 
Concentration 
mg/ml 
(mean ± s.d.)
c.v.
%
Accuracy
%
R 0.041 f-0.002 ± 0.02) (1378) (-4.9)
0.413 0.425 ± 0.05 12.5 102.9
0.929 0.862 ± 0.04 4.7 92.8
S 0.042 0.011 ±0.03 (307) (26.2)
0.424 0.435 ± 0.06 13.6 102.6
0.954 0.890 + 0.07 8.1 93.3
Spiked samp es analysed on 4 different days.
Table 28. Within day reproducibility of HPLC method for Moshers acid in urine using 
SPE with C8 cartridges.
Moshers
Acid
Enantiomer
Spiked
Concentration
mg/ml
Determined 
Concentration 
mg/ml 
(mean ± s.d.)
C.V.
%
Accuracy
%
R 0.413 0.524 ±0.17 31.7 126.9
0.929 0.754 ±0.12 15.4 81.2
S 0.424 0.522 ±0.17 32.2 123.1
0.954 0.750 ±0.12 16.3 78.6
6 aliquots of same spiked samp e analysed on the same day.
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Due to poor reproducibility of the method, extremely poor day to day precision and 
accuracy for the low concentration spiked solution (0.042 and 0.041mg/ml, S and R - 
Moshers acid respectively) and large variation in C.V. for solutions determined on the 
same day was obtained (table 28). As a result the method was considered unsuitable 
and validation of the method was not continued. The sample extraction stage of the 
method was reconsidered.
Examination of the batch to batch recovery of the C8 cartridges was undertaken. The 
results, shown in table 29, showed that there is considerable within batch variation in 
recovery.
Table 29. Recovery of Moshers acid at two different concentrations using Bakerbond 
C8 SPE Cartridges.
Batch 1 Batch 2 Batch 3
Low High Low High Low High
l-Moshers Acid
Peak 1.10 3.36 1.30 5.34 1.36 2.31
Height 1.15 2.52 0.83 3.51 0.91 1.98
ratio 0.73 1.82 0.89 2.19 0.85 1.64
Mean 0.99 2.57 1.01 3.68 1.04 1.98
s.d. 0.23 0.77 0.26 1.58 0.28 0.35
CV.% 23.1 30.0 25.4 42.9 26.8 16.9
S-Moshers Acid
Peak 1.08 3.36 1.26 5.32 1.34 2.20
Height 1.12 2.35 0.77 3.27 0.88 1.83
ratio 0.69 1.69 0.84 2.03 0.79 1.53
Mean 0.96 2.47 0.96 3.54 1.00 1.85
s.d. 0.24 0.84 0.27 1.66 0.29 0.33
CV. % 24.7 34.1 27.7 46.9 29.4 18.1
One batch involved the extraction of 3 aliquots of each solution.
Low and High refer to spiked Moshers acid solutions of low and high concentration 
respectively.
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As the recovery of the Moshers acid from the C8 cartridges was low, resulting in a 
lack of reproducibility of the method then improving the recovery of the sample should 
improve the method. Therefore the extraction of some of the other SPE cartridges was 
reconsidered with the 2M hydrochloric acid wash, the results are listed in table 30.
Table 30. Recovery of Moshers acid from various SPE cartridges with 2M 
hydrochloric acid wash.
Cartridge Make/type Recovery from water % Urine Blank
S-enantiomer R-enantiomer
Bakerbond C8 70 72 No interfering peaks
Varian C l8 55 56 No interfering peaks
Bakerbond Cyano 90 92 No interfering peaks
Elution solvent: Ethyl acetate.
Very good recovery was obtained with Bakerbond Cyano (CN) cartridges and so their 
batch to batch reproducibility was investigated briefly. While they also exhibited large 
CV’s, table 31, they were better than the C8 cartridges. Therefore CN cartridges were 
selected for the final method.
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Table 31. Reproducibility o f recovery o f Moshers acid from CN cartridges
R-Moshers Acid S-Moshers Acid
Low High Low High
Peak Heights (mm) 27.5 121.0 30.5 138.0
23.5 91.0 26.0 102.0
28.0 87.0 31.5 97.0
Peak Height Ratio 0.982 3.457 1.089 3.943
0.734 2.844 0.813 3.188
0.933 3.107 1.050 3.464
Mean of Ratio 0.883 3.136 0.984 3.532
s.d 0.131 0.308 0.149 0.382
C.V. % 14.9 9.8 15.2 10.8
Low and High refer to spiked Moshers acid solutions of low and high concentration 
respectively. 3 aliquots of each solution were analysed in the same batch.
The HPLC method for the determination of the enantiomers of Moshers acid in urine 
using SPE with Bakerbond CN cartridges was validated as described in the materials 
and methods section. All of the CN cartridges used were from the same batch (Lot.No. 
J03554). An example calibration plot is shown in fig.63 and the data obtained from 
it (slope etc.) are listed in table 32. The determined enantiomer concentrations of the 
spiked validation solutions, are listed in table 33.
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Fig.63.Calibration plot for S- Moshers acid for HPLC determination of enantiomer 
levels in urine.
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Table 32. Data obtained from calibration curves for determination of Method 
Detection Limit (MDL)
r Intercept Slope LOD (y value) MDL mg/ml
S-enantiomer
0.995 -0.073 3.925 0.275 0.089
0.997 0.129 5.643 0.026
0.998 -0.064 6.586 0.051
0.998 0.089 3.870 0.048
0.999 -0.047 3.347 0.096
0.992 -0.099 6.635 0.056
R-enantiomer
0.997 -0.017 3.596 0.322 0.094
0.999 0.187 5.072 0.027
0.999 -0.045 6.402 0.057
0.998 0.099 3.662 0.061
0.998 -0.024 3.164 0.109
0.994 -0.073 5.994 0.066
r = Correlation coefficient.
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Table 33. Validation of HPLC method for Moshers acid enantiomers in urine using 
SPE with Bakerbond CN cartridges - determined enantiomer levels in spiked solutions.
Concentrations (mg/ml) found for spiked solutions
R - Moshers Acid S- Moshers Acid
Day 1 0.058 0.120 0.969 0.069 0.114 0.990
Day 2 0.041 0.267 0.880 0.055 0.268 0.896
Day 3 0.043 0.276 0.869
0.909
0.927
0.818
0.599
0.045 0.261 0.923
0.960
0.983
0.839
0.609
Day 4 0.033
0.043
0.039
0.045
0.029
0.008
0.318 1.001 0.034
0.046
0.043
0.045
0.024
0.010
0.323 1.053
Day 5 0.049 0.646
0.487
0.313
0.495
0.474
0.312
1.459 0.041 0.640
0.479
0.283
0.495
0.459
0.311
1.479
Day 6 0.070 0.404 0.910 0.067 0.392 0.999
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Specificity of the method was confirmed during the development of the method with 
the pure enantiomers, with the elution order of the enantiomers being S- followed by 
R. The method was linear over the calibration range (0.025 to 1.011 mg/ml for the R- 
enantiomer and 0.026 to 1.040mg/ml for the S-enantiomer). The limit of quantitation 
for the method, the MDL was determined from the intercepts of the calibration curves 
(table 32) was 0.096mg/ml and 0.109mg/ml for the S- and R-enantiomers respectively. 
The MDL was high, and above the concentration of the lower calibration (spiked) 
standard.
The actual limit of detection was lower than the MDL, and the lowest calibration 
standard, 0.025 and 0.026 mg/ml for the R- and S-enantiomers respectively, could be 
considered the limit of detection as these concentrations resulted in visible peaks. 
However, due to the variation in slope (30%) of the calibration curves (table 34), and 
the fact that they do not pass through the origin the heights of such peaks would result 
in them being assigned negative concentrations and so they are not reliably quantitated 
at that lower limit. This is due to a deviation from linearity at the lower end of the 
calibration range.
Table 34. Day to Day Reproducibility of HPLC method for the determination of 
Moshers acid enantiomer levels.
Moshers
Acid
enantiomer
Spiked
Cone.
mg/ml
Determined 
Concentration 
mg/ml 
(mean ± s.d.)
n CV.
%
Accuracy
%
CV. of 
slope of 
calibration 
curve
R - 0.040 0.049 ±0.013 6 27.0 122.5 29.4
0.404 0.33610.176 6 52.3 83.2
0.910 1.022 ±0.220 6 21.5 112.3
S - 0.042 0.05210.014 6 27.5 123.8 29.3
0.416 0.333 10.176 6 52.7 80.0
0.936 1.05710.214 6 20.3 112.9
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Table 35. Within Day Reproducibility of HPLC method for the determination of 
Moshers acid enantiomer levels.
Moshers
Acid
enantiomer
Spiked
Cone.
mg/ml
Determined 
Concentration 
mg/ml 
(mean ± s.d.)
n CV.
%
Accuracy
%
R - 0.040 0.033 10.014 6 41.3 82.5
0.404 0.45510.127 6 27.8 112.6
0.910 0.82410.133 5 16.1 90.5
S - 0.042 0.03410.014 6 42.4 80.9
0.416 0.44510.131 6 29.5 106.9
0.936 0.863 10.152 5 17.6 92.2
As can be seen from the data in the tables above, both day to day (table 34) and within 
day (table 35) precision and accuracy were poor. Resolution of the enantiomers was 
adequate for the determination of their peak heights. The degree of chiral separation 
(Rp) varied within day between 40 and 70%, table 36. Sample preparation/extraction 
was optimised so as the peaks were clear of interfering peaks.
Table 36. Day to day retention and separation of Moshers acid by HPLC on Cyclobond 
1 column.
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6
Peak retention times 11.1 11.2 11.4 11.2 11.6 12.4
(mins.) 11.5 11.6 11.9 11.6 12.2 13.2
k 1.46 1.49 1.50 1.37 1.55 1.68
1.51 1.55 1.57 1.41 1.63 1.78
a 1.034 1.040 1.047 1.029 1.052 1.059
Rp (%) Lowest 75 63 57 60 70 83
Highest
53 54 42 60 62 64
Lowest refers to Rp (%) obtained with low concentration calibration standard. Highest refers to 
Rp (%) obtained with high concentration calibration standard.
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The actual rat urine samples and a rat urine blank (pooled blank rat urine) were 
analysed along with the validation samples on the final day, example chromatograms of 
extracted standard solutions and rat sample are given in figures 64 and 65. The 
enantiomer levels determined are listed with those determined by GC, later in this 
chapter (table 47).
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Fig.64. Chromatograms of Moshers acid following SPE using Bakerbond CN 
cartridges. A) Blank urine sample, B) Moshers acid ( 0.026mg/ml S-enantiomer, 
0.025mg/ml R-enantiomer) in urine, C) Moshers acid ( 1.040mg/ml S-enantiomer, 
1.011 mg/ml R-enantiomer) in urine. Cyclobond 1 column (P-CD 250X4.6mm), 
mobile phase: 8% methanol/92% TEAA (1%, pH7.1), flow rate 0.5ml/min, 2pl 
injection volume, UV detection at 260nm.
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Fig.65. Extracted rat sample (0-24Hrs., rat No. 6) for determination of Moshers acid 
enantiomer level, conditions as in fig.64.
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Discussion
Although the reproducibility of the HPLC method was poor, the method was used to 
analyse the rat samples. The chiral separation was good, and the degree of peak 
separation for the two enantiomers was adequate for the measurement of the peak 
heights (table 36). The peak separation (Rp) was lower with samples of high Moshers 
acid concentration due to overloading of the column.
The low recovery during the sample extraction stage is the most likely cause of the 
inaccuracy of the method. Variation in recovery obtained between batches resulted in 
the peaks for similar samples (the same concentration in urine) differing in size and 
causing variation in the slope of the calibration curves. The low and variable recoveries 
during the extraction also result in the calibration not passing through the origin.
The poor recovery may be due to elution of the sample during some stage of the 
extraction other than the final elution. The most likely stage being during the wash. 
The wash step was investigated by extracting a sample prepared in water and collecting 
the breakthrough and wash fractions. These were then blown down with nitrogen and 
the samples redissolved in methanol, so as to concentrate the samples, as the large 
volumes of wash solvent would make detection of the sample at such dilution 
impossible. Upon analysis no sample was detected in the breakthrough or wash.
Another possibility is that the sample was not fully recovered from the cartridge during 
elution with ethyl acetate. The analysis of a second elution fraction revealed a very 
small quantity of sample in this elution, but this did not account for the rest of the 
sample that had not been recovered.
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Reduction of sample concentration during analysis as a result of ester formation 
between the Moshers acid and the methanol solvent may also be responsible for some 
of the variation in peak heights for ‘similar’ solutions. If the ester formation is 
significant then this would affect the samples towards the end of the run, ie. those that 
‘waited’ longer in the autosampler, than those at the beginning. This was not 
appreciated at the time and so was not investigated further.
4,6.2 GLC of p-TFM and Moshers acid
Initial GC of the two compounds in their underivatised state did not yield peaks. Two 
small peaks were obtained with Moshers acid (pseudoracemate) on the G-TA column, 
but these peaks were of irreproducible size, and did not increase in size in relation to 
increasing Moshers acid concentration size. It was therefore concluded that they were 
not Moshers acid, but the methyl ester of the acid due to reaction with the methanol 
solvent, as observed with the ‘impurity’ found with the HPLC separation of the 
enantiomers.
The methyl ester derivatives of Moshers acid (single enantiomers and pseudoracemate) 
were prepared by reaction with methanolic hydrochloric acid and the enantiomers were 
resolved on the G-TA column with similar retention to the small peaks referred to 
above. The elution order of the enantiomers as their methyl esters was S (3.8 mins.) 
followed by R (4.1 mins.), see fig.66. The methyl ester derivative of p-TFM was not 
resolved on the G-TA column, lowering column temperature merely lengthened the 
retention time of the single peak.
However on the B-PH column the p-TFM methyl ester was resolved into two peaks, 
while the Moshers acid methyl ester gave a single peak. The two peaks obtained with 
the derivatised p-TFM were assumed to be due to the enantiomers, as the single 
enantiomers were not available it was not possible to confirm this and determine the 
elution order. For convenience, the first eluting enantiomer will be referred to as
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enantiomer -A, and the second eluting enantiomer -B. As both compounds contain 
fluorine atoms it was decided to use electron capture detection.
The optimum reaction time for the formation of the methyl esters was determined by 
derivatising aliquots of the same stock solution with different reaction times. After 
reaction the solutions were blown down to dryness with nitrogen and redissolved in 
solvent before running them on the G-TA column. Three solvents were evaluated, 
methanol, dichloromethane and hexane, the latter provided the cleanest chromatogram, 
although all resulted in large solvent fronts. Figure 66 shows the chromatograms 
obtained with the three different solvents. The peaks of the resulting esters were 
measured, and the reaction time responsible for the largest peaks was taken as the 
optimum reaction time for future deiivatisation. The results are listed in table 37, the 
optimum reaction time for Moshers acid was found to be 2 hours.
Table 37. Derivatization reaction times for the formation of Moshers acid methyl 
esters.
Reaction Time (mins.) 30 60 120 180
Peak Area - S lost in tail 2874 91283 lost in tail
Peak Area - R lost in tail 4802 273226 lost in tail
‘Lost in tail’ refers to peaks being hidden in the tailing solvent front.
It was possible to overcome the problem of the large solvent front by extracting the 
esters into the hexane solvent. Rather than blowing down the solutions and 
redissolving, hexane was instead added to the mixture after derivatisation, and the 
solution centrifuged. The ester derivatives were thus extracted into the hexane which 
could then be injected into the GC. The difference in peak areas reported for the S- and 
R- Moshers acid highlights the inaccuracy of integrator peak area determination, as to 
the eye the peaks were of similar size. Therefore peak height was used for future peak 
quantitation.
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Fig.66. GC separation of Moshers acid methyl esters for evaluation of three solvents. 
R,S-Moshers acid (1 mg/ml) derivatised with methanolic hydrochloric acid, solution 
evaporated to dryness and redissolved in; A) Methanol, B) Dichloromethane, C) 
Hexane. Conditions: Chiraldex G-TA column, helium carrier gas, 45Kpa, oven lOO^C, 
split injection (split flow 50ml/min.) of 1 pi, BCD (N2 make-up 30ml/min).
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A similar procedure was used for p-TFM although chromatography was performed on 
the B-PH column and the results are listed in table 38. The optimum reaction time for 
the formation of the p-TFM methyl ester was found to be 60 mins..
Table 38. Derivatization reaction times for the formation of p-TFM methyl esters.
Reaction Time (mins.) 15 30 60 120 180
Peak Height - A 53 68 297 238 230
Peak Height - B 22 50 278 263 55
Extracting the methyl esters into the hexane layer, rather than evaporation and 
reconstitution, had a further advantage in that it also allowed direct derivatisation of 
the compounds in urine with no need for any other sample pre-treatment or clean-up. 
Validation of the method for p-TFM was performed as described in the materials and 
methods section. New calibration curves were prepared on each day of analysis, an 
example calibration plot is shown in fig. 67, and data from the curves is listed in table 
39. The calibration curves were used to determine the enantiomer levels of three 
spiked solutions, table 40, for the evaluation of day to day (table 42) and within day 
(table 43) precision and accuracy.
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Fig.67. Calibration curve (y = mx + c) for p-TFM enantiomer A.
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Table 39. Data obtained from the calibration curves for the p-TFM GC method.
r Intercept Slope LOD (y value) MDL mg/ml
First eluting p-TFM enantiomer - A
0.998 50.86 768.88 127.05 0.099
0.999 -47.44 580.67 0.300
0.999 -76.69 754.38 0.270
0.997 -94.89 659.68 0.336
0.999 -82.19 744.70 0.281
Second eluting p-TFM enantiomer - B
0.998 28.09 1041.54 131.84 0.100
0.999 -59.54 731.70 0.262
0.999 -145.38 963.47 0.288
0.997 -135.51 827.50 ' 0.323
0.999 -129.35 938.77 0.278
The MDL for each enantiomer was calculated in a similar way to the Mosher acid 
HPLC method, and was 0.336 and 0.323 mg/ml for the first and second eluting 
enantiomers respectively. Again the actual amount detectable is lower, though reliable 
quantitation at this level (0.199mg/ml for both enantiomers) is not possible. The 
calibration curves were linear between the upper and lower calibration concentrations.
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Table 40. Validation of GLC method for p-TFM enantiomers in urine using Chiraldex
B-PH column - Determined enantiomer levels for spiked solutions.
Spiked
Concentration
(mg/ml)
Concentration (mg/ml) found
Day 1 Day 2 Day 3 Day 4 Day 5
A B B B B B
0.795 0.675 0.691 0.796 0.784 0.802 0.810 0.759
0.744
0.795
0.846
0.838
0.729
0.764
0.746
0.785
0.822
0.845
0.726
0.832 0.833
1.987 1.913 1.923 2.005 2.010 1.853 1.821 2.168 2.164
1.905 1.908
2.536 2.539
2.019 2.028
1.977 1.992
1.966 1.975
3.179 3.2043.179 3.241 3.250 3.483
4.490
3.378
3.275
8.401
*
3.278
3.513
4.509
3.398
3.281
8.379
♦
3.281
2.941 2.962 2.894 2.899
A=first eluting p-TFM enantiomer, B=second eluting enantiomer. 
* indicates cap leaked during derivatisation and so result ignored.
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The specificity of the method was confirmed with pure compound, although the single 
enantiomers were unavailable to confirm that the peaks obtained were due to the 
individual enantiomers. Specificity of the method was further enhanced by the use of an 
ECD for detection. Potential interferences would therefore not be detected, unless they 
contained suitable functional groups. The chromatograms obtained with samples 
extracted from urine showed another peak eluting just before those of the p-TFM 
enantiomers. The peak separation (Rp) varied within run between 30 to 40%, table 41. 
Although the p-TFM enantiomers were not fully resolved from this peak, the partial 
resolution was sufficient for the measurement of peak heights and was therefore 
considered adequate.
Table 41. Day to day retention and separation of p-TFM enantiomers by GLC with B- 
PH column.
Day 1 Day 2 Day 3 Day 4 Day 5
Peak retention times 32.7 32.7 32.7 32.7 32.8
(mins.) 34.5 34.5 34.5 34.5 34.5
k 99.0 163.5 163.4 163.4 163.9
104.6 172.7 172.5 172.3 172.6
a 1.057 1.056 1.056 1.054 1.053
Rp (%) Lowest 28 30 44 35 38
Highest
30 35 37 40 40
Lowest refers to Rp (%) obtained with ow concentration calibration stanc ard, Highe;
Rp (%) obtained with high concentration calibration standard.
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Table 42. Day to day reproducibility of GC method for p-TFM enantiomers in urine.
p-TFM
enantiomer
Spiked
Cone.
mg/ml
Determined 
Concentration 
mg/ml 
(mean ± s.d.)
n
CV.
%
Accuracy
%
CV.of slope 
of calibration 
curve
First eluting 
A
0.795 0.773 ± 0.06 5 7.8 97.2 11.4
1.987 1.985 + 0.14 4 6.9 99.9
3.179 3.148 ± 0.24 5 7.6 99.0
Second 
eluting B
0.795 0.776 ± 0.05 5 7.0 97.6 13.5
1.987 1.980 ± 0.15 4 7.3 99.6
3.179 3.166+ 0.25 5 7.8 99.6
Table 43. Within day reproducibility of GC method for p-TFM enantiomers in urine.
p-TFM
enantiomer
Spiked
Cone.
mg/ml
Determined 
Concentration 
mg/ml 
(mean + s.d.)
n CV.%
Accuracy
%
First
eluting A
0.795 0.785 ± 0.05 6 6.3 98.7
1.987 2.007 ± 0.10 5 4.9 101.0
3.179 3.354+ 0.10 4 2.9 105.5
Second 
eluting B
0.795 0.781 + 0.05 6 5.8 98.2
1.987 2.013 + 0.09 5 4.7 101.3
3.179 3.368 ± 0.11 4 3.3 105.9
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The reproducibility of the method was good, with the CV’s for the calibration curve 
slopes being less than 15% (table 42). Accuracy and precision for all of the spiked 
solutions was good, with CV’s less than 10% both within and between day, tables 42 
and 43.
It had previously been established that the enantioselectivity of the B-PH column had 
been reduced from that of a new column by the reduction in enantiomer separation of 
the test compound pantolactone and the CN epoxide. It is therefore anticipated that 
replacing the column would result in a better separation of the p-TFM enantiomers. As 
a result of the degradation of the B-PH column the calibration/validation was not 
performed on a sixth day.
The rat urine samples were analysed with the validation samples on two of the days, 
the results obtained are listed in table 44 (only the 0-24 Hr samples were analysed the 
second time). Example chromatograms of the calibration samples and rat samples are 
given in figures 68 to 71.
Table 44. p-TFM enantiomer levels in rat urine samples.
Sample Enantiomer Cone, mg/ml
1 St eluting A 2nd eluting B
Enantiomer Cone, mg/ml
1st eluting A 2nd eluting B
0-24 6.160 0 12.762* 0
24-48
0-24 2.998 3.336
24-48
0-24 1.832 1.707
24-48
Std 1 week 3.834 3.853 3.822 3.825
Std 1 month 0.511 0.525 0.478 0.493
*cap leaked.
(N.B. Std 1 week refers to an old standard solution of p-TFM in urine which was left at room 
temperature for 1 week before initial analysis. The 1 month old sample was an old standard solution 
that had been stored for 1 month in the fridge.)
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Fig.68. Chromatogram o f p-TFM (0.397mg/ml) following derivatisation with
methanolic hydrochloric acid. B-PH column, helium carrier gas, 45Kpa, oven 80°C,
split injection (split flow 50ml/min.) o f 1 pi, ECD (N2 make-up 30ml/min).
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Fig.69. Chromatogram o f p-TFM (7.947mg/ml) following derivatisation with
methanolic hydrochloric acid. B-PH column, helium carrier gas, 45Kpa, oven 80^0,
split injection (split flow 50ml/min.) o f 1 pi, ECD (N2 make-up 30ml/min).
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Fig.70. Blank rat urine sample following derivatisation with methanolic hydrochloric
acid. B-PH column, helium carrier gas, 45Kpa, oven 80®C, split injection (split flow
50ml/min.) of 1 pi, BCD (N2 make-up 30ml/min).
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Fig.71. Chromatogram of rat urine sample (0-24Hrs., rat No. 1) following 
derivatisation with methanolic hydrochloric acid. B-PH column, helium carrier gas, 
45Kpa, oven 80°C, split injection (split flow 50ml/min.) of 1 pi, ECD (N2 make-up 
30ml/min).
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The validation of the GC method for the determination of the enantiomers of Moshers 
acid followed the same procedure as performed previously. Calibration curves were 
linear over the range evaluated and an example plot is shown in fig.72. Data obtained 
from the curves is listed in table 45. The MDL for the enantiomers was calculated to be 
0.142mg/ml and 0.121mg/ml for S- and R- respectively. The concentrations of the 
spiked solutions determined on subsequent days are reported in table 46. The chiral 
separation (Rp) of all samples was always better than 50%, table 47, and varied 
between 55 to 90% (Rp) within analyses.
Table 45. Data obtained from calibration plots for Moshers acid GC method.
Intercept Slope LOD (y value) MDL mg/ml
S-enantiomer 46.85 830.8 165 0.142
51.77 1043.5 ' 0.108
70.46 1232.5 0.076
83.01 1302.7 0.063
104.21 1328.4 0.046
118.66 1513.9 0.030
R-enantiomer 36.59 938.8 150 0.121
42.54 1189.3 0.091
60.26 1403.3 0.064
74.75 1487.3 0.051
94.02 1509.2 0.037
103.76 1731.1 0.027
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Fig.72. Calibration curve (y = mx + c) for R-Moshers acid using GC method.
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Table 46. Validation of GC method for Moshers acid in urine using Chiraldex G-TA
column - Determined enantiomer levels for spiked solutions.
Concentrations mg/ml
R - Moshers Acid S - Moshers Acid
Day 1 0.064 0.586 1.119 0.065 0.639 1.209
Day 2 0.058 0.968* 1.162 0.059 1.052* 1.261
Day 3 0.040 0.531 1.060
1.003
1.114
1.143
1.120
1.106
0.038 0.582 1.146
1.088
1.202
1.235
1.209
1.197
Day 4 0.038
0.216*
0.045
0.050
0.045
0.041
0.511 1.102 0.037
0.238*
0.048
0.052
0.048
0.045
0.560- 1.191
Day 5 0.041 0.529
0.544
1.651*
0.615
0.580
0.496
1.100 0.039 0.575
0.594
1.761*
0.672
0.632
0.540
1.183
Day 6 0.049 0.538 1.057 0.047 0.584 1.143
Calibration curves linear with r > 0.995. *=cap leaked, result ignored.
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Table 47. Day to day retention and separation of Moshers acid by GLC with G-TA
column.
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6
Peak retention times 3.80 3.80 3.81 3.82 3.82 3.82
(mins.) 4.12 4.12 4.13 4.13 4.13 4.14
k' 13.6 13.6 13.6 13.6 13.6 13.1
14.7 14.7 14.7 14.7 14.7 14.3
a 1.084 1.084 1.084 1.081 1.081 1.084
Rp (%) Lowest 83 75 88 89 80 73
Highest 63 66 61 60 60 58
Lowest refers to Rp (%) obtained with ow concentration calibration stanc ard. Highest refers to
Rp (%) obtained with high concentration calibration standard.
The accuracy of the method was good, though slightly low for the samples of low 
enantiomer concentration. Precision, both day to day (table 48) and within day (table 
49) was also good and far superior to that of the HPLC method.
Table 48. Day to day reproducibility of GC method for Moshers acid enantiomers in 
urine.
Moshers
Acid
enantiomer
Spiked
Cone.
mg/ml
Determined 
Concentration 
mg/ml 
(mean ± s.d.)
n CV.
%
Accuracy
%
CV. of 
slope of 
calibration 
curve
R - 0.065 0.048 ±0.011 6 22.1 73.8 20.1
0.524 0.539 ± 0.028 5 5.2 102.9
1.088 1.100 ±0.039 6 3.6 101.1
S - 0.065 0.048 ±0.012 6 25.1 73.8 19.8
0.523 0.588 ±0.030 5 5.1 112.4
1.178 1.189 ±0.044 6 3.7 100.9
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Table 49. Within day reproducibility of GC method for Moshers acid enantiomers in 
urine.
Moshers
Acid
enantiomer
Spiked
Cone.
mg/ml
Determined 
Concentration 
mg/ml 
(mean ± s.d.)
n CV.
%
Accuracy
%
R - 0.065 0.044 ±0.005 5 10.4 67.7
0.524 0.553 ±0.046 5 8.3 105.5
1.088 1.091 ±0.051 6 4.7 100.3
S - 0.065 0.046 ± 0.006 5 12.2 70.8
0.523 0.603 ±0.051 5 8.5 115.3
1.178 1.179 ±0.053 6 4.5 100.1
The rat urine samples were analysed with the validation samples on two separate days 
and are listed alongside those from the HPLC method in table 50. Example 
chromatograms of calibration standards and rat samples are shown in figures 73 to 75. 
All of the Moshers acid was eluted in the first 0-24 Hours. There was no evidence of 
any racémisation or enantiomer interconversion in vivo, as the single enantiomers were 
eluted as dosed.
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Fig.73. Chromatograms of Moshers acid following derivatisation with methanolic 
hydrochloric acid. A) Low concentration standard (0.033mg/ml S-enantiomer; 
0.030mg/ml R-enantiomer), B) High concentration standard (1.309mg/ml S- 
enantiomer, 1.209mg/ml R-enantiomer). G-TA column, helium carrier gas, 45Kpa, 
oven 100°C, split injection (split flow 50ml/min.) of 1 pi, ECD (N2 make-up 
30ml/min).
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Fig.74. Chromatogram of blank rat urine following derivatisation with methanolic
hydrochloric acid. G-TA column, helium carrier gas, 45Kpa, oven lOO^C, split
injection (split flow 50ml/min.) o f 1 pi, ECD (N2 make-up 30ml/min).
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*  *6 Chromatogram of rat urine sampie i^u-z^nrs., rat Mo.6) tollowing 
derivatisation with methanolic hydrochloric acid. G-TA column, helium carrier gas, 
45Kpa, oven 100®C, split injection (split flow 50ml/min.) of 1 pi, ECD (N2 make-up 
30ml/min).
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Table 50. Moshers acid enantiomer levels in rat urine as determined by both HPLC and 
GC.
HPLC Method GLC Method
Sample Enantiomer Cone. Enantiomer Cone. Enantiomer Cone.
mg/ml mg/ml mg/ml
Rat No. Sample
timeHrs
R S R S R S
4 0-24 1.246 0 1.745 0 1.559* 0
24-48 0.072 0.087 0.076 0 0.061 0
5 0-24 0 0.451 0 0.916 0 0.906
24-48 0.046 0.090 0 0 0 0
6 0-24 0.576 0.569 0.715 0.690 0.662 0.635
24-48 0.041 0.049 0 0 0 0
*cap leaked.
An investigation of the reproducibility of sample injection into the GC using the split 
injection technique was performed, by making 4 injections of the same standard 
solution. The peak heights obtained had CV’s of 4.5% for both enantiomers, table 51.
Table 51. Reproducibility of split injection (split flow rate 50ml/min.) of R,S-Moshers 
acid on Chiraldex G-TA column.
S-Moshers acid R-Moshers acid
Peak Heights 1487, 1651, 1522, 1542 1556, 1730, 1592, 1614
Mean 1550.5 1623
Standard deviation 70.7 75.2
Injection volume 1 pi.
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Discussion
The GLC methods for both p-TFM and Moshers acid were satisfactory and allowed 
the determination of the enantiomer levels of the respective compounds in the rat urine 
samples as required. The ‘loss’ of sample, resulting in reduced peak heights, and 
subsequent variation in calibration curve slopes experienced with both GC methods 
may be caused by evaporation of the derivative during the derivatisation reaction or 
variations in the amount injected on the column.
Sample loss during the derivatisation step, by leakage of sample from the glass tubes 
was observed. If the lids were not tight enough then sample vapour could escape due 
to the incomplete seal. On some occasions if the lids were done up too tightly then 
they either shattered, or caused the neck of the glass tubes to crack. In the more 
obvious cases of leakage the sample was reduced to a residue and so sample loss was 
easily noticed. Small reductions in sample volume due to slight leakage were not so 
easily noticed. In the cases where sample loss was visibly obvious the sample was 
ignored. A change of glassware to reaction vials capable of providing a better seal and 
the subsequent prevention of sample leakage would obviously improve precision, due 
to less variation of sample size.
The use of split injection can result in variations in the actual amount injected due to 
fluctuations in the split vent flow rate during a chromatographic run, however the CV 
of 4.5% obtained was considered acceptable. The reproducibility of injection could be 
improved by the use of an injection standard. The use of an internal standard could, in 
addition to cancelling the slight variations in injection volume, also allow for losses 
during the sample preparation.
If reauired the instrument detection limits could be lowered to allow the detuwicction of
smaller peaks by reduction in recorder/integrator attenuation. Slight changes in the 
sample preparation could also be used to enhance the peak sizes (concentration of the 
sample on the column), firstly more urine could be used, ie. by taking a 400pl aliquot
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instead of 200|il the peak sizes would be doubled. Reducing the amount of organic 
solvent added would result in a more concentrated extract.
The HPLC method for the determination of the Moshers acid enantiomers was not as 
good as the GC method. The lower specificity of the HPLC method was demonstrated 
by the ‘presence’ of Moshers acid being detected in the 24-48 hour samples (table 50). 
Although peaks were detected at the retention times of the Moshers acid peaks and 
quantified as such, no Moshers acid was detected in the same samples by the GC 
method. It is therefore concluded that these peaks were not Moshers acid, but 
metabolites or some other compounds in the urine samples which eluted at similar 
retention time to the Moshers acid. The increased specificity of the GC method was a 
result of the use of the more specific (electron capture) detector. The same compounds 
as detected by the HPLC method are obviously not derivatised, or do not contain 
electron capturing groups and are therefore not detected by the ECD. '
Although all the rats (1 to 3) were dosed with racemic p-TFM, only one of the 
enantiomers was detected, (table 44). The absence of the second eluting enantiomer 
could be due to extensive metabolism or biological storage of that particular 
enantiomer whereas the other is excreted unchanged. Alternatively, the absence of the 
second peak may be due to conversion of the undetected enantiomer, B, into its 
antipode, A.
The interconversion from one enantiomer is the most likely explanation due to the high 
concentration of the single enantiomer. A, detected. From the protocol, assuming that 
all of the dosed compound is excreted in the first 24 hours then the maximum 
concentration of p-TFM in the urine would be as follows:
Rat 1, approx. 2.9 mg/ml (25mg in 8.5ml of urine)
Rat 2, approx. 7.1 mg/ml (25mg in 3.5ml of urine)
Rat 3, approx. 3.3 mg/ml (25mg in 7.5ml of urine)
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These are the total content of p-TFM and so each enantiomer should be 50% of the 
total if eluted unchanged. As can be seen in all cases the concentration of enantiomer A 
detected (table 44) was greater than the concentration expected, while enantiomer B 
was undetected. Therefore it does appear that the undetected enantiomer B is 
converted into its antipode A. The unexpectedly high value for the concentration of the 
Rat 1 sample (6.16 mg/ml), may have been caused by slight leakage of sample during 
derivatisation which was not as complete or noticeable as other leaked samples.
There are a number of possible stages at which this conversion from one enantiomer to 
the other could have occurred. Conversion during sample handling, such as during the 
derivatisation reaction can be discounted as this was not observed with the standards 
and calibration samples. Another possibility is conversion during sample storage. While 
stability of the samples in storage was not tested, two ‘old’ p-TFM standard solutions 
(Std 1 week and Std 1 month, table 44), left over from the method development, were 
analysed and found not to have undergone any form of enantiomeric conversion, with 
their enantiomer levels unaffected by the storage.
This therefore leaves the rat as the most likely source of the interconversion. Such 
metabolic interconversion of enantiomers has been reported with the profen group of 
drugs [Carey 1993]. Due to the similarity in structure it is likely that the conversion of 
p-TFM enantiomer B into enantiomer A within the rat follows a similar pathway to 
that experienced by the profens. Indeed if the same or similar pathway is involved then 
it would also account for the lack of such an interconversion for the enantiomers of 
Moshers acid.
With ibuprofen, in vivo the inactive R-enantiomer is converted into the active S- 
enantiomer. The mechanism involved was covered in chapter 1. The stereoselective 
step in the inversion of (R)-ibuprofen involves the formation of a coenzyme-A thioester 
which is also the rate determining step. This requires abstraction of the proton at the 
a-methine position. The thioester then undergoes epimerization resulting
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in (S)-ibuprofenyl-CoA thioester, which is then hydrolysed to give (S)-ibuprofen 
[Tracy and Hall 1992]. The reverse reaction does not occur as (S)-ibuprofen does not 
form the thioester.
Moshers acid does not possess an a-hydrogen, and so would not be capable of forming 
the CoA-thioester and therefore does not undergo any enantiomeric interconversion in 
vivo. p-TFM however does contain an a-hydrogen and so can proceed via the same 
mechanism as the profens. It is anticipated that the p-TFM interconversion would also 
mimic the profens in that the R-(p-TFM) would be converted to the S-enantiomer, 
although further work would be required to confirm this.
4.7 General Discussion
The two CD capillary GC columns (Chiraldex B-PH and G-TA) separated the 
enantiomers of the racemic epoxides investigated. The use of capillary GC allows for 
the separation of enantiomers with small separation factors because of the increased 
efficiency afforded by the columns. Factors influencing the retention of the compounds 
and discrimination of the enantiomers were then identified by the evaluation of the 
thermodynamics of the separation process.
The mechanism responsible for enantiomer recognition/discrimination of the epoxides 
was concluded to be a complex combination of interactions. Inclusion within the CD 
cavity is not the dominating enantiomer discriminating interaction. The extent of 
inclusion is likely to be similar for both enantiomers as the aromatic ring (which is 
expected to include) is remote from the chiral centres. Inclusion does however affect 
the retention of the epoxides.
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The extent of retention experienced for a particular epoxide is therefore controlled by 
the substituent group attached to the aromatic ring system. Epoxides with electron 
donating groups were the least retained, while those with electron withdrawing 
substituents were more retained. This knowledge could prove useful for prediction of 
retention times for future separations of similar compounds (ie. compounds with the 
same basic epoxide structure) with other substituent groups. As the chirality of the 
epoxides is unaffected by the substituents on the aromatic ring, then it is expected that 
the enantiomers of similar epoxides would also be distinguished by the columns.
For example the retention of an epoxide containing an amine (NH2) substituent, should 
be less retained on both columns than all of the epoxides studied so far. This is because 
the amine group is electron donating (more so than the fluoroalkyl groups). On the 
other hand if the substituent group was bromine, then its retention should be similar to 
that of the chloro epoxide, albeit slightly longer, reflecting its slightly greater electron 
withdrawing effect.
It is clear that these columns could be used for the enantiomeric purity determination 
of the epoxides. The reversal of enantiomeric elution order afforded by changing 
between the columns would prove useful for determination of small quantities of one 
enantiomer in the bulk of its antipode, as detection and quantification is improved with 
the small peak eluting first.
As for the chiral separation of other compounds, the CD capillary columns are limited 
to compounds that can be eluted at relatively low temperatures (less than 150^0). 
Compounds that require higher elution temperatures, such as the P-blockers and 
benzodiazepines studied, are not favoured as the high temperatures are unfavourable 
for chiral recognition mechanisms to function. In addition prolonged use at high 
temperatures can have a detrimental effect on the enantioselectivity of the columns, 
although in the case of the TA phase regeneration with trifluoroacetic anhydride can 
restore enantioselectivity.
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The major drawback in the use of CSP’s for enantiomer analysis is the rather ‘trial and 
error’ approach required for phase selection. Educated ‘guesses’ can be made as to the 
most suitable phases/mode (i.e. HPLC, GLC) based on the analytes structure, but 
chiral discrimination is not guaranteed. This may explain why there are relatively few 
examples of CSP separations of ‘real’ samples (such as in pharmacodynamic and 
pharmacokinetic studies) in the literature. Many of the separations on CSP’s reported 
in the literature are of samples chosen to demonstrate the phases at their best.
Bioanalysis of pharmaceutical samples still is achieved mainly by
diastereoisomer formation and achiral stationary phases. This may in part be due to a 
lack of publication of results/studies performed within the pharmaceutical industry on 
compounds in development. As CSP’s tend to be expensive, particularly when 
compared to chiral reagents the prospect of unsuccessful separations means that for 
establishments working under tight budgets the screening of a number of possible 
CSP’s is not always possible or economically viable.
The problem of column selection has been addressed, and recently a computer 
database system has been described. Chiral molecules were fragmented around the 
chiral centre and the four fragments assigned values such as polarizability, molecular 
volume and hydrogen bonding strength. A similarity search is then performed and the 
most suitable CSP selected by comparing the fragments to those contained in the 
computer database for molecules which have already been separated [Stauffer and 
Dessy 1994]. The study only covered separations on cellulose and crown-ether based 
CSP’s, but could obviously be expanded to include others.
A similar approach, involving breaking down a chiral molecule into its four substituents 
about the chiral centre has also been reported for normal phase separations on CD 
based CSP’s. The individual groups or fragments were assigned energy values (AG). 
Addition of these values gave the total A(AG) value, which being related to a  indicates 
the degree of separation expected on the particular phase under set conditions 
[Berthod, Chang and Armstrong 1992]. A number of substituents were
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assigned values, although the study was limited to the CSP, (1- 
naphthylethyl)carbamoylated p-CD (both S- and R-). Good agreement between the 
calculated and experimentally confirmed a-values were obtained, and the system could 
be expanded to other CSP’s upon generation of a database for the particular phases.
The screening of potential phases for enantiomer discrimination may also be time 
consuming, with changing columns and eluents requiring equilibration of systems prior 
to sample injection. The use of column switching has been reported as a useful 
technique for the screening of columns and eluents for potential chiral separations and 
optimisation of separations. A number of columns and eluents can be screened 
overnight using automated systems to switch between them [Whatley 1995]. This 
approach saves analyst time, but still relies somewhat on trial arid error. The method is 
therefore only likely to appeal to laboratories that can afford to try a number of 
columns.
The modelling of CSP/analyte interactions could also provide a useful method for the 
selection of suitable CSP’s for particular compounds. Once a suitable model is 
established then future separations of new compounds could be predicted. Such 
modelling was not possible during this study, but is an area for further research. The 
inertness of the mobile phase in GC should enable easier and more accurate modelling. 
In addition to the use for column selection, an accurate model of CSP/analyte 
interactions would also be useful for the development of new phases.
There was no problem in the use of CSP’s in the analysis of biological samples, once 
suitable separations have been obtained. However confirmation that a separation is that 
of the enantiomers is important. The HPLC separations of Moshers acid and its methyl 
ester, and the reported chiral separation on the AGP column [Gregory 1993] 
demonstrate that the presence of two peaks in the chromatograms of racemic mixtures 
may not be due to a separation of the individual enantiomers. Such pseudo-separations 
can in some cases be identified, either due to a lack of reproducibility (i.e. the
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separation is not always achieved) or by grossly different peak sizes (as separation of a 
racemate should produce peaks of equal size, except when the separation between the 
two peaks is large).
With the racemic epoxides, the cyano substituted epoxide was available as single 
enantiomers and so it was possible to confirm that the peaks obtained with the 
racemate were due to the individual enantiomers and establish the enantiomeric elution 
order. While the single enantiomers of the other epoxides were not available it was 
considered a safe assumption that the two peaks obtained with the racemic mixtures 
were due to a separation of the single enantiomers, as the peaks were of equal size and 
the separations were reproducible.
For Moshers acid, as with the cyano epoxide, the single enantiomers were available to 
confirm that separations obtained with the racemic compound were enantiomer 
separations and establish the enantiomer elution order. The single enantiomers of p- 
TFM were not available, although the separations achieved with the racemate were 
concluded to be a result of enantiomer separation based on similar peak size and 
reproducibility of the separation. In the case of HPLC separations, the use of a 
chiroptic (circular dichroism) detector would allow enantiomer peak identification and 
the confirmation of chiral separations.
For the HPLC determination of the enantiomer levels of Moshers acid in urine, 
extensive sample clean-up was required, which resulted in poor reproducibility of the 
method. The HPLC analysis of Moshers acid was not as reproducible as the GC 
method, and was more expensive (requiring SPE cartridges) and more labour intensive, 
although the manual SPE stage of the method could be automated. The SPE step of 
the procedure could also be improved by further optimisation of the 
extraction/recovery fi’om the cartridges. The low capacity of the CD columns can be a 
problem when concerned with samples of low analyte concentration as it is not 
possible to inject large quantities of sample onto the column without sacrificing chiral 
separation. However this can be overcome by sample concentration during sample
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preparation, or with the use of more sensitive detectors.
The use of the capillary GC columns for bioanalysis of suitable compounds was 
confirmed with the methods developed. The sample preparation for the analysis from 
urine of the enantiomers of p-TFM and Moshers acid was far simpler than that 
required for HPLC, even though it involved derivatisation to increase sample volatility. 
The non-polar derivatives formed had a greater affinity for an organic phase and were 
thereby easily extracted from the urine matrix. This combined with the highly specific 
detection system (ECD) allowed for chromatograms clear of interferences.
The detection of only one of the enantiomers of p-TFM in the rat urine suggests that 
p-TFM does undergo an jn vivo enantiomeric interconversion similar to the profens. 
Confirmation of this is therefore an area for further consideration. For such work it 
would be necessary to obtain the single enantiomers of p-TFM, which would also be 
usefiil to confirm the chiral separations obtained and identify the enantiomer elution 
order. Small amounts could be obtained by HPLC with the CD (cyclobond I) column 
by collecting fractions as the enantiomers are eluted.
In conclusion, the use of chiral stationary phases for the separation of enantiomers is an 
extremely useful method. Chiral separations with CSP’s are not limited to the 
separation of pure compounds and can be used for the analysis of biological samples, or 
those of environmental origin. The analysis of enantiomers in complex matrices may 
require sample preparation and clean-up prior to analysis, but this is no different to that 
required for non-chiral analyses. The use of GC for chiral bioanalysis was also found to 
be suitable for the compounds studied. While GC often requires derivatisation to 
improve sample volatility, this can easily be incorporated into the sample preparation.
199
5.0 References
Abdalla, S.; Bayer, B.; Frank, H., Derivatives for separation of amino acid 
enantiomers. Chromatographia 23, 83-85, 1987.
Alak, A.; Armstrong, D.W., Thin layer chromatographic separation of optical, 
geometrical, and structural isomers. Anal. Chem. 582-584, 1986.
Albert, K.; Bayer, E , High-performance liquid chromatography proton nuclear 
magnetic resonance on-line coupling. HPLC Detection: Newer Methods. G. Patonay 
(Ed.), VCHPubl. Inc. 1992.
Allenmark, S., Optical resolution by liquid chromatography on immobilized bovine 
serum albumin. J. Liq. Chromatogr. 9, 425-442, 1986.
Allenmark, S.; Bomgren, B.; Boren, H., Direct liquid chromatographic separation of 
enantiomers on immobilized protein stationary phases. III. Optical resolution of a 
series of N-aroyl D,L-amino acids by high-performance liquid chromatography on 
bovine serum albumin covalently bound to silica. J. Chromatogr. 264. 63-68, 1983 .
Allenmark, S.; Bomgren, B.; Boren, H., Direct liquid chromatographic separation of 
enantiomers on immobilized protein stationary phases. IV. Molecular interaction forces 
and retention behaviour in chromatography on bovine serum albumin as a stationary 
phase. J. Chromatogr. 316. 617-624, 1984.
Almquist, S.R.; Petersson, P.; Walther, W.; Markides, K.E., Direct and indirect 
approaches to enantiomeric separation of benzodiazepines using micro column 
techniques. J. Chromatogr. A. 139-146, 1994.
Andersson, L. I.; O’Shannessy, D.J.; Mosbach, K., Molecular recognition in synthetic 
polymers: preparation of chiral stationary phases by molecular imprinting of amino acid 
amides. J. Chromatogr. 513. 167-179, 1990.
200
Ariens, E.J., Stereoselectivity of bioactive agents: General aspects.. Stereochemistry 
and biological activity of drugs. Ariens, E.J.; Soudijn, W.; Timmermanns, 
P.B.M.W.M. (Eds.), Blackwell Scientific Publishing, Oxford, 1983.
Ariens, E.J., Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics 
and clinical pharmacology. Eur. J. Pharmacol. 26, 663-668, 1988.
Ariens, E.J., Nonchiral, homochiral and composite chiral drugs. TiPS. 14, 68-75,
1993.
Ariens, E.J.; Wuis, E.W.; Veringa, E.J., Stereoselectivity of bioactive xenobiotics. A 
pre-Pasteur attitude in medical chemistry, pharmacokinetics and clinical pharmacology. 
Biochem. Pharm. 37, 9-18, 1988.
Armstrong, D.W., Chiral stationary phases for high performance liquid 
chromatographic separation of enantiomers: A mini review. J. Liq. Chromatogr. 7, 
353-376, 1984.
Armstrong, D.W.; Demond, W., Cyclodextrin bonded phases for the liquid 
chromatographic separation of optical, geometric and structural isomers. J. 
Chromatogr. Sci. 22, 411-415, 1984.
Armstrong, D.W.; Demond, W.; Alak, A ; Hinze, W.L.; Riehl, T.E.; Bui, K.H., Liquid 
chromatographic separation of diastereomers and structural isomers on cyclodextrin- 
bonded phases. Anal. Chem. 57. 234-237. 1985.
Armstrong, D.W.; Faulkner, JR.Jr.; Han, S.M., Use of hydroxypropyl- and 
hydroxyethyl- derivatised p-cyclodextrins for the thin layer chromatographic separation 
of enantiomers and diastereomers. J. Chromatogr. 452. 323-330, 1988.
201
Armstrong, D.W.; Jin, H.L., Acylation effects on chiral recognition of racemic amines 
and alcohols by new polar and non-polar cyclodextrin derivative gas chromatographic 
phases. J. Chromatogr. 502. 154-159, 1990.
Armstrong, D.W.; Li, W.; Chang, C-D.; Pitha, J., Polar-liquid derivatised cyclodextrin 
stationary phases for the capillary gas chromatography separation of enantiomers. 
Anal. Chem. 914-923, 1990.
Armstrong, D.W.; Li, W.; Pitha, J., Reversing enantioselectivity in capillary gas 
chromatography with polar and non-polar cyclodextrin derivative phases. Anal. 
C h e m .^ , 214-217, 1990.
Armstrong, D.W.; Stalcup, AM.; Hilton, M.L.; Duncan, J.D.; Faulkner Jr., JR.; 
Chang, S.C., Derivatised cyclodextrins for normal-phase liquid chromatographic 
separation of enantiomers. Anal. Chem. 62, 1610-1615, 1990.
Armstrong, D.W.; Tang, Y.; Chen, S.; Zhou, Y.; Bagwill, C.; Chen, J-R., Macrocyclic 
antibiotics as a new class of chiral selectors for liquid chromatography. Anal. Chem. 
M, 1473-1484, 1994.
Armstrong, D.W.; Tang, Y.; Zukowski,J., Resolution of enantiomeric hydrocarbon 
biomarkers of geochemical importance. Anal. Chem., 2858-2861, 1991.
Armstrong, D.W.; Ward, T.J.; Armstrong, R.D.; Beesley, T.B., Separation of drug 
stereoisomers by the formation of g-cyclodextrin inclusion complexes. Science 232. 
1132-1135,1986.
Armstrong, D.W.; Zhou, Y., Use of a macrocyclic antibiotic as the chiral selector for 
enantiomeric separations by TLC. J. Liq. Chromatogr. 17, 1695-1707, 1994.
202
Asaoka, M.; Shima, K.; Takei, H., Synthesis of chiral 5-substituted cyclohex-2-enones 
from 5-trimethylsilylcyclohex-2-enone. J. Chem. Soc. Chem. Commun. 430-431, 
1988.
Bargmann-Leyder, N.; Sella, C.; Bauer, D.; Tambute, A.; Caude, M., Supercritical 
fluid chromatographic separation of P-blockers on Chyrosine-A: Investigation of the 
chiral recognition mechanism using molecular modeling. Anal. Chem. 61_, 952-958, 
1995.
Bayer, B.; Gil-Av, E.; Konig, W.A; Nakaparksin, S.; Oro, J.; Parr, W., Retention of 
configuration in the solid phase synthesis of peptides. J. Am. Chem. Soc. 92, 1738- 
1740,1970.
Bereuter, T.L., Enantioseparation by capillary electrophoresis. LC-GC Int. 7, 78-93, 
1994.
Berrueta, L.A.; Gallo, B.; Vicente, F., A review of solid phase extraction: Basic 
principles and new developments. Chromatographia 40, 474-483, 1995.
Berthod, A.; Chang, S-C.; Armstrong, D.W., Empirical procedure that uses molecular 
structure to predict enantioselectivity of chiral stationary phases. Anal. Chem. 64. 
395-404, 1992.
Berthod, A.; Li, W.Y.; Armstrong, D.W., Chiral recognition of racemic sugars by 
polar and nonpolar cyclodextrin-derivative gas chromatography. Carbohydr. Res. 
201. 175-184, 1990.
Berthod, A.; Li, W.; Armstrong, D.W., Multiple enantioselective retention mechanisms 
on derivatized cyclodextrin gas chromatographic chiral stationary phases. Anal. 
Chem. M, 873-879, 1992.
203
Berthod, A.; Zhou, B.Y.; Le, K.; Armstrong, D.W., Determination and use of 
Rohrschneider-McReynolds constants for chiral stationary phases used in capillary gas 
chromatography. Anal. Chem. 849-857, 1995.
Bertucci, C.; Salvadori, P.; Lopes Guimaraes, L.F., Determination of optical purity by 
high-performance liquid chromatography upon non-chiral stationary phases with dual 
circular dichroism/adsorption detection. J. Chromatogr. 6 6 6 . 535-539, 1994.
Bicchi, C.; Artuffo, G.; D’Amato, A.; Nano, G.M.; Galli, A.; Galli, M., Permethylated 
cyclodextrins in the GC separation of racemic mixtures of volatiles: Part 1. J. High 
Résolut. Chromatogr. 14, 301-305, 1991.
Blaschke, G., Chromatographic resolution of racemates. Angew. Chem. Int. Ed. 
Engl. 19, 13-24, 1980.
Blout, E.R.; Doty, P.; Yang, J.T., Polypeptides. XII. The optical rotation and 
configurational stability of a-helices. J. Am. Chem. Soc. 79, 749-750, 1957.
Bonate, P.L., Chromatographic calibration revisited. J. Chromatogr. Sci. 28, 559- 
562, 1990.
Boue, J.; Audebert, R.; Quivoron, C , Direct resolution of a-amino acid enantiomers 
by ligand exchange: Stereoselection mechanism on silica packings coated with a chiral 
polymer. J. Chromatogr. 204. 185-193, 1981.
Bridges, J.W.; Chasseaud, L.F.; Gibson, G.G., Progress in Drug Metabolism 
Gibson, G G (Ed), Vol. 10, Taylor and Francis, London, 1987.
Brinkman, U.A.Th.; Kamminga, D., Rapid separation of enantiomers by thin layer 
chromatography on a chiral stationary phase. J. Chromatogr. 330. 375-378, 1985.
204
Brooks, C.J.W.; Gilbert, M.T., Studies of urinary metabolites of 2-(4- 
isobutylphenyl)propionic acid by gas-liquid chromatography-mass spectrometry. J. 
Chromatogr. 99, 541-551, 1974.
Bruckner, H.; Lupke, M., Determination of amino acid enantiomers in orange juices by 
chiral phase capillary gas chromatography. Chromatographia 31, 123-128, 1991.
Brunner, C.A.; Wainer, I., Direct stereochemical resolution of enantiomeric amides via 
thin-layer chromatography on a covalently bonded chiral stationary phase. J. 
Chromatogr. 472, 277-283, 1989.
Budahegyi, M.V.; Lombosi, E.R.; Lombosi, T.S.; Meszaros, S.Y.; Nyiredy, Sz.; Taijan, G.; Timar, I.; Takacs, JJvt, 
25th Anniversary of the retention index in GLC. J.Chromatogr., 271. 213-307, 1983.
Burden, R.S.; Deas, A.H.B.; Clark, T., Separation of enantiomers of fungicidal and 
plant growth regulatory triazole alcohols using chiral derivatisation and capillary gas- 
chromatography. J. Chromatogr. 391. 273-279, 1987.
Cahn, R.S.; Ingold, C.K., Specification of configuration about quadricovalent- 
assymmetric atoms. J. Chem. Soc. 612-622, 1951.
Cahn, R.S.; Ingold, C.K.; Prelog, V., Specification of molecular chirality. Angew.
Chem. Int. Ed. Engl. 5, 385-415, 1966.
Caldwell, J., ‘Chiral Pharmacology’ and the regulation of new drugs. Chem. & Ind. 
176-179, 1995.
Caldwell, J.; Hutt, A.J.; Foumel-Gigleux, S., The metabolic chiral inversion and 
dispositional enantioselectivity of the 2 -arylpropionic acids and their biological 
consequences. Biochem. Pharm. 37, 105-114, 1988.
205
Camilleri, P.; DeBiasi, V.; Hutt, A., Resolving the problem. Chem. in Britain, 43-46,
1994.
Carey, J., New resolutions in drug design. Chem. in Britain, 1053-1056, 1993.
Chang, S.C.; Reid III, G.L.; Chen, S.; Chang, C.D.; Armstrong, D.W., Evaluation of a 
new polar-organic high-performance liquid chromatographic mobile phase for 
cyclodextrin-bonded chiral stationary phases. Tr. Anal. Chem. 12, 144-153, 1993.
Chiraldex Capillary GC Columns: A guide to using cyclodextrin bonded phases for gas 
chromatography, Astec Inc., Whippany, USA. (Supplied by Technicol, Cheshire).
Ciucanu, I.; Konig, W.A., Immobilization of peralkylated P-cyclodextrin on silica gel 
for high-performance liquid chromatography. J. Chromatogr. A. 685. 166-171, 1994.
Cyclobond Handbook: A guide to using cyclodextrin bonded phases, Astec Inc., 
Whippany, USA. (Supplied by Technicol, Cheshire).
Dalgliesh, C.E., The optical resolution of aromatic amino-acids on paper 
chromatograms. J. Chem. Soc. 3940-3942, 1952.
Dale, J.A.; Dull, D.L.; Mosher, H.S., a-Methoxy-a-trifluoromethylphenylacetic Acid, 
a versatile reagent for the determination of enantiomeric composition of alcohols and 
amines. J. Org. Chem. 34, 2543-2549, 1969.
Dappen, R.; Arm, H.; Meyer, V.R., Applications and limitations of commercially 
available chiral stationary phases for high-performance liquid chromatography. J. 
Chromatogr. Chrom. Reviews 373. 1-20, 1986.
206
Davankov, V.A.; Kurganov, A A ; Bochkov, A.S., Resolution of racemates by high- 
performance liquid chromatography. Advances in Chromatography Vol.22, 
Giddings, J.C.; Grushka, E.; Gazes, J.; Brown, P R. (Eds.), Marcel Dekker Inc., New 
York. 71-116, 1983.
Davies, C.L., Chromatography of g-adrenergic blocking agents. J. Chromatogr. 
Biomed.Appl. 531, 131-180, 1990.
Debowski, J.; Jurczak, J.; Sybilska, D., Resolution of some chiral mandelic acid 
derivatives into enantiomers by reversed-phase high-performance liquid 
chromatography via a - and p-cyclodextrin inclusion complexes. J. Chromatogr. 282,
83-88, 1983.
Deger, W.; Gessner, M ; Heusinger, G.; Singer, G.; Mosandl, A., Critical remarks on 
the interpretation of chiral stereodifferentiation in gas chromatography. J. 
Chromatogr. 366. 385-390, 1986.
Demian, I.; Gripshover, D.F., Enantiomeric purity determination of 3- 
aminoquinuclidine by diastereomeric derivatization and high-performance liquid 
chromatographic separation. J. Chromatogr. 466. 415-420, 1989.
Divoll, M.; Greenblatt, D.J., Plasma concentrations of temazepam, a 3-hydroxy 
benzodiazepine, determined by electron-capture gas-liquid chromatography. J. 
Chromatogr. Biomed. Appl. 222. 125-128, 1981.
Djerassi, C., Optical rotary dispersion - Applications to organic chemistry, McGraw-Hill, 
New York, I960. ;
Domenici, E.; Bertucci, C.; Salvadori, P.;Felix, G.; Cahagne, I.; Motellier, S.; Wainer,
I.W., Synthesis and chromatographic properties of an HPLC chiral stationary phase 
based upon human serum albumin. Chromatographia 29, 170-176, 1990.
207
Duncan, J.D.; Armstrong, D.W.; Stalcup, A.M., Normal phase TLC separation of 
enantiomers using chiral ion interaction agents. J. Liq. Chromatogr. J3, 1091-1103,
1990.
Duthel, J.M.; Constant, H.; Vallon, J.J.; Rochet, T.; Miachon, S., Quantitation by gas 
chromatography with selected-ion monitoring mass spectrometry of “natural” 
diazepam, N-desmethyldiazepam and oxazepam in normal human serum. J. 
Chromatogr. Biomed. Appl. 579, 85-91, 1992.
Dyas, A.M.; Robinson, M L.; Fell, A.F., The design of chiral separations for p-blocker 
drugs on Pirkle high-performance liquid chromatography phases using achiral 
derivatisation. Recent Advances in Chiral Separations, D.Stevenson and 
LD.Wilson (Eds.), Plenum Press, New York, 1991.
Easson, L.H.; Stedman, E., CLXX. Studies on the relationship between chemical 
constitution and physiological action. V. Molecular dissymmetry and physiological 
action. Biochem. J. 27, 1257-1266, 1933.
Eichelbaum, M., Pharmacokinetic and pharmacodynamic consequences of 
stereoselective drug metabolism in man. Biochem. Pharm. 17, 93-96, 1988.
Eliel, E.L.; Wilen, S.H.; Mander, L.N., Stereochemistry of Organic Compounds., 
John Wiley & Sons, Inc., New York, 214-275, 1994.
Enquist, M.; Hermansson, J., Comparison between two methods for the determination 
of the total and free (R)- and (S)- disopyramide in plasma using an a i-  acid 
glycoprotein column. J. Chromatogr. Biomed. Appl. 494. 143-156, 1989a.
Enquist, M.; Hermansson, J., Separation and quatitation of (R)- and (S)-atenolol in 
human plasma and urine using an ai-AGP column. Chirality i ,  209-215, 1989b.
208
Enquist, M.; Hermansson, J., Influence of uncharged mobile phase additives on 
retention and enantioselectivity of chiral drugs using an a r  acid glycoprotein column. 
J. Chromatogr. 519, 271-283, 1990.
Ervik, M.; Kylberg-Hanssen, K.; Johansson, L., Determination of metoprolol in plasma 
and urine using high-resolution gas chromatography and electron-capture detection. J. 
Chromatogr. Biomed. Appl. 381. 168-174, 1986.
Evans, J.M.; Smith, R.J.; Stemp, G., Separation of the enantiomers of some potassium 
channel activators using an ai- acid glycoprotein column. J. Chromatogr. 623. 163- 
167, 1992.
Feibush, B., Interaction between a symmetric solutes and solvents. N-lauroyl-L-valyl- 
t-butylamide as stationary phase in gas liquid partition chromatography. Chem. 
Commun. 544-545, 1971.
Findlay, J.W.A., Applications of immunoassay methods to drug disposition studies. 
Drug Metab. Rev. 18, 83-129, 1987.
Foley, J.P., Systematic errors in the measurement of peak area and peak height for 
overlapping peaks. J. Chromatogr. 384. 301-313, 1987.
Frank, H.; Nicholson, G.J.; Bayer, E., Chiral polysiloxanes for resolution of optical 
antipodes. Angew. Chem. Int. Ed. Engl. 17, 363-365, 1978a.
Frank, H.; Nicholson, G.J.; Bayer, E., Enantiomer labelling, a method for the 
quantitative analysis of amino acids. J. Chromatogr. 167. 187-196, 1978b.
Fuji, K., Asymmetric creation of quaternary carbon centres. Chem. Rev. 93, 2037- 
2066,1993.
209
Fukushima, T.; Kato, M.; Santa, T.; Imai, K., Enantiomeric separation and 
spectrofluorometric detection of the racemic drugs (±)-l-(2 ,6 -dimethylphenoxy)-2 - 
propamine (Mexiletine) and (3RS)-4-amino-3 -hydroxybutanoic acid (GABOB), 
derivatised with 4-fluoro-7-nitro-2,1,3-benzoxadiazole on a phenylcarbamylated 
cyclodextrin bonded stationary phase. Analyst 120. 381-383, 1995.
Gal, J., Stereochemistry of metabolism of amphetamines: Use of (-)-a-methoxy-a- 
(trifluoromethyl)phenylacetic chloride for GLC resolution of chiral amines. J. Pharm. 
S c ! .^ ,  169-172, 1977.
Gibson, G.G.; Skett, P., Introduction to drug metabolism, pl-79. Chapman and 
Hall, 1986.
Gil-Av, E.; Feibush, B.; Charles-Sigler, R , Separation of enantiomers by gas-liquid 
chromatography with an optically active stationary phase. Tetrahedron Lett. 10, 
1009-1015, 1966.
Gregory, L, Separation of drug enantiomers by use of HPLC chiral stationary phases. 
BSc chemistry project. University of Surrey, 1993.
Gubitz, G.; Mihellyes, S., Optical resolution of p-blocking agents by thin-layer 
chromatography and high-performance liquid chromatography as diastereomeric R-(-)- 
1 -( 1 -naphthyl)ethylureas. J. Chromatogr. 314, 462-466, 1984.
Gunther, K., Thin-layer chromatographic enantiomeric resolution via ligand exchange. 
J. Chromatogr. 448. 11-30, 1988.
Gyllenhaal, O.; Konig, W.A; Vessman, J., Enantiomer separation of metoprolol and its 
analogues and metabolites by capillary column gas chromatography after derivatization 
with phosgene. J. Chromatogr. 350. 328-331, 1985.
210
Hage, D.S., Immunoassays. Anal. Chem. 65, 420R-424R, 1993.
Haginaka, J.; Seyama, Ch.; Yasuda, H.; Takahashi, K., Retention, enantioselectivity 
and enantiomeric elution order of propranolol and its ester derivatives on an a r  acid 
glycoprotein-bonded column. C hrom atographia^, 127-132, 1992.
Halterman, R.L.; Roush, W.R.; Hoong, L.K., Analytical resolution of secondary 
methyl ethers by chiral complexation gas chromatography. J. Org. Chem. 1152- 
1155,1987.
Hargitai, T.; Okamoto, Y., Evaluation of 3,5-dimethylphenyl carbamoylated a-, P-, 
and y- cyclodextrins as chiral stationary phases for HPLC. J. Liq. Chromatogr. 16. 
843-858, 1993.
Hermansson, J., Direct liquid chromatographic resolution of racemic drugs by means 
of ai-acid glycoprotein as the chiral complexing agent in the mobile phase. J. 
Chromatogr. 316. 537-546, 1984.
Hermansson, J.; Hermansson, I., Dynamic modification of the chiral bonding properties 
of a CHIRAL-AGP column by organic and inorganic additives. Separation of 
enantiomers of anti-inflammatory drugs. J. Chromatogr. 6 6 6 . 181-191, 1994.
Hinze, W.L.; Pharr, D.Y.; Fu, Z.S.; Burkert, W.G., Thin-layer chromatography with 
urea-solubilized P-cyclodextrin mobile phases. Anal. Chem. M, 422-428, 1989.
Hinze, W.L.; Riehl, T.E.; Armstrong, D.W.; Demond, W.; Alak, A.; Ward, T., Liquid 
chromatographic separation of enantiomers using a chiral P-cyclodextrin bonded 
stationary phase and conventional aqueous-organic mobile phases. Anal. Chem. 57. 
237-242, 1985.
211
Hutt, A.J., Enantiospecificanalyticalmethodology: Applications in drug metabolism and 
pharmacokinetics. Progress in Drug Metabolism, Gibson, G.G. (Ed) Vol. 12., p257- 
363, Taylor and Francis, London, 1990.
Huynh, T.K.X.; Lederer, M., Adsorption chromatography on cellulose. X. Adsorption 
of tryptophan and derivatives from CUSO4 - containing eluents. J. Chromatogr. M l, 
185-188, 1993.
Huynh, T.K.X.; Lederer, M., Adsorption chromatography on cellulose. XI. Chiral 
separations with aqueous solutions of cyclodextrins as eluents. J. Chromatogr. A. 
659. 191-197, 1994.
lUPAC., Recommendations on the nomenclature for chromatography. Pure Appl. 
Chem. 37, 447-462, 1973.
lUPAC., Rules for the nomenclature of organic chemistry. Section E: Stereochemistry. 
Pure Appl. Chem. 45, 11-30, 1976.
Jacobson, S.C.; Guiochon, G., Contribution of ionically immobilized bovine serum 
albumin to the retention of enantiomers. J. Chromatogr. 600. 37-42, 1992.
Jennings, W., Gas chromatography with glass capillary columns 2nd Ed., 
Academic Press, New York, 1980.
Jennings, W., Selecting the injection mode. Sample introduction in capillary gas
chromatography. Vol.l., Sandra, P. (Ed.) Dr. Alfred Huthig Verlag, Heidelberg, 
Germany, 23-33, 1985.
Jung, M.; Schmalzing, D.; Schuiig, V., Theoretical approach to the gas 
chromatographic separation of enantiomers on dissolved cyclodextrin derivatives. J. 
Chromatogr. 552. 43-57, 1991.
212
Kaneda, T., Gas-liquid chromatographic separation of enantiomers as their 
diastereomeric derivatives, illustrated with 2-methylbutyric acid. J. Chromatogr. 366. 
217-224, 1986.
Katsanos, N.A.; Lycourghiotis, A ; Tsiatsios, A , Thermodynamics of adsorption on 
gas-solid chromatography. J. Chem. Soc. Faraday Trans. I. 74, 575-582, 1978.
Kingston, G. PhD Thesis. University of Surrey, 1990.
Kirkland, K.M.; Neilson, K.L.; McCombs, D.A., Comparison of a new ovomucoid and 
a second generation ai-acid glycoprotein based chiral column for the direct high- 
performance liquid chromatography resolution of drug enantiomers. J. Chromatogr. 
545. 43-58. 1991.
Knoche, B.; Blaschke, G., Investigations on the in vitro racemization of thalidomide by 
high-performance liquid chromatography. J. Chromatogr. 6 6 6 . 235-240, 1994.
Knox, J.H.; Scott, H P., B and C terms in the Van Deemter equation for liquid 
chromatography. J. Chromatogr. 282. 297-313, 1983.
Koller, H.; Rimbock, K-H.; Mannschreck, A., High-pressure liquid chromatography on 
triacetylcellulose. Characterization of a sorbent for the separation of enantiomers. J. 
Chromatogr. 282. 89-94, 1983.
Konig, W.A, Separation of enantiomers by capillary gas chromatography with chiral 
stationary phases. J. High Résolut. Chromatogr. 5, 588-595, 1982.
Konig, W.A; Benecke, I.; Ernst, K., Separation of chiral ketones by enantioselective 
gas chromatography. J. Chromatogr. 253. 267-270, 1982.
213
Konig, W.A.; Ernst, K., Application of enantioselective capillary gas chromatography 
to the analysis of chiral pharmaceuticals. J. Chromatogr. 280. 135-141, 1983.
Konig, W.A.; Gehrcke, B., Gas chromatographic enantiomer separation with modified 
cyclodextrins: Carboxylic acid esters and epoxides. J. High. Résolut. Chromatogr. 
16,175-181, 1993.
Konig, W.A.; Lutz, S.; Mischnick-Lubbecke, P.; Brassat, B ; Wenz, G., Cyclodextrins 
as chiral stationary phases in capillary gas chromatography. 1. Pentylated a- 
cyclodextrin. J. Chromatogr. 447, 193-197, 1988.
Konig, W.A.; Parr, W.; Lichenstein, H.A.; Bayer, E.; Oro, J., Gas chromatographic 
separation of amino acids and their enantiomers non-polar stationary phases and a new 
optically active phase. J. Chromatogr. Sci. 8 , 183-186, 1970.
Koppenhoefer, B.; Allmendinger, H., Direct enantiomer resolution of primary, 
secondary and tertiary alcohols by gas chromatography on Chirasil-Val. 
Chromatographia 21. 503-508. 1986.
Krupcik, J.; Benicka, E.; Majek, P.; Skacani, I.; Sandra, P., Relationship between 
structure and chromatographic behaviour of secondary alcohols and their derivatives 
separated by high resolution gas chromatography with a modified p-cyclodextrin 
stationary phase. J. Chromatogr. A. 665. 175-184, 1994.
Kupfer, A.; Brilis, G.M.; Throck-Watson, J.; Harris, T.M., A major pathway of 
mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoin. 
Drug Metab. Disp. 8 , 1-4, 1980.
Kupfer, A.; Roberts, R.K.; Schenker, S.; Branch, R.A., Stereoselective metabolism of 
mephenytoin in man. J. Pharm. and Exp. Ther. 218. 193-199, 1981.
214
Lamparczyk, H.; Zarzycki, P.K., Effect of temperature on separation of estradiol 
stereoisomers and equilin by liquid chromatography using mobile phases modified with 
p-cyclodextrin. J. Pharm. Biomed. Anal. 13., 543-549, 1995.
Lederer, M., Adsorption chromatography on cellulose. VII. Chiral separations on 
cellulose with aqueous solvents. J. Chromatogr. 604. 55-62, 1992.
Lehman, P.A.F., Stereoisomerism and drug action. TiPS. 281-285, 1986.
Lepri, L.; Coas, V.; Desideri, P.G., Planar chromatography of optical isomers with 
bovine serum albumin in the mobile phase. J. Planar Chromatogr. 5, 175-178, 1992.
Lepri, L.; Coas, V.; Desideri, P.G.; Pettini,L., Thin layer chromatographic 
enantioseparation of miscellaneous compounds with bovine serum -albumin in the 
eluent. J. Planar Chromatogr. 6 , 100-104, 1993.
Li, S.; Purdy, W.C., Cyclodextrins and their applications in analytical chemistry. 
Chem. Rev. 92, 1457-1470, 1992.
Li, W-Y.; Jin, H.L.; Armstrong, D.W., 2,6-DiO-pentyl-3-0-trifluoroacetyl cyclodextrin 
liquid stationary phases for capillary gas chromatographic separation of enantiomers. J. 
Chromatogr. 509. 303-324, 1990.
Lienne, M.; Caude, M.; Rosset, R.; Tambute, A , Optimization of the direct chiral 
separation of potential cytotoxic a-methylene-y-butyrolactones and a-methylene-y- 
butyrolactams by liquid chromatography. J. Chromatogr. 448. 55-72, 1988.
V -
Lindner, W.; Leitner, Ch.; Uray, G., Liquid chromatographic separation of 
enantiomeric alkanolamines via diastereomeric tartaric acid monoesters. J. 
Chromatogr. 316. 605-616. 1984.
215
Lipkowitz, K.B.; Baker, B., Computational analysis of chiral recognition in Pirkle 
phases. Anal. Chem. 770-774, 1990.
Lipkowitz, K.B.; Baker, B.; Zegarra, R., Theoretical Studies in molecular recognition: 
Enantioselectivity in chiral chromatography. J. Comput. Chem. 10, 718-732, 1989.
Majors, R.E., New chromatography columns and accessories at the 1995 Pittsburgh 
Conference, Part 2. LC-GC I n t . , 8 , 312-323, 1995.
Martin, P.; Leadbetter, B ; Wilson, I.D., Immobilized phenylboronic acids for the 
selective extraction of P-blocking drugs from aqueous solution and plasma. J. Pharm. 
Biomed. Anal. 11, 307-312, 1993.
Martin, A.J.P.; Synge, R.L.M., A new form of chromatogram employing two liquid 
phases. 1 . A theory of chromatography. 2 . Application to the micro-determination of 
the higher monoamino-acids in proteins. Biochem. J. 35, 1358-1368, 1941.
Mason, S.F., Biomolecular handedness: Origins and significance. Biochem. Pharm. 
37, 1-7, 1988.
Mass, B.; Dietrich, A.; Beck, T.; Borner, S.; Mosandl, A., Di-tert- 
butyldimethylsilylated cyclodextrins as chiral stationary phases: Thermodynamic 
Investigations. J. Microcol. Sep. 7, 65-73, 1995.
Maurer, H.; Pfieger, K., Identification and differentiation of beta-blockers and their 
metabolites in urine by computerized gas chromatography-mass spectrometiy. J. 
Chromatogr. Biomed. Appl. 382. 147-165, 1986.
McDaniel, D.M.; Snider, B.G., Resolution of a-aiylacetic acid enantiomers on two 
chiral stationary phases. J. Chromatogr. 404. 123-132, 1987.
216
McReynolds, W.O., Characterisation of some liquid phases. J.Chromatogr. Sci. ^  
685-691, 1970.
Meyer, V.R., Errors in the area determination of incompletely resolved 
chromatographic peaks. J. Chromatogr. Sci. 33, 26-33, 1995.
Meyer, V.R., Error sources in the determination of chromatographic peak size ratios. 
Advances in Chromatography. Vol. 35. 383-416, 1995.
Midgley, J.M.; Andrew, R.; Watson, D.G.; MacDonald, N.; Reid, J.L.; Williams, D.A., 
Dichlorotetrafluoroacetone as a derivatisation reagent in the analysis of mandelic acids 
in human urine. J. Chromatogr. Biomed. Appl. 527. 259-265, 1990.
Miller, J.C.; Miller, J.N., Statistics for analytical chemistry. 2nd Ed ,'Ellis Horwood, 
London, 1992.
Mislow, K.; Siegel, J., Stereoisomerism and local chirality. J. Am. Chem. Soc. 106. 
3319-3328, 1984.
Miwa, T.; Miyakawa, T.; Kayano, M.; Miyake, Y., Application of an ovomucoid- 
conjugated column for the optical resolution of some pharmaceutically important 
compounds. J. Chromatogr. 408. 316-322, 1987.
Moffat, A C.; Jackson, J.V.; Moss, M.S.; Widdop, B. (Eds.), Clarke’s Isolation and 
Identification of Drugs., The Pharmaceutical Press, London, 1986.
Nakaparksin, S.; Birrell, P.; Gil-Av, E.; Oro, J., Gas chromatography with optically 
active stationary phases: Resolution of amino acids. J. Chromatogr. Sci. 8 , 177-182, 
1970.
217
Nimura, N.; Toyama, A.; Kinoshita, T., Optical resolution of amino acid enantiomers 
by high performance liquid chromatography. J. Chromatogr. 316, 547-552, 1984.
Noctor, T A G.; Felix, G.; Wainer, I.W., Stereochemical resolution of enantiomeric 2- 
aryl propionic acid non-steroidal anti-inflammatory drugs on a human serum albumin 
based high performance liquid chromatographic chiral stationary phase. 
Chromatographia 31. 55-59. 1991.
Novotny, M.; Soini, H.; Stefansson, M., Chiral separation through capillary 
electromigration methods. Anal. Chem. 646A-655A, 1994.
Nowakowski, R.; Cardot, P.J.P.; Coleman, A.W.; Villard, E.; Guichon, G., Elution 
mechanisms of cyclodextrins in reversed phase chromatography. Anal. Chem. §1_, 
259-266, 1995.
Okamoto, Y.; Kawashima, M.; Hatada, K., Useful chiral packing materials for high- 
performance liquid chromatographic resolution of enantiomers: Phenylcarbamates of 
polysaccharides coated on silica gel. J. Am. Chem. Soc. 106. 5357-5359, 1984.
O’Shannessy, D.J.; Ekberg, B.; Mosbach, K., Molecular imprinting of amino acid 
derivatives at low temperature (O^C) using photolytic homolysis of azobisnitriles. Anal. 
Biochem. 177. 144-149. 1989.
Pettersson, C., Chromatographic separation of enantiomers of acids with quinine as 
chiral counter ion. J. Chromatogr. 316. 553-567, 1984.
Pettersson, C.; Arvidsson, T.; Karlsson, A.L-.; Marie, I., Chromatographic resolution 
of enantiomers using albumin as complexing agent in the mobile phase. J. Pharm. 
Biomed. Anal. 4, 221-235, 1986.
218
Pettersson, C.; S chill. G., Separation of enantiomeric amines by ion-pair 
chromatography. J. Chromatogr. 204. 179-183, 1981.
Pinkerton, T.C.; Howe, W.J.; Ulrich, E.L.; Comiskey, J.P.; Haginaka, J.; Murashima, 
T.; Walkenhorst, W.F.; Westler, W.M.; Markley, J.L., Protein binding chiral 
discrimination of HPLC stationary phases made with whole, fragmented, and third 
domain turkey ovomucoid. Anal. Chem. §1_, 2354-2367, 1995.
Pirkle, W.H., Unusual effect of temperature on the retention of enantiomers on a chiral 
column. J. Chromatogr.558. 1-6, 1991.
Pirkle, W.H.; Finn, J.M.; Schreiner, J.L.; Hamper, B.C., A widely useful chiral 
stationary phase for the high-performance liquid chromatography separation of 
enantiomers. J. Am. Chem. Soc. 103. 3964-3966, 1981.
Pirkle, W.H.; House, D.W., Chiral high-pressure liquid chromatographic stationary 
phases. 1. Separation of the enantiomers of sulphoxides, amines, amino-acids, alcohols, 
hydroxyacids, lactones and mercaptans. J. Org. Chem. 44, 1957-1960, 1979.
Pirkle, W.H.; House, D.W.; Finn, J.M., Broad spectrum resolution of optical isomers 
using chiral high-performance liquid chromatographic bonded phases. J. Chromatogr. 
192. 143-158. 1980.
Pirkle, W.H.; Hyun, M.H.; Bank, B., A rational approach to the design of highly- 
effective chiral stationary phases. J. Chromatogr. 316. 585-604, 1984.
Pirkle, W.H.; Murray, P.G., Chiral stationary phase design. Use of intercalative effects 
to enhance enantioselectivity. J. Chromatogr. 641. 11-19, 1993.
219
Pirkle, W.H.; Murray, P.G.; Burke, J.A., Use of homologous series of analytes as 
mechanistic probes to investigate the origins of enantioselectivity on two chiral 
stationary phases. J. Chromatogr. 641. 21-29, 1993.
Pirkle, W.H.; Rinaldi, P.L., Nuclear magnetic resonance determination of enantiomeric 
compositions of ox^aridines using chiral solvating agents. J. Org. Chem. 42, 3217- 
3219, 1977.
Pirkle, W.H.; Rinaldi, P.L., Nuclear magnetic resonance determination of absolute 
configuration and enantiomeric compositions of chiral oxazaridines using chiral 
solvating agents. J. Org. Chem. 43, 4475-4480, 1978.
Politzer, I.R.; Crago, K.T.; Hollin, T.; Young, M., TLC of p-nitroanilines and their 
analogues with cyclodextrins in the mobile phase. J. Chromatogr. Sci. 33, 316-320,
1995.
Poole, C.F.; Poole, S.K., Characterization of solvent properties of gas 
chromatographic liquid phases. Chem. Rev. 377-395, 1989.
Purdie, N.; Swallows, K.A., Analytical applications of polarimetry, optical rotary 
dispersion and circular dichroism. Anal. Chem. 6X, 77A-89A, 1989.
Riddell, F.G; Robinson, M.J.T., J.H. Van’t Hoff and J.A. Le Bel - Their historical 
context. Tetrahedron 30, 2001-2007, 1974.
Rizzi, A.M., Coupled column chromatography in chiral separations. 1. Enantiomeric 
separation on swollen microcrystalline cellulose triacetate columns after a 
preseparation on a non-chiral alkylsilica column. J. Chromatogr. 513. 195-207, 1990.
220
Rosanoff, M A., On Fischers classification of stereo-isomers. J. Am. Chem. Soc. 28. 
114-121, 1906.
Ruffolo, R.R., Stereoselectivity in adrenergic agonists and adrenergic blocking agents. 
Stereochemistry and Biological Activity of Drugs. Ariens, E.J.; Soudjin, W.; 
Timmermanns, P.B.M.W.M. (Eds.) Blackwell Scientific Publ., Oxford, 1983.
Sallstrom Baum, S.; Rommelspacher, H., Determination of total dopamine, R-, and S- 
salsinol in human plasma by cyclodextrin bonded phase liquid chromatography with 
electrochemical detection. J. Chromatogr. B. 660. 235-241, 1994.
Schmarr, H-G.; Mosandl, A.; Neukom, H-P.; Grob, K., Modified cyclodextrins as 
stationary phases for capillary GO: Consequences of dilution in polysiloxanes. J. High 
Résolut. Chromatogr. 14j 207-210, 1991.
Schurig, V., Gas chromatographic separation of enantiomers on optically active metal- 
complex-free stationary phases. Angew. Chem. Int. Ed. Engl. 23, 747-765, 1984.
Schurig, V., Enantiomer analysis by complexation gas chromatography. Scope, merits 
and limitations. J. Chromatogr. 441. 135-153. 1988.
Schurig, V.; Burkle, W., Extending the scope of enantiomer resolution by 
complexation gas chromatography. J. Am. Chem. Soc. 104. 7573-7580, 1982.
Schurig, V.; Nowotny, H-P., Gas chromatographic separation of enantiomers on 
cyclodextrin derivatives. Angew. Chem. Int. Ed. Engl. 29, 939-1076, 1990.
Schurig, V.; Ossig, J.; Link, R., Evidence for a temperature dependant reversal of the 
enantioselectivity in complexation gas chromatography on chiral phases. Angew. 
Chem. Int. Ed. Engl. 28, 194-196, 1989.
221
Schurig, V.; Schmalzing, D.; Muhleck, U.; Jung, M.; Schleimer, M.; Mussche, P.; 
Duvekot, C.; Buyton, J.C., Gas chromatographic enantiomer separation on 
polysiloxane anchored p ermethyl- p -cy cio d extrin (Chirasil-Dex). J. High Résolut. 
Chromatogr. 13. 713-717. 1990.
Schurig, V.; Weber, R., Use of glass and fused-silica open tubular columns for the 
separation of structural, configurational and optical isomers by selective complexation 
gas chromatography. J. Chromatogr. 289. 321-332, 1984.
Schmarr, H-G.; Mosandl, A.; Neukom, H-P.; Grob, K., Modified cyclodextrins as 
stationary phases for capillary GC: Consequences of dilution in polysiloxanes. J. High. 
Résolut. Chromatogr. 14, 207-210, 1991.
Silber, B.; Riegelman, S., Stereospecific assay for (-) and (+)-propranolol in human 
and dog plasma. J. Pharm. and Exp. Ther. 215. 643-648, 1980.
Simonyi, M.; Fitos, I.; Visy, J., Chirality of bioactive agents in protein binding storage 
and transport processes. TiPS. 112-116, 1986.
Sinibaldi, M.; Federici, F.; Fanali, S.; Messina, A., High performance liquid 
chromatography resolution of racemates using a chiral additive to the eluent. J. High 
Résolut. Chromatogr. Chrom. Commun. 10, 206-207, 1987.
Souter, R.W., Gas chromatographic resolution of enantiomeric amphetamines and 
related amines. 1. Structural effects on some diastereomer separations. J. 
Chromatogr. 108. 265-274. 1975.
Srinivas, N.R.; Igwemezie, L.N., Chiral separation by high performance liquid 
chromatography. 1. Review on indirect separation of enantiomers as diastereomeric 
derivatives using ultraviolet, fluorescence and electrochemical detection. Biomed. 
Chromatogr. 6 , 163-167, 1992.
222
Stalcup, A.M.; Faulkner Jr., J.R.; Tang, Y.; Armstrong, D.W.; Levy, L.W.; Regaldo, 
E., Determination of the enantiomeric purity of scolopamine isolated from plant extract 
using achiral/chiral coupled column chromatography. Biomed. Chromatogr. 5, 3-7,
1991.
Stauffer, S T.; Dessy, R.E., Chimie; A chiral chromatographic column selection system 
utilizing similarity searching. J. Chromatogr. Sci. 32, 228-235, 1994.
Stoev, G., Application and chiral recognition of heptakis (2,6-di-0-methyl-3-0- 
trifluoroacetyl)- P-cyclodextrin as a stationary phase for the gas chromatographic 
separation of enantiomers. J. Chromatogr. 589. 257-263, 1992.
Stoschitzky, K.; Lindner, W.; Klein, W., Chiral aspects of P-adrenoreceptor 
antagonists. TiPS. 102, 1994.
Takasu, A.; Ohya, K., Separation and determination of the enantiomers of 
pantolactone by gas-liquid chromatography. J. Chromatogr. 389. 251-255, 1987.
Tamai, G.; Edani, M.; Imai, H., Chiral separation and determination of propranolol 
enantiomers in rat or mouse blood and tissue by column switching high-performance 
liquid chromatography with ovomucoid bonded stationary phase. Biomed. 
Chromatogr. 4, 157-160, 1990.
Taylor, DR.; Maher, K., Chiral separations by high-performance liquid 
chromatography. J. Chromatogr. Sci. 67-85, 1992.
Terabe, S.; Otsuka, K.; Nishi, H., Separation of enantiomers by capillary 
electrophoretic techniques. J. Chromatogr. A. 6 6 6 . 295-319, 1994.
Testa, B., Chiral aspects of drug metabolism. TiPS. 60-64, 1986.
223
Testa, B., Substrate and product stereoselectivity in monooxygenase-mediated drug 
activation and inactivation. Biochem. Pharm. 37, 85-92, 1988.
Testa, B., Pharmacokinetic criteria for drug research and development 
Advances in drug research., 6-138, Academic Press Ltd., London, 1990.
Tracy, T.S.; Hall, S.D., Metabolic inversion of (R)-Ibuprofen: Epimerization and 
hydrolysis of ibuprofenyl-Coenzyme A. Drug Metab. Dispos. 20, 322-327, 1992.
Turner, M., Pasteurised Chemistry. Chem. in Britain, 658, 1995.
Valko, I.E.; Billiet, H.A.H.; Corstjens, H.A.L.; Frank, J., Chiral separation using high 
performance capillary electrophoresis: An overview. LC-GC Int. 6, 420-427, 1993.
Van Deemter, J.J.; Zuiderweg, F.J.; Klinkenburg, A., Longitudinal diffusion and 
resistance to mass transfer as causes of non-ideality in chromatography. Chem. Eng. 
Sci. 5, 271-289, 1956.
Vandenbosch, C.; Hamoir, T.; Massait, D.L.; Lindner, W., Evaluation of the 
enantioselectivity towards p-blocking agents of the ai-acid glycoprotein type chiral 
stationary phase: Chiral-AGP. Chromatographia 33, 454-462, 1992.
Van Ginneken, C.A.M.; Rodrigues de Miranda, J.F.; Beld, A.J., Stereoselectivity and 
drug distribution. Stereochemistry and Biological Activity of Drugs. Ariens, E.J.; 
Soudjin, W.; Timmermanns, P.B.M.W.M. (Eds.) Blackwell Scientific Publ., 
Oxford, 1983.
Varian Bond-Elut Instruction Manual, Varian 1987.
Wainer, I.W.; Alembik, M.C., Resolution of enantiomeric amides on a cellulose-based 
chiral stationary phase. Steric and electronic effects. J. Chromatogr. 358. 85-93, 
1986.
224
Wainer, I.W.; Brunner, C.A.; Doyle, T.D., Direct resolution of enantiomers via thin- 
layer chromatography using a chiral adsorbent. J. Chromatogr. 264. 154, 1983.
Ward, T.J., Chiral media for capillary electrophoresis. Anal. Chem. 633A-640A,
1994.
Watabe, K.; Charles, R.; Gil-Av, E., Temperature dependant inversion of elution 
sequence in the resolution of a-amino acid enantiomers on chiral diamide selectors. 
Angew. Chem. Int. Ed. Engl. 28, 192-194, 1989.
Wernicke, R , Separation of underivatised amino acid enantiomers by means of a chiral 
solvent generated phase. J. Chromatogr. Sci. 23, 39-47, 1985.
Whatley, J.A., Rapid method development for the separation of enantiomers by means 
of chiral column switching. J. Chromatogr. A. 697. 257-261, 1995.
Williams, R.C.; Edwards, J.F.; Potter, M.J., Retention characteristics of protein-based 
chiral HPLC columns. J. Liq. Chromatogr. 16, 171-196, 1993.
Wilson, T.D., Sample solvent effects in an apparent chiral high-performance liquid 
chromatographic separation on p-cyclodextrin. J. Chromatogr. 448. 31-39, 1988.
Wilson,K.; Walker, J. (Eds.) Principles and techniques of Practical Biochemistry. 4 ^^
Ed., Cambridge University Press, 366-368, 1994.
Wistuba, D.; Diebold, H.; Schurig, V., Enantiomer separation of DNP-amino acids by 
capillary electrophoresis using chiral buffer additives. J. Microcol. Sep. 7, 17-22,
1995.
225
Witherow, L.; Spurway, T.D.; Ruane, R.J.; Wilson, I D.; Longdon, K., Problems and 
solutions in chiral thimlayer chromatography: a two-phase “Pirkle” modified amino- 
bonded plate. J. Chromatogr. 553. 497-501, 1991.
Yang, S.K., Stereoselectivity of cytochrome P-450 isozymes and epoxide hydrolase in 
the metabolism of polycyclic aromatic hydrocarbons. Biochem. Pharm. 37, 61-70, 
1988.
Yamazaki, S.; Ozaki, K.; Saito, K.; Tanimura, T., Enantiomeric separation of p-amino 
alcohols with a primary or tertiary amine moiety by reversed phase liquid 
chromatography with a chiral mobile phase containing copper (II) and (R)-mandelic 
acid. J. High Résolut. Chromatogr. 18, 68-70, 1995.
Yashima, E.; Huang, S.; Okamoto, Y., An optically active stereoregular 
polyphenylacetylene derivative as a novel chiral stationary phase for HPLC. J. Chem. 
Soc. Chem. Commun. 1811-1812, 1994.
Yuasa, S.; Shimada, A.; Kameyama, K.; Yassui, M.; Adzuma, K., Cellulose thin layer 
and column chromatography for the resolution of DL-Tryptophan. J. Chromatogr. 
Sci. 18, 311-314, 1980.
Yun, K.S.; Zhu, C.; Parcher, J.F., Theoretical relationships between the void volume, 
mobile phase volume, retention volume, adsorption, and Gibbs free energy in 
chromatographic processes. Anal. Chem. 613-619, 1995.
226
UNVERSITY O F SURREY LIBRARY
